













This thesis has been submitted in fulfilment of the requirements for a postgraduate degree 
(e.g. PhD, MPhil, DClinPsychol) at the University of Edinburgh. Please note the following 
terms and conditions of use: 
 
This work is protected by copyright and other intellectual property rights, which are 
retained by the thesis author, unless otherwise stated. 
A copy can be downloaded for personal non-commercial research or study, without 
prior permission or charge. 
This thesis cannot be reproduced or quoted extensively from without first obtaining 
permission in writing from the author. 
The content must not be changed in any way or sold commercially in any format or 
medium without the formal permission of the author. 
When referring to this work, full bibliographic details including the author, title, 










Bonnie M Nicholson 
 
Submitted for the degree of Doctor of Philosophy 
The University of Edinburgh 
2019




I declare that the work presented in this thesis is entirely my own work, except where stated 
in the text. This work has not been submitted for any other degree, and to the best of my 
knowledge contains no material published or written by any other person, except where 
stated in the text. 
 
Bonnie Nicholson 
February 2019  
  The role of TET1 in adipose tissue 
  ii 
Acknowledgements 
A number of people have made this work possible. Firstly, many people have willingly 
offered their time and expertise. Thank you to Dr John Thompson for sharing his technical 
expertise in bioinformatics, and to Lynne Ramage for sharing her skills and knowledge in 
primary adipose culture, and for always being willing to drop what she was doing to offer 
guidance. Likewise, thank you to Dr Rod Carter for his technical help with adipose tissue 
culture and use of the Seahorse, and to Clare McFadden for helping with dissections. My 
gratitude goes to Dr Roland Stimson for being available for brainstorming PhD ideas and 
providing new inspiration. Thank you to our collaborators at the University of Birmingham, 
Dr Daniel Tenant, Dr Alpesh Thakker, Dr Christian Ludwig and Prof Gareth Lavery, for 
carrying out and providing expertise in GC-MS. I’d also like to thank the staff at the 
Wellcome Trust Clinical Research Facility for carrying out the sequencing and being patient 
when experiments took longer than planned. Further thanks to Dr Jimi Wills and Dr Andrew 
Finch of the mass spectrometry facility, Institute for Genetic and Molecular Medicine, 
University of Edinburgh, for carrying out the UPLC. 
 
I have been lucky enough to share my time with a wonderful group of CVS students. Thanks 
to all the students in the centre who have made the QMRI a friendly and enjoyable place to 
spend each day. I must also thank Amy Sandison, who joined Team Drake for her 
undergraduate project and contributed to some of the phenotyping analyses, and Eamon 
Fitzgerald for teaching me how to do pyrosequencing. A huge thanks must go to all past and 
present members of Team Drake, especially Dr Jessy Cartier and Dr Marcus Lyall for 
training me technically, for sharing with me protocols they had spent months optimising, and 
for allowing me to pester them constantly with questions. 
 
Thanks to Dr Will Cawthorn and members of his group who guided me in my bone-related 
studies; and thank you to my second supervisor, Prof Nik Morton, who always made time to 
offer specialist metabolism knowledge and technical advice and provide feedback on my 
reports, as well as spending hours calibrating the PhenoMaster so that it was just right. 
 
Finally and most importantly, I am hugely grateful to my primary supervisor, Dr Mandy 
Drake. Her positive attitude motivated me to get back in the lab when science ‘wouldn’t 
work’; her supportive nature encouraged me to progress scientifically and professionally; 
and her baking kept me suitably sugared up during lab meetings.   
  The role of TET1 in adipose tissue 
  iii 
Abstract 
The global obesity epidemic is associated with 2.8 million deaths per year and contributes to 
the prevalence of numerous cardiometabolic disease risk factors, including non-alcoholic 
fatty liver disease (NAFLD), hypertension, type 2 diabetes, hyperlipidaemia and stroke. 
 
The Ten-Eleven-Translocation enzymes (TET1-3) modify DNA by adding a methyl group to 
generate 5-hydroxymethylcytosine (5hmC) from 5-methylcytosine (5mC). This DNA 
methylation mark can alter the nature of the information conveyed by DNA; for example by 
modulating access of transcription factors. TET1 plays an important role in promoting 
adipocyte differentiation. I hypothesised that Tet1 gene deficiency impairs adipocyte 
development and function, thereby counteracting the development of obesity. TET 
enzymatic activity requires the TCA cycle metabolite α-ketoglutarate (α-KG) as a substrate, 
and is allosterically inhibited by TCA cycle metabolites succinate and fumarate. Obesity is 
associated with a number of key metabolic changes including increased levels of glutamate 
and many constitutive metabolites of the tricarboxylic acid (TCA) cycle (such as α-
ketoglutarate, succinate, fumarate, and malate). I therefore additionally hypothesised that 
TET activity is altered as a consequence of the metabolic perturbations that accompany 
obesity. 
 
To test these hypotheses, male Tet1 gene knockout (Tet1–/–) mice and littermate mice 
wildtype for the Tet1 allele (Tet1+/+) were fed a high-fat diet (HFD) for 11 weeks. Food 
intake, adiposity (TD-NMR), energy expenditure (indirect calorimetry) and fat depot mass, 
including bone marrow adipose tissue (MAT) were measured. RNA-sequencing of adipose 
tissue gene expression and analysis of 5hmC in adipose tissue DNA was performed. 
 
Fat mass of Tet1–/– mice was 50% lower than that of Tet1+/+ littermates after 11 weeks HFD. 
No changes in MAT were observed. Tet1–/– mice showed a relative reduction in food intake 
over 11 weeks and a reduction in energy expenditure in the absence of changes in activity 
levels. RNA-sequencing of mesenteric adipose tissue revealed changes in gene expression 
related to muscle organ development, synaptic vesicle exocytosis and acyl-coA metabolic 
processes in Tet1–/– mice. Notably, leptin mRNA and circulating leptin levels were lower in 
Tet1–/– mice compared to Tet1+/+. Tet1–/– mice challenged with exogenous leptin had a greater 
reduction in food intake, indicating higher leptin sensitivity. Hydroxymethylated DNA 
immunoprecipitation-sequencing (hMeDIP-seq) was performed to analyse 5hmC patterns: 
however, no global differences in 5hmC levels were identified between Tet1–/– and Tet1+/+ 
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mice. Specifically, despite the marked change in leptin mRNA expression, no changes in 
5hmC or 5mC were observed within the leptin promoter to indicate causality of DNA 
methylation changes in altered leptin expression. 
 
Brown adipose tissue (BAT) is the main organ of thermogenesis in rodents and has a high 
energy demand when activated. The recent discovery of active BAT, or an intermediate 
thermogenic fat called “beige”, in human adults has prompted research into the potential of 
therapeutic BAT activation for the treatment of obesity. A number of epigenetic marks, of 
which DNA methylation is one, have been associated with activation of thermogenesis in 
BAT including histone acetylation. However, the potential role of 5mC and 5hmC in BAT 
function has not been investigated. 
 
While histone modifications – most notably histone acetylation in the enhancer regions of 
Pparg and Ucp1, and putative regulatory regions of Ppara – have been shown to play a role 
in the transcriptional activation of the thermogenic gene programme, the role of 5mC and 
5hmC has not been investigated. I hypothesised that TET1 activity would be altered by 
changes in metabolite levels in cold-induced thermogenesis, resulting in altered 5hmC. 
 
To test this hypothesis, C57BL/6J mice were maintained at 30°C or 4°C for 48 hours, after 
which adipose tissue was collected. RNA and DNA were extracted from white (WAT), 
brown (BAT) and beige adipose tissue for RNA-seq and hMeDIP-seq, and the polar phase 
metabolites were extracted for gas chromatography mass-spectrometry. In mice exposed to 
4°C, all metabolites of the tricarboxylic acid (TCA) cycle were significantly increased in 
WAT and BAT compared to mice housed at 30°C, with the exception of α-KG and succinate 
in BAT. TET activity was decreased in WAT at 4°C but not in BAT or beige adipose tissue. 
No global changes in 5hmC were observed in WAT or BAT between the 4°C and 30°C 
conditions. However, there is a decrease in 5hmC in BAT at 30°C and 4°C, and in WAT at 
4°C, at 10% of gene length in a select subset of genes involved in neuromuscular synaptic 
transmission and perception of chemical stimuli. Many gene pathways were upregulated 
transcriptionally in all three adipose depots, including mitochondrial function, oxidative 
phosphorylation and the TCA cycle, but these transcriptional changes are not associated with 
changes in 5hmC. 
 
In summary, this data supports my original hypothesis by showing that Tet1–/– mice have 
decreased susceptibility to diet-induced obesity due to a reduction in food intake, in 
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association with higher leptin sensitivity.  However, in contrast to published data, 5hmC or 
5mC modification was not altered at the leptin promoter in adipocytes, and therefore the 
hypothesis that DNA methylation at the leptin promoter accounts for the observed Tet1–/– 
phenotype must be rejected. Finally, numerous changes occur in the TCA cycle metabolites 
in BAT and WAT with cold exposure, which may contribute to the selective decrease in 
TET activity in WAT. However, no changes are observed in 5hmC in WAT, rejecting the 
hypothesis that altered TET1 activity in cold exposure results in altered 5hmC. In 
conclusion, this thesis contends that TET enzymes and 5hmC are not primary drivers of gene 
expression changes in obesity or cold-induced thermogenesis. However, TET enzymes may 
act in synergy with other epigenetic changes to alter gene expression in this context, and may 
remain important contributors to altered adiposity and its metabolic consequences. 
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Lay summary 
Obesity is associated with 2.8 million deaths per year and contributes to the development of 
other related diseases, including fatty liver disease, high blood pressure, type 2 diabetes and 
stroke. The development of obesity is known to be partly controlled by our DNA. 
 
DNA is made up of smaller units, known as genes. Genes are responsible for all biological 
processes, by coding for proteins – molecules that have a vast array of functions within all 
organisms. The function of genes can be changed by adding or removing chemical groups to 
or from DNA; for example, the addition of a chemical group known as 5-methylcytosine 
(5mC), which causes genes to switch off. Three proteins, known as the Ten-Eleven-
Translocation enzymes (TET1-3), can convert 5mC into another chemical group: 5-
hydroxymethylcytosine (5hmC). In contrast to 5mC, 5hmC is thought to switch genes on.  
 
TET1 is important for fat cell development. I predicted that without the Tet1 gene, fat cell 
development and function would be impaired, thereby counteracting the development of 
obesity.  
 
To test this, mice lacking the Tet1 gene (termed ‘knockout’ or ‘KO’ mice) and animals with 
a normal Tet1 gene (termed ‘wildtype’ or ‘WT’ mice) were fed a high-fat diet for 11 weeks. 
I measured food intake, body composition and calorie expenditure of the mice. I then 
analysed how obesity affected the genes in fat tissue. 
 
KO mice lacking the Tet1 gene gained less fat than WT mice after 11 weeks high-fat diet. 
KO mice ate less and burned fewer calories than normal WT mice, but their levels of activity 
and movement were not different. I saw many differences in the genes in the fat tissue 
between KO and WT mice, including in genes important for the function of fat. In particular, 
the gene for the ‘satiety hormone’, leptin – the hormone that signals a feeling of fullness to 
the brain – was much lower in KO mice, which could explain why the KO mice eat less than 
the WT mice. Surprisingly, despite the lack of Tet1, no differences were seen in the levels of 
5hmC between KO and WT mice. 
 
Brown fat is responsible for producing body heat in rodents, and is turned on in the cold. 
Recently, brown fat has also been found in adult humans. Because it is a very energy-
demanding organ when turned on, many researchers believe that it can be ‘turned on’ to treat 
obesity. The role of 5hmC in brown fat has not been studied. I predicted that TET activity 
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would be altered when brown fat is turned on in the cold, and that there would be changes in 
5hmC levels and gene function.  
  
To test this, mice were kept in cages at either 30°C or 4°C for 48 hours. In mice kept in the 
cold, some of the molecules involved in generating energy were increased in brown fat 
compared to mice kept in the warm. Some of these molecules are also known to change the 
function of the TET proteins. Although I saw many differences in the genes of mice kept in 
the cold, I saw no changes in 5hmC levels in brown fat. 
 
In summary, these findings support my original prediction, by showing that Tet1 KO mice 
are less likely to become obese. However, this seems to be because they are eating less, 
rather than an effect specifically in the fat. Finally, in brown fat in the cold, I saw an increase 
in molecules that could possibly change the activity of the TET proteins. However, there 
were no changes 5hmC. In conclusion, this thesis finds that the TET proteins and 5hmC are 
not responsible for changes in fat cell gene function in obesity or in the cold.  
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1.1.1. The obesity epidemic 
The World Health Organisation defines obesity as “abnormal or excessive fat accumulation that 
presents a risk to health” [1]. In adults, being overweight is classified as having a body mass index of 
over 25kg/m2, while obesity is classified as a body mass index of over 30kg/m2. The global obesity 
epidemic is associated with 2.8 million deaths per year [2]. Additionally, obesity contributes to the 
prevalence of numerous cardiometabolic disease risk factors, including non-alcoholic fatty liver 
disease (NAFLD), hypertension, type 2 diabetes, hyperlipidaemia and stroke, as well as being 
associated with an increased risk of certain cancers (including mammary, renal, oesophageal, 
gastrointestinal and reproductive cancers), sleep apnoea, osteoarthritis, and gynaecological problems 
[3]. To put just two of these comorbidities in context, 44% of type 2 diabetes and 23% of ischaemic 
heart disease is attributable to obesity [4]. The direct cost of obesity to the NHS in 2007, excluding 
the cost of associated diseases, was £2.3 billion, and the direct cost of being overweight was 
£1.9 billion [5]. The impact of obesity now poses a global health challenge. 
 
In 2016, 39% of adults were overweight, and 13% were obese – figures that have nearly tripled since 
1975 [4]. This dramatic rise in the number of cases of obesity in the last 40 years has been attributed 
to multiple underlying causes; the most widely accepted of which are increased access to energy-
dense, high-sugar, high-fat foods, and decreased activity levels due to sedentary lifestyles [6, 7]. 
However, as a complex disease, obesity is a result of a combination of both environmental and genetic 
factors. Studying all causal factors will add to our understanding of the disease and improve our 
ability to treat it. 
 
1.1.2. The thrifty genotype hypothesis 
The ‘thrifty genotype hypothesis’, put forward in 1962 by J.V. Neel, proposes that there has been 
evolutionary selection for genes that contribute to increased fat deposition, for use as an energy 
storage in times of food shortage [8]. Today, the prevalence of these genes in combination with 
greater food availability causes increased susceptibility to disease rather than putting us at an 
evolutionary advantage over our leaner relatives. While there has been debate over the validity of the 
thrifty genotype hypothesis due to conflicting evidence [9, 10], recent studies have undisputedly 
found genetic factors that contribute to susceptibility to obesity. Identification of such ‘thrifty’ allele 
variants could provide new targets for therapeutic intervention of obesity and type 2 diabetes. 
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1.1.3. The genetic influence on obesity 
The identification of the obese (Ob) gene in 1994 [11, 12], later named leptin, lead to the discovery of 
a population of severely obese individuals with mutations in the gene who, when treated with a 
recombinant form of the leptin protein, recovered remarkably, decreasing fat mass by 15.6kg in a year 
[13]. 
 
Monogenic mutations in the leptin signalling pathway are rare and account for only 1-5% of severe 
obesity [14]. However, the discovery of a direct genetic influence opened up the field of study to other 
candidate genes. It is now estimated that genetic differences account for between 40-70% of the 
variation in obesity susceptibility [15, 16]. Mutations in MC4R, PCSK1, and enzymes required for the 
processing of POMC have since been found to cause human obesity, as well as other components of 
the neural circuit that regulates food intake including BDNF and SIM1 [17]. 
 
Genome wide association studies (GWAS) have provided several key candidate genes for common 
polygenic obesity and its metabolic complications [18-28], most notably FTO (fat mass and obesity 
associated) [29]. Single nucleotide polymorphisms (SNPs) in the FTO gene region on chromosome 16 
were strongly associated with type 2 diabetes and obesity [29]. However, many other findings from 
GWAS have proved controversial, due to poor replicability of results [30, 31]. 
 
1.2. Adipose tissue biology 
1.2.1. White adipose tissue 
Adipose tissue, made up of adipocytes with unilocular lipid droplets, is present in discrete depots in 
both mice and humans. Classical adipose tissue is known as white adipose tissue (WAT), which is 
mainly responsible for storing excess energy for use in peripheral tissues. In mice and humans, the 
largest WAT depots are: subcutaneous/inguinal, retroperitoneal, mesenteric and gonadal/epididymal; 
with smaller depots including pericardial, intramuscular, omental and perirenal. 
 
WAT is a dynamic energy store in a state of constant flux, storing energy in the form of triglycerides 
(through the process of esterification/lipogenesis) and mobilising energy from triglycerides in the 
form of fatty acids and glycerol ( through hydrolysis/lipolysis) [32]. During times of energy shortage, 
a greater net rate of lipolysis occurs. During lipolysis, triacylglyceride (TAG) is hydrolysed 
sequentially to form diacylglyceride (DAG) and then monoacylglyceride (MAG) with the release of a 
fatty acid at each step. MAG is then hydrolysed to release a final fatty acid and glycerol. Hormone 
sensitive lipase (HSL) is the enzyme that controls the initial rate-limiting step of lipolysis (hydrolysis 
of TAG) [33]. HSL activity is increased by catecholamines and adrenocorticotropic hormone (ACTH) 
and inhibited by insulin. Alterations in lipolysis are often associated with obesity. For example, a 
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decrease in basal rates of lipolysis was observed in obese subjects, with a concomitant decrease in 
HSL mRNA expression, protein expression and enzyme activity [34]. 
 
White adipose tissue is also a major endocrine organ, secreting hormones such as leptin and 
adiponectin – to name two of the most prominent – and the list of adipose-secreted proteins is still 
growing [35].  They include cytokines, proteins involved directly in lipid metabolism, those involved 
in the complement system and those involved in vascular haemostasis [36]. For many of these 
proteins, the functional significance of their secretion from adipose tissue is undetermined. However, 
this importance of the secretory functions of WAT is demonstrated in conditions such as cancer 
cachexia [37], malnutrition [38] and anorexia nervosa [39-42], during which there are markedly 
decreased levels of WAT, resulting in significant modulation in the production of most of the adipose-
secreted proteins. For example, in anorexia nervosa patients and other states of energy deprivation, 
hypoleptinaemia is associated with amenorrhoea [39]. This is thought to be because in healthy 
patients, luteinising hormone (LH) and oestradiol levels are regulated by leptin, so hypoleptinaemia 
leads to loss of LH and oestradiol regulation [40]. Thus a critical leptin threshold value for 
amenorrhoea has been set at 2µg/L [41, 42]. This demonstrates the importance of the secretory 
functions of WAT. 
 
1.2.2. Brown adipose tissue 
Brown adipose tissue (BAT) is responsible for the production of extra heat in response to cold 
exposure. BAT was identified as a thermogenic organ in 1961 [43], and in 1978, Foster et al. 
demonstrated the thermogenic activation of BAT in rats acclimatised to the cold [44]. 
 
In infants, BAT is present in several depots, including interscapular, supraclavicular, suprarenal, 
pericardial, para-aortic and around the pancreas, kidney and trachea [45]. In adults, however, 
fluorodeoxyglucose positron emission tomography (FDG PET) studies have revealed that BAT is 
mainly limited to the supraclavicular and neck region, with some additional activity in the 
paravertebral, mediastinal, para-aortic, and suprarenal regions [46, 47]. In mice, BAT is highly active 
and the main BAT depot is located in the interscapular region [48]. 
 
Until recently, BAT was thought only to have a functional role in rodents and human newborns, but in 
2009, a series of papers were published demonstrating its function and activity in adults [49, 50]. In 
2011 it was shown that BAT consumes more glucose per gram of tissue than other tissues, and this 
was increased 12-fold in response to cold exposure, indicating that BAT is far from redundant in 
human adults [51]. 
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Non-shivering thermogenesis 
The mechanism of action for heat production in BAT is via non-shivering thermogenesis, a process 
mediated mainly by mitochondrial uncoupling protein 1 (UCP1), whose expression is mainly limited 
to BAT. There are five known homologues of the uncoupling proteins (UCP1-5), but UCP1 is the 
only form that has proven thermogenic capacity [52]. 
 
UCP1 is a transmembrane proton transporter that decreases the proton gradient across the inner 
mitochondrial membrane, which is generated in oxidative phosphorylation of the tricarboxylic acid 
(TCA) cycle. It does so by acting as a proton ‘leak’, allowing protons to be transported across the 
inner mitochondrial membrane, down the gradient, thus uncoupling proton transport from ATP 
synthesis (demonstrated in Figure 1.1). By decreasing the proton gradient, UCP1 decreases the rate of 
ATP production but increases the rate of substrate oxidation, generating heat as a by-product. 
 
 
Figure 1.1. The mechanism of action of UCP1. 
The electron transport chain pumps protons across the mitochondrial matrix into the intermembrane space, 
generating the proton gradient that is required for ATP-synthase. The production of ATP via ATP-synthase 
requires the transport of protons from the intermembrane space into the mitochondrial matrix. However, UCP1 
in brown adipose tissue transports protons across the inner mitochondrial membrane without the production of 
ATP, acting as a proton ‘leak’. This uncouples proton transport from ATP synthesis, decreasing the proton 
gradient generated by the electron transport chain. This increases the rate of substrate oxidation in the electron 
transport chain without increasing the production of ATP, generating heat as a by-product. Image adapted from 
Brondani et al. 2012 [53]. 
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BAT activation 
The level of activity of BAT varies between species [54] and individuals [55-57]. BAT mass and 
activity has been shown in several independent studies to be increased in females as compared to 
males [55, 56, 58] and also decreased with age [59]. BAT has also been shown to have seasonal 
variability [56], with around a three-fold increase in the number of individuals with measurable BAT 
activity in the winter months in the UK compared to summer months, and also a four-fold mean 
increase in the activity of BAT – as measured by PET/CT – in patients whose BAT activity was 
measured monthly. 
 
As the thermogenic organ, exposure to cold temperatures is a potent stimulus of BAT activation [49-
51]. This activation is dependent upon innervation of the tissue from the sympathetic nervous system 
(SNS). Cold exposure induces the release of norepinephrine in brown adipocytes, which binds to β3-
adrenergic receptors in the mature brown adipocyte cell membranes. The β3-adrenergic receptors are 
coupled with guanine nucleotide-binding proteins (G-proteins), which activate adenylyl cyclase and 
its downstream signalling pathway (cAMP, protein kinase A, and p38MAPK). 
 
This signalling pathway in turn activates lipolysis-stimulating enzymes, such as hormone-sensitive 
lipase, adipose triacylglycerol lipase and monoacylglycerol lipase, increasing the availability of free 
fatty acids (substrates for oxidation within the mitochondria) [60]. In addition, the transcription factor 
ATF2 (activating transcription factor 2) is activated, which directly triggers UCP1 transcription [61]. 
The process of browning is also dependent on β3-adrenergic receptors (further discussed in section 
1.2.3) [62]. 
 
In addition to cold exposure, chronic treatment (three days or longer) with thiazolinediones (TZDs), a 
group of PPARγ agonists (such as rosiglitazone), induces browning of WAT [63-66]. The long-
believed hypothesis for TZD-induced BAT activation was that it occurred simply as a result of 
increased binding of PPARγ agonists to PPAR response elements on beige-selective genes [67, 68]. 
However, it has since been suggested that TZDs increase the stability of PRDM16 (a key 
transcriptional co-regulator in BAT and beige activation) from 5.9 hours to 17.5 hours [69]. 
 
Furthermore, a group of novel activators of BAT have been identified that are associated with 
exercise and act independently of the SNS. These include cardiac natriuretic peptides [70], 
interleukin-6 (IL-6) [71], β-aminoisobutyric acid (BAIBA) [72], fibroblast growth factor 21 (FGF21) 
[73] and irisin [74-76]. Of these, the most extensively studied is irisin, a myokine released from 
muscles following exercise [75]. In 2012, Boström et al. showed that irisin binds to the surface of 
white adipocytes, inducing the expression of UCP-1, and inducing the browning of subcutaneous 
WAT in mice [75]. This was associated with weight loss, an increase in total body energy 
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expenditure, and improved glucose tolerance. Finally, BAT activity and abundance is known to 
decrease with age in both humans [50, 77] and mice [78]. 
 
The tricarboxylic acid cycle 
The tricarboxylic acid (TCA) cycle takes place in the mitochondrial matrix and produces the 
substrates required for the electron transport chain (see Figure 1.2). As such, changes in the levels of 
TCA cycle metabolites can influence substrate availability, with subsequent effects on the rate of the 
electron transport chain, proton transport and ATP production. 
 
 
Figure 1.2. The tricarboxylic acid (TCA) cycle and electron transport chain. 
Q = conenzyme Q; Cyto C = cytochrome C; NADH = nicotinamide adenine dinucleotide; ADP = adenosine 
diphosphate; ATP = adenosine triphosphate; FADH = flavin adenine dinucleotide; GTP = guanosine 
triphosphate. Adapted from Osellame et al. 2012 [79]. 
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Upon BAT activation, there is an increase in rate of glucose uptake into BAT [80]. This was 
demonstrated by Ouellet et al. in 2012 [80] using PET-CT analysis of 18F-fluorodeoxyglucose 
(18FDG), a radioactive glucose analogue. This was accompanied by an increased uptake of saturated 
fatty acid (measured using fatty acid tracer 18F-fluoro-thiaheptadecanoic or 18FTHA) and non-
esterified fatty acids [80]. In addition, the rate of TCA cycle oxidation was measured using 11C-
acetate, a tracer for acetate. Acetate is the main input molecule to the TCA cycle, in the form of 
acetyl-CoA. 11C-acetate levels were increased in BAT throughout cold exposure, indicating increased 
oxidative metabolism [80]. These findings were confirmed by Blondin et al. in 2014 [81]. Taken 
together, this indicates an increased rate of oxidation within the TCA cycle, and thus an increased rate 
of turnover of TCA cycle metabolites. 
 
In addition, in human males, cold-induced increases in BAT activity are associated with increased 
BAT glutamate uptake [82]. Glutamate is a precursor to α-ketoglutarate, and converted to α-
ketoglutarate in a reaction catalysed by the enzyme glutamate dehydrogenase. 
 
A therapeutic target 
Due to its potential to increase energy expenditure, increasing BAT activity is a therapeutic target for 
the treatment of obesity. Estimations suggest that 50g of active BAT in humans could equate to 
around a 5–20% increase in resting energy expenditure [49, 83], which could equate to a loss of 4–
4.5kg of fat mass per year [84]. Indeed, increased BAT or beige activity in mouse models is 
associated with a leaner phenotype [75, 85-88], while mice lacking BAT or beige adipose tissue 
activity are susceptible to obesity [89, 90]. Furthermore, human BAT activity has an inverse 
correlation with body mass [91]. 
 
BAT activation may also have beneficial metabolic effects outside of its ability to increase energy 
expenditure. It has been suggested that BAT activation could delay the development of type 2 
diabetes due to increased oxidation of excess glucose and lipids [92]. A recent study by Lee et al. [93] 
demonstrated that cold-induced BAT activation increased insulin sensitivity in humans, although 
further study is needed in this area. 
 
Cold-induced BAT activation has also been shown to reduce plasma triacylglycerol levels in mice 
[94, 95]. Furthermore, SNS-induced BAT activation decreased plasma triacylglycerols in 
hyperlipidaemic mouse models through increased uptake of these specific lipids into BAT [96], which 
subsequently decreased the cholesterol levels and slowed down the rate of atherosclerosis 
development. This has been confirmed in a human study, in which 68 hypercholesterolaemic patients 
showed reduced levels of total serum cholesterol and serum LDL cholesterol following exposure of 
the whole body to cold water for 5–20 minutes per day for 90 days [97]. 
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Therefore, the beneficial effects of therapeutic BAT activation may not be solely limited to the 
generation of a negative energy balance. 
 
1.2.3. Beige adipose tissue 
UCP1 expression is almost exclusively limited to brown adipose tissue as the main thermogenic organ 
[98]. However, it is now well established that in certain populations of white adipose tissue (WAT), 
UCP1 expression can be induced [63, 99], as well as the expression of a panel of genes associated 
with uncoupled proton transport and heat production [100]. These populations of WAT are known as 
‘beige’ or ‘brite’ adipocytes, and can be activated, like BAT, by cold exposure or sympathetic 
innervation [101]. 
 
Beige adipocyte populations are present in subcutaneous white adipose tissue, while visceral white 
adipose tissue is typically non-browning [102]. However, beige adipocytes lack other intrinsic 
characteristics associated with brown adipocytes, such as the myf-5 cellular lineage and myocyte-
associated genes [99] and the expression of transcription factors PRDM16, ZIC1, LHX8 and MEOX2 
[63]. They also retain certain characteristics unique to WAT, such as HOXC9 expression [63]. The 
induction of browning in WAT has been the subject of extensive research in recent years due to its 
potential therapeutic application in the treatment of obesity. 
 
1.2.4. Bone marrow adipose tissue 
Marrow adipose tissue (MAT) is an anatomically and functionally distinct adipose depot located in 
the marrow cavity of bones. Bone marrow adipocytes occupy over 70% of the bone cavity volume 
[103]. While the presence of adipose tissue in bone marrow has been recognised for around 100 years 
[104-107], it was only with the discovery that adipose tissue is also an endocrine organ (rather than an 
inert energy storage organ) [108] that the possibility of MAT as an important factor in energy 
metabolism was considered. 
 
A distinct depot 
It has been proposed that MAT is similar to brown adipose tissue (BAT) [109], and that it has 
comparable functions in thermogenesis. MAT and BAT have overlapping gene expression profiles 
(including expressing UCP1, PRDM16, DIO2, and PGC1a) and show a comparable decrease in these 
genes during ageing and in diabetes [109]. However, MAT is unlike BAT both histologically and 
structurally. 
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Histologically, MAT looks identical to white adipose tissue (WAT) [110]. MAT and WAT also 
exhibit similar lipid contents, being made up mostly of triglycerides[111].  Furthermore, MAT, like 
WAT, can function as an adipokine-secreting endocrine organ (discussed further on page 11). 
 
However, despite similar lipid content, the lipid saturation profiles of WAT and MAT differ [112], 
with a greater proportion of saturated fatty acids and a lower proportion of monounsaturated fatty 
acids in MAT compared to WAT. MAT also has a distinct gene expression profile in comparison to 
WAT [113], with higher expression of genes associated with early adipogenesis (e.g. CEBPb, RGS2) 
and a lower expression of mature adipocyte-specific genes (e.g. PPARg, FABP4, PLIN1, CFD). A 
group of genes that could be linked to MAT-bone signalling have also been identified, including 
SFRP4, TNFa, TGFb1, GPR109A, and IL-6 [113]. 
 
MAT also responds differently to WAT in response to energy deficit: in rabbits fasted for 3 weeks, 
the ability of MAT to esterify fatty acid was not altered; whereas that of perinephric WAT was 
decreased by 60% [114]. Furthermore, in animal models of calorie restriction (CR) including in rabbit 
[115] and mouse [116], MAT has been shown to increase in volume in response to energy deficit, in 
contrast to the decreased WAT mass that is observed in response to energy deficit. This observation in 
MAT has been verified in several human studies investigating cohorts of patients with anorexia 
nervosa [117-119]. 
 
Thus, the characteristics of MAT are distinct from other previously well-characterised adipose tissue 
depots. This leaves the function of MAT a question largely unanswered. 
 
Mechanisms for MAT development and deposition 
MAT development differs from typical WAT development in several ways: 
 
MAT development 
Visceral WAT development and constitutive MAT development occur at similar stages of 
development (Table 1.1). However, in adulthood, WAT expansion depends primarily on hypertrophy 
(cell size increase), with a generally very tightly maintained adipocyte cell number in healthy adults. 
Hyperplasia (cell number increase) is therefore reserved as a secondary mechanism for lipid storage 
when capacity is exceeded [120, 121]. In contrast, expansion of MAT is dependent on both 
hypertrophy and hyperplasia: 66.2% of MAT expansion is dependent on adipocyte size alone; and 
97.2% is dependent on the combination of both adipocyte size and number [122]. 
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In addition, MAT behaves differently to WAT in response to certain dietary stimuli. As discussed on 
page 8, MAT is increased in CR and anorexia nervosa [116, 123, 124]. This apparently contradictory 
observation has led to the theory that MAT may act as a reserve energy storage for times of severe 
starvation that can be utilised to provide several extra days of life during the final stages of starvation 
[125]. This supports the idea that WAT and MAT may respond differently to nutritional status. 
Consistent with this, MAT does not generally correlate with commonly used clinical measures of 





Visceral WAT Constitutive MAT Regulated MAT 
Mice Embryonic days 
14-18 [129] 
Several weeks 
after birth [129] 






response to various 
stimuli throughout 
life [130, 131] Humans Final third of 
gestation [132] 
Final third of 
gestation [132] 
At birth or slightly 
before birth 
(further expansion 
4-8 weeks of age) 
[110, 133] 
Table 1.1. The stages of development of adipose tissue. 
The stages of development at which subcutaneous and visceral white adipose tissue (WAT), and constitutive 
and regulated marrow adipose tissue (MAT) are formed. 
 
The origin of MAT 
WAT is thought to be of mesodermal origin [134], with adipocytes derived from self-renewing 
mesenchymal stem cells. Adipocyte progenitor cells are characterised by the expression of PPARγ, 
marking commitment to the adipogenic lineage, yet they do not accumulate lipid [135]. A study by 
Rodeheffer et al. [136] identified a subset of adipocyte progenitor cells expressing CD29, CD34, Sca-
1 and CD24 (negative markers for the haematopoietic lineage), which have the potential to regenerate 
an entire fat depot in lipodystrophic mice and stimulate de novo vascularisation. BAT, on the other 
hand, is thought to be of distinct origin from WAT. BAT is thought to share a common early 
developmental program with skeletal muscle, and the transcriptional signature of BAT differentiation 
may act to inhibit myogenesis [137]. Brown adipocytes, but not white or beige adipocytes, were 
shown to arise from myogenic marker Myf5-expressing precursors [138]. 
  The role of TET1 in adipose tissue 
Chapter 1. Introduction  11 
 
It is thought that MAT adipocytes, like WAT adipocytes, differentiate from mesenchymal stem cells 
and can further differentiate into white and beige adipocytes [139, 140]. Some recent studies have 
identified the leptin receptor (LepR) as a marker for adult bone marrow adipocyte progenitors [141], 
and showed that conditional knockout of LepR in Prx1-Cre positive cells (a mesenchymal stem cell 
marker) caused increased osteogenesis, decreased adipogenesis, and accelerated fracture healing 
[142], indicating that leptin/LepR signalling to bone marrow mesenchymal stem cell populations is 
required for bone marrow adipogenesis. Furthermore, a study by Ambrosi et al. [143] identified the 
properties of bone marrow adipocyte precursors using flow cytometry, isolating a population of 
CD45−CD31−Sca1+CD24+/− adipocyte progenitor cells: the same markers used to identify white 
adipocyte progenitors. In addition, the bone marrow adipocyte progenitor cell population had a gene 
expression profile (including PPARγ and CEBPα) and in vitro adipogenic capacity that most closely 
resembles inguinal (subcutaneous) WAT. 
 
MAT contribution to local and systemic metabolism 
The triglycerides in MAT have been shown to affect regulation of the populations of osteoblasts, 
osteoclasts and blood cells [111, 144], contributing to the hypothesis that MAT may influence the 
local metabolism and growth of bones. 
 
Comprising around 7% of the total fat mass in an average adult [128], MAT is also thought to make a 
significant contribution towards systemic metabolism, particularly in individuals with an exaggerated 
MAT:WAT ratio, such as those with anorexia nervosa or MAT-sparing lipodystrophy. In these 
individuals, it is estimated that MAT comprises around 30-40% of the total fat mass [110]. Cases of 
congenital lipodystrophy (CGL) have been pivotal in the study of the role of MAT in systemic 
metabolism, due to the fact that some CGL manifest as MAT-depleting (CGL1, CGL2) and some are 
MAT-sparing (CGL3, CGL4) [110]. The prevalence of hyperinsulinemia, high serum triglycerides, 
acanthosis nigricans (a sign of insulin resistance), and diabetes is higher in patients with CGL1 and 
CGL2 in comparison to patients with CGL3 or CGL4 [110], suggesting that the presence of MAT in 
CGL4 could contribute to the reduced severity of diabetes and insulin resistance. 
 
The endocrine properties of MAT are also thought to contribute to systemic metabolism. In cultured 
explants of rabbit WAT and MAT, adiponectin was found to be expressed at higher levels in MAT 
than WAT [123]. This finding was also confirmed in humans, with MAT adipocyte cultures 
demonstrating a greater capacity for adiponectin secretion than WAT [123]. Adiponectin is a peptide 
hormone associated with improved glucose tolerance, insulin sensitivity, cell survival and vascular 
function [145]. Levels of circulating adiponectin are generally inversely correlated with WAT mass, 
so that obesity is generally associated with hypoadiponectiaemia [146], and low circulating 
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adiponectin is a proposed biomarker for risk of both cardiometabolic disease and cancer [147]. The 
role of specific MAT-derived adiponectin is a subject of ongoing research, although CR studies 
suggest that MAT-derived adiponectin is required for CR-derived adaptations in skeletal muscle, such 
as upregulation of transcripts involved in mitochondrial function (including Ppargc1a, Tfam and 
Acadm) [148]. The potential for MAT-derived adiponectin to impact on other systemic functions, 
such as glucose tolerance and hepatic gene transcription, is a subject of ongoing research (reviewed in 
[149]). 
 
It is also thought that MAT has some capacity for leptin expression and secretion, first demonstrated 
in cultured adipocytes differentiated from bone marrow-derived mesenchymal stem cells in vitro 
[150-152]; a finding confirmed in primary bone marrow adipocytes in vitro [153, 154]. Leptin 
expression at the transcript level in isolated bone marrow adipocytes has also been shown in vivo in 
mice [113] and rabbits [124].  Leptin is a satiety hormone, and depletion of the leptin gene or the 
leptin receptor results in insatiable hunger and severe obesity [108, 155]. Leptin also has effects on 
energy balance, fertility and immune function [156], and as such MAT-derived leptin may have the 
potential to influence any of these systemic functions. 
 
Regulated and constitutive MAT 
MAT is present in the marrow of long bones in two distinct depots: regulated (rMAT) and constitutive 
(cMAT). The two depots differ in their histological profiles, their fatty acid content, and their stage of 
development [130]. cMAT develops 1-4 weeks after birth in mice (at the same time as WAT 
development); appears histologically as confluent, rounded adipocytes; and has a greater proportion of 
unsaturated fatty acids. rMAT develops later in life in response to certain metabolic or endocrine 
stimuli or disease states (see Table 1.2); histologically is present as smaller, more discrete adipocytes; 
and has a higher proportion of saturated fatty acids compared to cMAT [130]. 
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Stimulus/disease state Human MAT 
response 
Rodent MAT response Reference 
Calorie restriction/Anorexia 
nervosa 
Increased Increased [123, 124, 
157] 
High fat diet/Obesity Increased Increased [158-163] 
Type I Diabetes No change Increased (tibia/fibula) or 
no change (vertebrae) 
[164, 165] 
Type II Diabetes Increased or no 
change 
Increased [166-168] 
Cold exposure - rMAT decreased, cMAT 
no change 
[130] 
Congenital lipodystrophy 1 Absent Not applicable [110] 
Congenital lipodystrophy 2 Absent Not applicable [110] 
Congenital lipodystrophy 3 Retained Retained [110, 130] 
Congenital lipodystrophy 4 Retained rMAT decreased, cMAT 
no change 
[110, 130] 
Ageing Increased Increased [127, 130] 
Glucocorticoid treatment Increased Increased [169, 170] 
Oestrogen deficiency Increased Increased [171, 172] 
Table 1.2. Marrow adipose tissue response to various stimuli. 
Adapted from Scheller et al. 2016 [173]. 
 
MAT and obesity 
As shown in Table 1.2, MAT is increased in states of obesity. This increase is particularly associated 
with an increase in visceral fat: in a study on 47 pre-menopausal women of varying BMI, there was a 
positive correlation between the amount of visceral adipose tissue and amount of MAT [159], a 
finding confirmed in 35 healthy obese men [158]. In mice, both long-term (12 weeks) and short-term 
(2 and 3 weeks) high fat diet (HFD) was associated with increased MAT, with contradictory findings 
on the associated effect on bone mass [160, 162]. Additionally, both regular diet- and HFD-fed mice 
with access to an exercise wheel exhibited decreased MAT by more than half compared to those 
without access to an exercise wheel [163], demonstrating that MAT is highly responsive to exercise. 
 
The effect of MAT on bone structure and bone mineral density 
Increases in MAT are associated with decreased bone mineral density following the menopause [174] 
and in various human disease states, including ageing [127, 175] and anorexia nervosa [117]. The 
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inverse association between MAT content and bone mineral density has also been demonstrated in 
animal models of ageing [176], ovariectomy [177], calorie restriction [116] and glucocorticoid 
treatment [178]. There are two hypotheses to explain the contribution of MAT expansion to the 
process of bone demineralisation. Firstly, it has been suggested that adipogenesis and 
osteoblastogenesis are competitive processes, with increases in pro-osteogenic factors (growth 
hormone, Wnt proteins, insulin-like growth factor 1) associated with an increase in adipogenesis [179-
181]. The alternative hypothesis is that certain paracrine factors secreted by MAT can inhibit 
osteoblastogenesis and favour adipogenesis, such as such as Wnt signaling inhibitors [182] and 
chemerin [183]. 
 
1.3. Physiological control of food intake 
1.3.1. Leptin 
Leptin is a 16kDa protein secreted from adipose tissue in response to eating. Frequently referred to as 
the satiety hormone, leptin is secreted into the blood, attaches to the leptin binding protein, and 
reaches the hypothalamus via the cerebrospinal fluid (CSF). In the brain, it acts by decreasing 
neuropeptide Y, which suppresses appetite [184]; and promoting α-MSH (α-melanocortin stimulating 
hormone) synthesis, which decreases hunger [185]. 
 
Recent evidence also demonstrates that leptin influences energy metabolism as well as energy intake. 
For example, in rodents, leptin treatment increases energy expenditure and decreases fat mass without 
affecting lean mass [186, 187]. In addition, in mice genetically lacking leptin (Ob/Ob mice), 
recombinant leptin treatment normalises serum glucose, insulin and lipid concentration [186]. Leptin 
is also involved in numerous other processes, including fertility [188-190], puberty [191], 
angiogenesis [192, 193] and bone metabolism [194]. 
 
1.3.2. Leptin receptors 
Leptin acts by binding to its receptors (OB-R), of which there are 7 known isoforms (OB-R a-f), 
produced by alternative splicing [195]. Leptin receptors are single membrane-spanning receptors with 
homology to the cytokine receptor superfamily. OB-R a, b, c, d & f contain transmembrane domains 
and can be divided into two groups: those that have a short amino acid residue intracellular domain 
(short form: includes OB-Ra, OB-Rc, OB-Rd and OB-Rf) and those with a long amino acid residue 
intracellular domain (long form: OB-Rb only) [195]. OB-Rb is mainly expressed in the hypothalamus 
[196] and is responsible for the anorectic action of leptin. The long form has two Janus kinase (Jak) 
sites in the intracellular domain while the short form has only one.  The long form activates the signal 
transducers and activators of the transcription family STAT [197]. Short leptin isoforms are able to 
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activate some signal transduction cascades, although the effect of short isoform activation differs from 
that of long isoform activation [198, 199]. 
 
The short forms are expressed in a variety of tissues with distinct tissue distributions [200]. It was 
initially suggested that the main function of the short form receptors is to internalise and degrade 
leptin [201]. However, the short form leptin receptors are now believed to be important for the 
peripheral metabolic effects of leptin [202]. Leptin has been suggested to have direct peripheral action 
via the short-form receptors in key metabolic organs including skeletal muscle, pancreas, liver, 
gastrointestinal tract and adipose tissue [202]. 
 
OB-Re is the soluble leptin receptor and has no transmembrane domain. This isoform is thought to be 
either a result of alternative transcript splicing or a consequence of transmembrane Ob-R receptor 
destruction [203]. Plasma Ob-Re can bind serum leptin and inhibit its signal transduction. It can also 
regulate serum leptin levels and act as a carrier protein, delivering the hormone to its membrane 
receptors to initiate cellular signal transduction [204]. 
 
1.3.3. Serum leptin fluctuations 
Serum leptin levels increase in response to feeding, particularly in response to foods with a high 
glycemic index (GI) [205, 206]. Plasma leptin levels are positively correlated with BMI [207, 208], 
and leptin increases not linearly but exponentially with fat mass [209]. Conversely, starvation causes 
hypoleptinaemia, a change that takes place acutely, even prior to the depletion of adipose tissue [210]. 
Leptin levels increase diurnally between midnight and early morning, acting to suppress appetite 
during the night [211]. However, this diurnal variation in leptin levels can be modified by meal timing 
[212]. 
 
In a study of 1062 male office workers, leptin levels were found to be increased in those who rated 
themselves as more psychologically stressed [213]. In addition, physical exercise (12 weeks aerobic 
exercise training) causes a chronic reduction in plasma leptin in females but not males. These changes 
were seen in the absence of a reduction in body fat [214]. Glucocorticoids directly stimulate leptin 
synthesis in cultured adipocytes [215, 216], and chronic cortisol elevation in humans causes increased 
leptin expression [217]. For a full summary of conditions known to influence leptin levels, please see 
Table 1.3. 
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Feeding (especially high GI foods) Fasting 
Overfeeding Starvation 
Obesity Testosterone 
Insulin Beta-adrenergic agonists 
Glucocorticoids Thiazolidinediones (in vitro) 
Acute infection Thyroid hormone 





Glucocorticoids Low birth weight 
Hypoxia - 






Stomach fundus (rat) - Feeding 
   
Table 1.3. Conditions that regulate plasma leptin levels. 
Table adapted from Ahima et al. 2000 [218] 
 
 
1.3.4. Regulation of leptin plasma levels 
Leptin is regulated at multiple levels: expression, secretion and protein binding. It has been suggested 
that insulin can stimulate leptin expression and secretion in adipocytes in vitro [219, 220], although 
there is contradictory evidence for this [221, 222]. Similarly, in vivo, some groups have reported that 
insulin increases plasma leptin levels in rodents and humans [223, 224], while other groups have not 
observed any acute change in leptin expression or secretion in response to insulin [225, 226]. 
 
Another known regulator of leptin secretion is cold exposure [227], which acts by activating the 
sympathetic nervous system and β3-adrenergic receptors, increasing the circulating levels of 
norepinephrine, in turn decreasing plasma insulin and leptin levels [228-230] and leptin mRNA 
expression in adipose tissue [231]. Sympathetic innervation and β3-adrenergic receptor activation in 
adipose tissue has been shown to be the mechanism responsible for decreasing leptin gene expression 
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in response to leptin injections [232] and also for fasting-induced reduction in circulating leptin levels 
[233]. 
 
Another method of regulation of serum leptin levels is through sequestering of the protein in the 
serum by the soluble leptin receptor (OB-Re) [234]. The ratio of serum leptin to OB-Re provides the 
measure of free leptin index (FLI), which is proposed to be a more accurate determinant of leptin 
action than serum leptin levels alone [235]. An example in which OB-Re may be actively regulating 
free leptin levels is in anorexia nervosa. In this case, plasma leptin levels are decreased and OB-Re 
levels are increased, resulting in a decreased FLI [236]. This suggests that high OB-Re levels in 
anorexia nervosa may act to suppress leptin action during energy deficiency. Weight recovery in 
anorexic patients was associated with a decrease in plasma OB-Re and an increase in plasma leptin, 
with no change in FLI [236]. 
 
1.3.5. Leptin deficiency 
In ob/ob mice, a mutation in the leptin gene coding sequence results in leptin deficiency and obesity. 
In db/db mice, mutations in leptin receptors are associated with an almost identical phenotype [197]. 
Treatment with recombinant leptin reduces fat mass in ob/ob mice but not db/db mice. 
 
In humans, mutations in the LEP gene result in hyperphagia and severe obesity from childhood [155]. 
Following the first identification of a mutation in the human LEP gene in 1997 [155], a further seven 
distinct human mutations have been identified. While these mutations vary in structure, the result in 
vivo is the absence of plasma leptin. Treatment with a recombinant form of the protein, Metreleptin, in 
these patients lead to a "rapid change in eating behaviour, a reduction in daily energy intake, and 
substantial weight loss" [237]. 
 
In addition, polymorphisms in the leptin receptor gene LEPR have been associated with a similar 
clinical presentation including hyperphagia and obesity [238]. These polymorphisms were 
accompanied by high plasma leptin levels, indicating leptin resistance [238]. 
 
1.3.6. Leptin resistance 
The discovery of leptin as a satiety hormone was met with much excitement regarding its potential 
application as a treatment for obesity. However, while recombinant leptin therapy is effective in 
treating monogenic forms of obesity that involve mutations in leptin and its signalling pathway [239] 
this possibility of its application in polygenic obesity was soon disregarded when it was found that 
leptin sensitivity, much like that of insulin in Type 2 diabetes, is plastic and overexposure to the 
hormone results in leptin resistance [240]. This is the case in obesity, in which high levels of leptin 
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are secreted due to increased adipose tissue, but the subject no longer receives the satiety signals. In 
this regard, plasma leptin levels can be used to predict the physiological potency of leptin, such 
that ob/ob mice show marked responses to injected leptin, while hyperleptinemia results in diminished 
leptin response [241]. 
 
There are a number of hypotheses for a molecular explanation for leptin resistance, including 
alterations in the transport of leptin across the blood brain barrier (BBB), alterations in cellular OB-
Rb signalling and perturbations in developmental programming [242-244]. It is possible that all of 
these mechanisms may act together to give the combined effect of leptin resistance. Although there 
are no changes in the transcription or abundance of OB-Rb in the hypothalamus in most cases of 
leptin resistance [245, 246], the majority of studies in the field confirm that defects in OB-Rb 
signalling play a crucial role [242, 243, 247]. 
 
One hypothesis for leptin resistance is that leptin transport across the BBB is altered. In humans, it 
was found that the ratio of leptin in the CSF compared to the blood is lower in obese people compared 
to healthy weight controls [248]. It has been suggested that obesity causes high levels of triglyceride 
transport across the BBB, which can in turn affect the transport of leptin across the BBB. In support 
of this, a study using CSF from Lou/C rats, an inbred strain of Wistar origin that are resistant to age- 
and diet-related obesity, found decreased levels of triglycerides in the CSF of the Lou/C rats 
compared to age-matched Wistar controls, which could be consistent with increased leptin transport 
across the BBB [249]. Consistent with this, they found improved hypothalamic leptin signalling in 
Lou/C rats, indicated by increased pSTAT3/STAT3 (signal transducer and activator of transcription 3) 
ratio following acute peripheral leptin administration, as well as by decreased hypothalamic mRNA 
expression of the suppressor of SOCS3 (cytokine signalling 3), known to downregulate leptin 
signalling. All of these changes were found in the absence of changes in leptin transporter expression 
in the choroid plexus. 
 
However, changes in the leptin receptor are not believed to be the main cause of leptin resistance. 
This is because, although there is a deficit in the transfer of leptin from the plasma to the CSF in 
obesity, obese subjects still have 30% more leptin in their CSF compared to lean subjects, which fails 
to prevent obesity [248]. Leptin mRNA levels indicate that the amount and quality of leptin receptors 
in the hypothalamus are normal in the majority of obese subjects [246]. Therefore, it is more likely 
that leptin resistance in obesity develops from a post-receptor deficit, similar to the mechanism seen 
in type 2 diabetes. For example, leptin resistance may be caused by defects in the JAK/STAT pathway 
downstream of leptin receptor activation. Phosphotyrosine phosphatase (PTP1B) recognises a specific 
consensus substrate motif found in JAK2. Over-expression of PTP1B resulted in hypophosphorylation 
of endogenous JAK2 and blocked the leptin-induced transcription of endogenous SOCS3 and c-fos in 
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a hypothalamic cell line [250]. PTP1B appears to be a negative mediator of both the JAK/STAT and 




The most widely accepted definition of epigenetics is the study of heritable phenotype changes that do 
not involve alterations in the DNA sequence [251-253]. Epigenetics is usually used to describe 
molecular mechanisms that affect transcription without change to the primary nucleotide sequence. 
Examples include histone modifications, DNA methylation, and can include non-coding RNAs with 
transcription-modulating properties, such as microRNAs. 
 
Epigenetic modifications can persist through multiple cell divisions, throughout life and may be 
heritable throughout multiple generations [254]. They can also be responsible for tissue-specific gene 
expression and developmental changes in gene expression [255]. Furthermore, they are also 
dynamically influenced in various environmental exposures and disease states, most notably cancer 
(reviewed in [256] and [257]). 
 
1.4.1. DNA packaging and chromatin accessibility 
To enable several metres of eukaryotic DNA to fit within a cell nucleus of 2-10µm, DNA must be 
efficiently packaged, while still remaining accessible to the critical protein machinery that allow it to 
function [258]. The histone proteins are a solution to this problem, allowing around 147 base pairs of 
DNA to wrap around a histone octamer (2 copies each of H3, H4, H2A and H2B), forming a 
nucleosome complex which repeats throughout the DNA [259]. Chromatin occurs in distinct domains: 
regions that are compacted (heterochromatin) and regions that are relaxed (euchromatin). 
Euchromatin is typically transcriptionally permissive, while heterochromatin is typically 
transcriptionally repressive [260]. Chromatin state is influenced by several factors, such as histone 
chaperones that can facilitate deposition and eviction of histones [261, 262], histone variants in the 
nucleosome core particle [263], chromatin remodellers that use ATP to evict histones [264], and small 
chemical modifications to histones and DNA [265-268], which compose a large part of the 
mechanisms under the term “epigenetics”. 
 
1.4.2. Histone post-translational modifications 
A huge number of histone modifications, such as lysine acetylation, lysine and arginine methylation, 
lysine ubiquitination, arginine citrullination, lysine sumoylation, ADP-ribosylation, proline 
isomerization, and serine/threonine/tyrosine phosphorylation can occur on histones [265, 269], 
although only a few have known transcriptional regulatory function [270]. Histone 3 lysine 4 
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trimethylation (H3K4me3) [271-273] and histone 3 lysine 36 trimethylation (H3K36me3) [270] are 
associated with transcriptional activation. Histone 3 lysine 27 trimethylation (H3K27me3) [274], 
histone 3 lysine 9 di- and tri-methylation (H3K9me2/3) [269, 275] and histone 4 lysine 20 
trimethylation (H4K20me3) [276, 277] are four marks that are associated with transcriptional 
repression. In addition, the “histone code” hypothesis suggests that in addition to the role of histone 
modifications mediating chromatin compaction or relaxation, they may be able to selectively recruit 
effector proteins that dock onto histone modifications and elicit a transcriptional response [270, 278] 
that may well be contradictory to the direct physical effect of the histone modification on chromatin 
structure [279]. 
 
1.4.3. DNA methylation 
Methylation of the C5 position of the cytosine in a CpG dinucleotide, mediated by DNA 
methyltransferase enzymes 1-3 (DNMTs), generates 5-methylcytosine (5mC) [280]. 5mC is 
associated with long-term transcriptional repression, particularly when present in gene promoters. 
DNA methylation is essential for normal development and is associated with a number of key 
developmental processes including genomic imprinting, X-chromosome inactivation and repression 
of transposable elements. DNA methylation may influence gene transcription in two ways: either 
DNA methylation can physically prevent the binding of transcriptional proteins [281]; or methylated 
DNA may be bound by methyl-CpG-binding domain proteins (MBDs). MBD proteins are able to 
recruit further repressive proteins to the locus, such as histone deacetylases, thus generating 
compact heterochromatin [282]. 
 
1.4.4. CpG islands 
Chemical instability of methylated CpG dinucleotides has resulted in an evolutionary global depletion 
of CpGs and a lower-than-expected incidence of CpG sites within the genome [283]. The exception to 
this is within CpG-rich regions known as CpG islands, which are constitutively unmethylated [284]. 
Around 50% of CpG islands are located in gene promoters, and another 25% are located in gene 
bodies, where they often serve as alternative promoters [284]. Likewise, around 60-70% of gene 
promoters in mice and humans contain CpG islands [285, 286]. 
 
1.4.5. Active and passive DNA demethylation 
The methyl group of 5mC can be removed in a cell type-specific manner. This removal can be 
achieved passively through failure of DNMT1 during DNA replication [287], or actively through 
enzymatic DNA demethylation. During active DNA demethylation, 5mC is oxidized to sequentially 
produce 5-hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC), and 5-carboxylcytosine (5caC) in 
a manner independent of DNA replication [288] by the action of the ten-eleven-translocation (TET) 
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enzymes [289]. Following oxidation, the DNA base-excision repair (BER) pathway can remove the 
methylated cytosine and replace it with an unmodified cytosine. Furthermore, it has been suggested 
that passive DNA demethylation is enhanced by active DNA demethylation, because DNMT1 activity 
can be reduced by 5hmC in vitro [288, 290]. 
 
1.4.6. DNA hydroxymethylation 
As well as being an intermediate in active DNA demethylation, 5hmC is also a stable, functional and 
relatively abundant epigenetic mark involved in transcriptional regulation [291].  5hmC is 10- to 100-
fold more abundant than 5fC/5caC and it is relatively enriched in neurons, stem cells, and decreased 
in cancer cells [292-294]. An increasing number of studies demonstrate that 5hmC plays important 
roles during maintenance of pluripotency in embryonic stem cells (ESCs), central nervous system 
development and tumorigenesis [295]. 
 
5hmC was initially identified in 1952 in viral DNA [296, 297], not long after the discovery of 5mC; 
but it wasn’t until 2009 that it gained attention following the discovery that it was abundant in 
Purkinje fibres and granule cells [298, 299]. Shortly after, it was discovered in all cell types in the 
mouse, with particularly high levels in the central nervous system [300]. 
 
Increased levels of 5hmC are present in the gene bodies of actively transcribed genes, and TET1 is 
often present at the transcriptional start site of genes with CpG promoters that are marked by the 
bivalent histone signature of H3K27me3 and H3K4me3 [301]. Because of this, it is assumed that 
5hmC and TET proteins may initiate active gene expression by modulating chromatin accessibility of 
the transcriptional machinery, or by inhibiting repressor binding. 
 
In support of this, 5hmC is enriched within gene bodies, promoters, and transcription factor-binding 
regions [302]. In addition, 5hmC accumulates in gene-rich regions marked by H3K4me2/3, as 
demonstrated by immunostaining [301, 303]. The relationship between 5hmC peaks and gene 
expression level is complicated. For example, actively transcribed genes have depleted 5hmC in their 
transcriptional start site regions, while genes of low expression show 5hmC peaks at promoters in 
both embryonic stem cells and neural progenitor cells [304]. To complicate it further, 5hmC peaks in 
gene bodies are positively correlated with gene expression levels in embryonic stem cells, but with 
lower expression levels in neural progenitor cells [304]. In this regard, patterns of 5hmC peaks seem 
to be a cell type-dependent regulatory network rather than simple activation or repression of gene 
activity. 
 
Furthermore, during cell differentiation, patterns of 5hmC peaks and troughs are affected by the 
presence of histone modifications, epigenetic marker binding proteins, and chromatin configuration. 
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5hmC is present at high levels at the transcriptional start sites of genes whose promoters have dual 
histone marks (H3K27me3 for transcriptional repression and H3K4me3 for transcriptional activation) 
[305]. 5hmC levels are also high at “poised” and active enhancers labelled with H3K4me1, H3K18ac, 
and H3K27ac [303]. 
 
5hmC is also highly enriched at polycomb target gene promoters where it is associated with the 
generation of the repressive histone mark H3K27me3 and transcriptional repression [306, 307]. TET1 
is necessary for chromatin binding of the Polycomb Repression Complex 2 (PRC2), which is required 
for initial targeting of genomic regions to be silenced. Therefore, 5hmC has both activating and 
repressive influences on transcription [307]. 
 
5hmC levels are highly dynamic, and can be altered in states of disease [308] or drug treatment [309, 
310]. For example, in mice treated with phenobarbital (a rodent hepatocarcinogen) for 4 weeks, 5hmC 
at specific loci in liver DNA were dramatically changed [309, 310]. In the promoters of genes 
displaying highly upregulated expression, increased levels of 5hmC and decreased levels of 5mC 
were observed in addition to increased levels of the activating histone mark H3K4me2. 
 
1.4.7. The Ten Eleven Translocase enzymes 
The Ten Eleven Translocase (TET) enzymes, which include TET1, TET2 and TET3, were identified 
in 2009 as homologues of J-binding protein 1 & 2 (JBP1 & 2) and members of the 2-oxoglutarate 
(2OG)- and Fe(II)-dependent oxygenase superfamily [299, 311, 312]. TET1 was first identified as a 
fusion partner of the MLL gene in acute myeloid leukaemia [313]. All three TET isoforms have been 
shown to oxidize 5mC into 5caC efficiently in vitro and in vivo [314], although TET depletion studies 
suggest that TET1 is responsible primarily for activity in the gene promoters, while TET2 is more 
active at CpGs in gene bodies [315]. 
 
The three TET isoforms show temporal and tissue-specific patterns of expression [316-318]. TET1 is 
highly expressed in embryonic stem cells [299] and primordial germ cells [319], suggesting an 
association with the pluripotent state. TET2 is most widely expressed in somatic tissues, especially 
haematopoietic cells [320], and has overlapping roles with TET1 in regulating haematopoietic stem 
cell (HSC) maintenance, hematopoietic homeostasis, and leukemogenesis [321]. TET3 is most highly 
expressed at the oocyte to zygote stage of development, and contributes to paternal global DNA 
demethylation [322]. 
 
Because the TET1 and TET2 isoforms in humans show higher activity for 5mC than for 5hmC/5fC, it 
is not easy to oxidize it to 5fC and 5caC once 5hmC is established in genomic DNA [323]. However, 
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TET3 acts as 5caC reader during 5caC excision in BER, since its CXXC domain shows high affinity 
for 5caC [324]. 
 
Finally, although the enzymatic activity of the TET proteins has been shown to be highly important 
for their function, one study suggested that TET proteins might also exert functions independently of 
their catalytic activity [325]. In this study, it was reported that TET1 associates with the Sin3a co-
repressor complex in 293T and mouse embryonic stem cells (mESCs). Importantly, they found that 
the upregulation of TET1 target genes upon Tet1 knockdown can also be observed in DNMT triple 
knockout ES cells in which both 5mC and 5hmC modifications are absent. These results suggest that 
TET1 might repress gene transcription in a manner independent of their catalytic activity. 
 
1.4.8. The Tet1 knockout mouse model 
A study published in 2011 was the first to investigate the effects of Tet1 deletion [326]. Initial studies 
on Tet1 KO in ESCs found that levels of global 5hmC was reduced by around 35%, and subtle 
differences occurred in global gene expression (221 genes were significantly dysregulated > 2-fold; 
mostly genes involved with development). However, Tet1 KO ESCs were still pluripotent. In 
addition, a tetraploid complementation assay was carried out. This is a test for assessing pluripotency 
as the cells of the recipient tetraploid (4n) blastocyst can only contribute to the trophectoderm but not 
the epiblast, thus generating embryos that are generated exclusively from the injected diploid mESCs 
[327]. The tetraploid complementation assay revealed that Tet1 KO ESCs still supported development 
of live-born mice, although differentiation in vitro was skewed towards mesoderm and endoderm 
developemnt. 
 
The same study generated the first Tet1 KO mouse [328], which has a global knockout (KO) of the 
Tet1 gene. Tet1 KO mice are viable, fertile and grossly normal, although 75% of KOs were slightly 
smaller at birth. In this study, Tet1 KO mice were reported to be born at expected Mendelian ratios 
[328], although subsequent studies have contradicted this [329-331]. Yamaguchi et al. reported that 
progenies resulting from mating between Tet1 KO males and wildtype females display several 
variable phenotypes including placental, fetal and postnatal growth defects, and some early embryonic 
lethality [331]. 
 
A number of studies have used the Tet1 global KO mouse model to investigate the function of TET1 
in various tissues. For example, the Tet1 KO mouse was found to display aberrant hypermethylation 
in the paternal allele of differential methylated regions of imprinted genes in sperm, which can be 
traced back to primordial germ cells, indicating that TET1 acts to wipe out remaining methylation, 
including imprinted genes, at the late reprogramming stage [331]. In addition, Tet1 KO oocytes were 
reported to display univalent chromosomes, DNA double-strand breaks, and defective DNA 
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demethylation and decreased expression of a subset of meiotic genes [330], indicating that TET1 is 
important for meiosis. A further study using a Tet1 KO mouse model found that Tet1 KO causes 
altered expression of neuronal activity-regulated genes and compensatory upregulation of active 
demethylation pathway genes [332]. In addition, Tet1 KO mice displayed an enhanced fear 
conditioning response and object location memories, suggesting that TET1 plays an important role in 
maintaining the epigenetic state of the brain associated with memory consolidation and storage [332]. 
A further study found that Tet1 KO caused an increase in H2O2-induced apoptosis and an increase in 
sensitivity to oxidative stress of cerebellar granule cells, suggesting a role for TET1 in neuronal 
protection against oxidative stress [333]. Thomson et al. also characterised the liver epigenome of the 
Tet1 KO mouse [308] and found a dramatic reduction in 5hmC over a large number of gene 
promoters, suggesting that TET1 is important for liver function. 
 
Further studies have generated and characterised the phenotypes of other Tet isoform knockouts, 
including double and triple knockouts (summarised in Table 1.4). 
  
  The role of TET1 in adipose tissue 









Tet1-/- Normal Small body size Small body size [326] 
Tet2-/- Normal Normal Spontaneous 
myeloid leukemia 
[334-337] 
Tet1-/- Tet2-/- Normal Normal, some 




and normal mice 
were also obtained 
[338] 
Tet3-/- Normal Normal Neonatal lethality [339] 




A high frequency 




and small body size 
[339] 




Nanog and Cdx2 
Global loss of 
5hmC and gain of 
5mC, dysregulation 
of lineage markers, 
poor ectoderm and 
endoderm 
development 
Perinatal lethality [329] 





Perinatal lethality [340] 
Table 1.4. Phenotypes of Tet knockout mice. 
Table adapted and expanded upon from Tan et al, 2012 [341]. 
 
 
1.5. Epigenetics and metabolism 
1.5.1. The ‘thrifty phenotype’ and ‘thrifty epigenotype’ hypotheses 
In addition to the ‘thrifty genotype hypothesis’ discussed previously in section 1.1.2, the ‘thrifty 
phenotype hypothesis’ [342] and the ‘thrifty epigenotype hypothesis’ [343] propose the importance of 
environmental influence (e.g. food shortage or availability) on the epigenome, gene expression and 
consequently phenotype. 
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The most well-known example of the thrifty phenotype/epigenotype is the ‘Dutch Hunger Winter’ 
study, in which a cohort of 300,000 men exposed during the first half of gestation to the Dutch famine 
in 1944-45 had significantly increased obesity rates at the age of 19 [344]. On the other hand, those 
exposed to famine during the last trimester or the first few months of life had significantly decreased 
rates of obesity. A later study identified increased DNA methylation levels in whole blood samples of 
those exposed to famine in early gestation, but not mid or late gestation [345], indicating that the 
inclination towards the ‘thrifty’ or obese phenotype is associated with changes in the epigenome. This 
has justified further investigation into the influence of the epigenome in adipose tissue and the 
development of obesity. 
 
1.5.2. The role of TCA cycle metabolites in control of epigenetic factors 
The TET enzymes are part of a group of α-ketoglutarate dependent dioxygenases [289]. It has also 
been shown that succinate and fumarate can inhibit the activity of enzymes in this group, including 
the TETs [346]. This provides a mechanism by which the rate of metabolite oxidation in the TCA 
cycle of adipose tissue can affect TET activity. This may subsequently influence levels of 5mC and 
5hmC in DNA in the tissues of interest. Other members of the α-ketoglutarate dependent 
dioxygenases include the Jumonji C (JmjC)-domain-containing demethylases (JMJD), a group of 
histone demethylases [289]. Therefore, there is reason to believe that changes in metabolite 
concentrations could also influence histone modifications. 
 
In support of this hypothesis, intracellular α-KG has been shown to maintain embryonic stem cell 
pluripotency by controlling H3K27me3 and DNA methylation [347]. Isocitrate dehydrogenases 1 and 
2 (IDH1 and IDH2), the enzymes that catalyse the formation of α-KG from isocitrate within the TCA 
cycle, are frequently mutated in several types of cancer [348-350]. The mutant IDH enzyme produces 
2-hydroxyglutarate from α-KG, which acts as an inhibitor of α-KG-dependent enzymes including the 
TETs and JMJDs. In addition, mutations in IDH2 have been shown to increase levels of H3K9me3 
and H3K27me3 in the 3T3-L1 adipocyte cell line, specifically in the promoter regions of Pparg and 
Cebpa [351] (see Figure 1.3). This was associated with a decrease in capacity for in vitro 
adipogenesis. 
 
Other TCA cycle metabolites that can influence epigenetic enzyme activity include NAD+, which is 
required for the activity of the NAD+-dependent histone deacetylases (sirtuins). Moreover, acetyl-
CoA, a key metabolite in the TCA cycle, can serve as a donor for histone acetylation. It has been 
shown that changes in acetyl-CoA availability can control histone acetylase activity, with resulting 
modulation of differentiation of 3T3-L1 pre-adipocytes and embryonic stem cells [352, 353]. The 
interaction between TCA cycle metabolites and epigenetic factors are summarised in Figure 1.3. 
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Figure 1.3. The role of metabolites in regulating epigenetic factors. 
a) Metabolites of the tricarboxylic acid cycle can modulate a variety of epigenetic factors. Acetyl-CoA and S-
adenosyl methionine (SAM) are donors for histone acetyltransferases (HATs) and histone and DNA 
methyltransferases (HMTs and DNMTs), respectively. NAD+ and ATP regulate sirtuin demethylases (SIRTs) 
and kinases, respectively. α-ketoglutarate (α-KG) is a cofactor of JMJD histone demethylases (JMJDs) and ten 
eleven translocase methylcytosine dioxygenases (TETs). b) The effects of altered metabolite availability on 
adipogenesis. Isocitrate dehydrogenase (IDH) catalyses isocitrate to produce α-KG in the tricarboxylic acid 
(TCA) cycle. However, mutations in the IDH gene lead to the production of 2-hydroxyglutarate (2HG) from α-
KG, which in turn inhibits enzymatic activities of the α-KG-dependent histone and DNA demethylases, such as 
JMJD and TETs, thus inhibiting adipogenesis. Figure adapted from Inagaki et al. 2016 [354]. 
 
 
1.5.3. Metabolic changes in obese adipose tissue 
A number of key metabolic changes are characteristic of adipose tissue in obesity. Hypertrophied 
adipocytes in obese adipose tissue display hyperlipolytic activity, generating excess free fatty acids 
and glycerol [355, 356]. In addition, the production and secretion of uric acid from adipose tissue is 
increased in obesity [357]. Cummins et al found that adipose tissue levels of succinate and malate in 
high fat-fed mice were increased compared to control-fed animals, and that metabolites that can enter 
the Krebs cycle via anaplerosis (e.g. glutamine) were mostly decreased in high-fat-fed mice, 
suggesting altered mitochondrial metabolism [358]. Another study using a genetically obese mouse 
model (Ob/Ob) [359] found that static levels of glutamate and many constitutive metabolites of the 
TCA cycle (such as α-ketoglutarate, succinate, fumarate, and malate) were all increased in WAT, but 
not in liver or skeletal muscle. Using in vivo metabolic turnover analyses, the same study suggested 
that these increases in glutamate and TCA cycle metabolites were due to the cataplerotic TCA cycle 
flux in obese adipose tissue. 
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1.5.4. Epigenetic changes in obesity 
Metabolite modulation in obese adipose tissue, as described above, could therefore influence 
epigenetic modifiers (summarised in Figure 1.3). Indeed, it has been suggested that epigenetic 
changes could account for a portion of the heritable component of obesity [15]. 
 
For example, a study examining global histone methylation in obesity [360] demonstrated a 40% 
decrease in levels of histone H3K4me2 (H3 lysine 4 dimethylation) in adipocytes of overweight 
compared with lean individuals, and increased levels lysine 4 trimethylation was shown in adipocytes 
of obese and diabetic individuals. 
 
A 2015 meta-analysis on studies published between 2008-2013 [361] found that of the 46 studies 
included, 15 studies investigated global DNA methylation in obesity, 13 investigated DNA 
methylation in specific candidate genes in obesity, 5 used genome-wide approaches, 8 investigated 
DNA methylation profiles in relation to weight loss interventions and 9 investigated relationships of 
DNA methylation at early life with either parental health measures or later life health outcomes. The 
majority of studies investigating global DNA methylation found no association between obesity 
measures and global DNA methylation [362-366], with a few exceptions: two studies on women 
found a negative correlation between global methylation and BMI [367, 368]. On the other hand, a 
further two studies including both male and female subjects reported a positive correlation between 
global methylation in peripheral blood leukocytes and BMI [369, 370]; and another study reported an 
increase in global DNA methylation in obese women compared to lean women [371]. This 
demonstrates the contradictory nature of the findings of the field: while some studies have discovered 
a correlation between global methylation and obesity, most found no correlation. In addition, both 
global CpG hypomethylation and global CpG hypermethylation have been associated. 
 
Several studies have employed a candidate gene approach focusing on a range of genes involved in 
obesity, appetite regulation, metabolism, insulin signalling, immunity, circadian clock regulation, 
growth and imprinted genes. Decreased methylation has been reported in tumour necrosis factor alpha 
(TNFα) in peripheral blood leukocytes [372] pyruvate dehydrogenase kinase 4 (PDK4) in muscle 
[373] and leptin (LEP) in whole blood [374]. Increased methylation has been observed in 
proopiomelanocortin (POMC) in whole blood [375], PPARγ coactivator 1 alpha (PGC1α) in muscle 
[373], and CLOCK and aryl hydrocarbon receptor nuclear translocator-like (BMAL1) genes in 
peripheral blood leukocytes in obese compared to lean subjects [376]. In addition, methylation at the 
IGF2/H19 imprinting region in blood cells has been consistently associated with measures of 
adiposity [377, 378]. 
 
  The role of TET1 in adipose tissue 
Chapter 1. Introduction  29 
Genome-wide approaches have revealed small but abundant alterations in methylation at specific 
sites. Obesity-associated differentially methylated regions have been found in the genome in both 
obesity candidate genes [379] and in genes with a wide range of other functions, including immune 
response [380], cell differentiation [379] and transcriptional regulation [381]. 
 
1.6. Epigenetics and adipose tissue biology 
1.6.1. TET1 in adipose tissue development 
DNA methylation can affect the binding of many DNA-binding proteins to their target sequences 
[282]. Therefore, it is possible that 5hmC may also be involved in regulating protein-DNA 
interactions. A number of studies suggest that the TET enzymes play a crucial role in the development 
or function of adipose tissue, through interaction with the transcription factor peroxisome proliferator-
activated receptor gamma (PPARγ). PPARγ is a nuclear receptor involved in adipocyte differentiation 
and activation of adipocyte-specific gene expression (such as ADIPOQ, FABP4, ADSF and GLUT4). 
PPARγ recruits TET enzymes in a process facilitated by the CCCTC-binding factor (CTCF) [382] and 
directs local demethylation around PPREs resulting in the transcription of adipocyte-specific genes 
[383]. Enrichment of 5hmC has been identified at over 20% of PPARγ binding sites, suggesting this 
modification is functionally important in gene regulation at these sites [384]. Moreover, double 
knockout (DKO) of Tet1 and Tet2 inhibited the adipogenic differentiation of mouse embryonic 
fibroblasts (MEFs) in vitro, with a marked reduction in the number of lipid droplets and reduced 
mRNA expression of the adipogenic marker genes Pparγ, C/ebpα, and Igf1 [385]. The reduced 
adipogenesis in DKO MEFs was associated with pronounced hypermethylation of promoter regions 
of genes involved in adipogenesis (Igf1 and Pparg) and adipocyte function (Foxc1 and Foxc2) [385]. 
 
A recent study [386] found that 5hmC enrichment inhibits the binding of C/EBPβ (CCAAT/enhancer-
binding protein beta) – a transcription factor expressed by committed pre-adipocytes – to target DNA 
sequences. C/EBPβ expression, together with C/EBPδ expression, initiates expression of C/EBPα and 
PPARγ, which in turn promote differentiation by activating adipose-specific gene expression [387]. 
PPARγ binds with C/EBPα to the promoter/enhancer of the gene encoding the adipocyte fatty acid 
binding protein aP2 (FABP4) [388, 389]. While 5hmC enrichment was found to inhibit C/EBPβ 
binding to DNA target sites, binding was increased by 5mC, 5fC and 5caC [386]. 
 
These data suggest that activation of adipogenic-specific genes requires TET-mediated maintenance 
of low methylation levels in the corresponding promoters. 
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1.6.2. Epigenetics in thermogenic activation of brown and beige adipose tissue 
Transcriptional control of BAT activation 
Thermogenic activation of BAT and beige adipose tissue at the molecular level relies heavily upon 
transcriptional regulation of the BAT and beige gene programmes, a set of key genes involved in 
crucial aspects of BAT function; including glucose and fatty acid uptake, UCP1 gene expression and 
uncoupled cellular respiration. Examples of these key genes include UCP1, β3-AR, CPT1b, GLUT-1, 
GLUT-4, and ZFP516. Also frequently included in the BAT and beige thermogenic gene programmes 
are the transcription factors involved in regulation of the above genes, such as PGC1α, C/EBPβ, 
PPARα, PRDM16 and EBF2. The functions and interactions of these transcription factors are 
summarised in Figure 1.4. 
 
As previously mentioned, PR-domain containing protein-16 (PRDM16) is a well-established key 
transcription factor in BAT and beige adipocytes. Expression of PRDM16, together with its co-
regulator EHMT1, and the transcription factor EBF2, distinguishes the brown and beige adipocytes 
from their mesenchymal precursors [138, 390, 391]. Ectopic expression of PRDM16, together with its 
binding partners CCAAT/enhancer-binding protein-β (C/EBPβ) and PPARγ, is sufficient to convert 
nonadipogenic cells – including skin fibroblasts and myoblasts in both human and mouse – into 
brown adipose lineage [138, 392, 393]. When activated, PRDM16 acts as a coregulator for 
transcription factors PPARγ, PPARα, c/EBPβ, and Pgc1α to induce transcription of brown fat-specific 
genes [138, 392-394]. EBF2 interacts with PPARγ to directly regulate PRDM16 expression [395]. 
Loss of Ebf2 in mouse brown preadipocytes reduced expression levels of genes associated with the 
BAT gene programme, while ectopic Ebf2 expression in myoblasts induced a brown-like gene 
expression profile [395]. 
 
  The role of TET1 in adipose tissue 
Chapter 1. Introduction  31 
 
Figure 1.4. Transcription factors and coregulators responsible for the activation of brown and beige adipose 
tissue-specific gene programme. 
Blue double-headed arrows indicate protein interaction and complex formation; black arrow-headed and bar-
headed lines show stimulatory and inhibitory effects, respectively. Figure adapted from Inagaki et al. 2016 
[354]. 
 
Epigenetic control of BAT activation 
The dependence of BAT and beige adipose tissue on transcriptional activation of the thermogenic 
gene programme suggests that transcriptional regulation – including epigenetic control of 
transcription – is a major regulator of BAT and beige adipocyte function. Recent studies have 




A 2014 paper demonstrated that PRDM16-dependent activation of the BAT gene program is 
dependent upon the binding of PRDM16 to MED1, a component of the mediator complex, which 
subsequently causes alterations in the chromatin architecture at key thermogenic genes. MED1 
recruits PRDM16 to superenhancers of key BAT-selective genes [396]. Knockout of Prdm16 in 
cultured brown adipocytes disrupted chromatin architecture at Pgc1 and Ppara, and “superenhancer” 
activity of thermogenic genes [396] (superenhancers are large clusters of transcription factor binding 
sites that drive the expression of cell identity genes [397]). In particular, PRDM16-MED1-mediated 
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changes in the chromatin landscape of thermogenic genes changes the proximity of the enhancer 
region to the gene promoter [396, 398]. 
 
A 2017 study showed that histone deacetylase 3 (HDAC3) is required to activate brown adipose tissue 
[399]. BAT-specific Hdac3 ablation in mice exposed to cold exposure were unable to regulate their 
body temperature and suffered severe hypothermia. Ucp1 expression in these mice was nearly absent, 
and expression of mitochondrial oxidative phosphorylation genes was significantly decreased. The 
study gave a suggestion for the molecular basis for the dependence of BAT activation on HDAC3: 
although HDAC3 normally acts as a transcriptional corepressor, it is able to function as a coactivator 
of oestrogen-related receptor α (ERRα) in BAT. ERRα activation is required for the transcription of 
Ucp1 and Ppargc1a, which is controlled by HDAC3-mediated deacetylation of the PGC-1α protein. 
 
Just a month later, an independent group published that HDAC3 in WAT contributes to maintenance 
of WAT identity and acts as a “molecular brake” to prevent browning [400]. Adipose-specific 
knockout of Hdac3 in mice induced de novo fatty acid synthesis and β-oxidation. This subsequently 
increased WAT oxidative capacity and browning. This was accompanied by increased histone 
acetylation – a mark of transcriptional activation – in the enhancer regions of Pparg and Ucp1 and the 
putative regulatory regions of Ppara. In addition, HDAC1 was shown to inhibit thermogenesis 
through deacetylation of histone 3 lysine 27 (H3K27) on the regulatory regions of Ucp1. This was 
associated with a reduction in Atf2-mediated transcription of Ucp1 [401]. 
 
In addition, an epigenome profiling study in 2016 tracking the differentiation of a mesenchymal stem 
cell line into brown adipocytes found that the presence of two histone markers were indicators for 
brown preadipocytes: H3K4me1 and H3K27me3 [402]. However, the removal of H3K27me3 was 
required for cells to progress through the late stage of brown adipogenesis. H3K4me1, on the other 
hand, was found to remain present in the late stage of brown adipogenesis, indicating its involvement 
in poising the thermogenic genes for transcriptional activation [402]. 
 
Further enzymes that have been shown to be involved in transcriptional activation of thermogenic 
genes include the Jumonji C (JmjC)-domain-containing demethylases (JMJD). In particular, JMJD1A 
has been implicated [403]. The phosphorylated form of the protein forms a complex with the 
SWItch/Sucrose Non-Fermentable (SWI/SNF) chromatin remodeller, which together is recruited to 
the PPAR response elements of key thermogenic genes, including Ucp1 and Adrb1 (β3-
adrenoreceptor), where it demethylates H3K9me2. Histone demethylation at this site reduces the 
distance between transcription factor-bound enhancers and the thermogenic gene promoters [403]. 
The study found that these changes occurred within minutes, peaking just 60 minutes after the initial 
protein phosphorylation occurred [403]. The stability of histone markers provides a mechanism by 
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which such epigenetic changes may provide a form of “epigenetic memory”, which can activate 
thermogenic gene expression faster in response to future exposure to the cold [403]. 
 
Furthermore, Lysine-specific histone methylase 1 (LSD1) is required for transcriptional activation of 
the thermogenic gene programme [404]. Mice with a BAT-specific inactive Lsd1 mutation – but not a 
knockout of Lsd1 – had BAT that was histologically more similar to WAT (with an increase in 
adipocyte size and number of unilocular lipid droplets), an increase in expression of WAT-selective 
genes (such as Bmp4, Egfr, Pdk3 and Apoe) and a decrease in expression of BAT-selective genes 
(such as Ucp1, Slc27a2, Cox8b and Prdm16). The fact that the enzymatic capacity of the protein was 
inactivated demonstrates that the specific histone demethylase activity of LSD1 is required for BAT 
gene expression. 
 
Recently, Shapira et al. [405] demonstrated that the EBF2-mediated transcriptional activation in BAT 
is in part controlled by the histone reader Double PHD Fingers 3 (DPF3). EBF2 was shown to 
physically interact with the chromatin remodeller BRG1 and the BAF chromatin remodelling complex 
in brown adipocytes to regulate BAT identity and function [405]. A key regulatory component of the 
BAF complex is DPF3, a histone reader protein capable of binding methylated and acetylated lysine 
residues on histones 3 and 4. In vitro knockdown of Dpf3 by 80% revealed that Dpf3 expression was 
specifically required for both basal brown fat gene expression and function, and for β-adrenergic-
stimulated upregulation of the thermogenic gene programme [405]. This suggested that the histone-
modifying properties of Dpf3 are involved in transcriptional activation of the thermogenic gene 
programme. 
 
DNA methylation and hydroxymethylation 
Despite the known importance of transcriptional regulation in BAT activation, as of yet there is no 
published data on the methylation states of CpGs in key BAT genes and their influence on gene 
expression. The dependence of the TET enzymes on the availability of key TCA cycle metabolites 
[346] provides further justification for investigating the role of DNA methylation states in BAT and 
beige activation. 
 
Metabolite changes in BAT activation 
As discussed previously, the activity of many epigenetic modulators is dependent upon the presence 
of various metabolites. Given the known role of JMJD activity in BAT thermogenic gene expression 
[403], it is plausible that α-KG availability is central to modulating the activity of these enzymes in 
activation of BAT gene expression. It is therefore not too large a leap to hypothesise that the TET 
enzymes may be similarly modulated in response to α-KG changes in BAT activation. 
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Data from our collaborators demonstrate that in humans exposed to mild cold exposure (18°C), there 
is a decrease in glutamate concentrations in the interstitial fluid within the supraclavicular brown 
adipose tissue [82]. This indicates an increased uptake of glutamate into the BAT, suggesting an 
increased rate of glutamate oxidation and uptake into the TCA cycle. 
 
Glutamate is a precursor to α-KG, and is converted to α-KG by the enzyme glutamate dehydrogenase 
(GDH). Therefore, increased utilisation of glutamate in activated BAT may modulate α-KG levels, 
and could subsequently influence the activity of the α-ketoglutarate dependent dioxygenases. This is 
further evidence that BAT activation could influence TET activity and consequently alter CpG 
methylation states, which may be a key factor in the transcriptional activation of the thermogenic gene 
programme. 
 
1.7. Preliminary studies 
Recent studies in our lab, using a colony of Tet1 KO mice [328], show that male Tet1 KO mice have 
an obesity-resistant phenotype when maintained on a high fat diet (HFD), with reduced weight gain 
and the maintenance of insulin sensitivity (Lyall et al, unpublished). These studies were aimed at 
establishing genome-wide differences in hepatic gene expression and 5hmC profiles in Tet1 KO 
compared to littermate wildtype (WT) animals. However, the metabolic phenotype of the Tet1 KO 
mouse has not been further characterised, and the mechanisms accounting for the differences in 
weight gain are still unclear. My project aims to use the Tet1 KO mouse as a model in which to 
understand the effects of epigenetic dysregulation on obesity and metabolism, and investigate the 
mechanisms behind the differences in weight gain, focusing specifically on the adipose tissue 
phenotype. 
 
1.8. Hypotheses & aims 
1.8.1. Hypotheses: 
1. Tet1 KO causes alterations in the adipose tissue hydroxymethylome and transcriptome, which 
lead to decreased adiposity. 
o Global deletion of Tet1 results in decreased 5hmC in adipose tissue DNA and 
subsequent transcriptional effects. 
o Global deletion of Tet1 results in reduced capacity for adipogenesis due to 
transcriptional effects mediated by the PPAR family of transcription factors. 
2. Reduced food intake in the Tet1 KO mouse is sufficient to account for the reduced weight 
gain. 
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o Tet1 KO mice have reduced transcription of Lep mRNA across all adipose tissue 
depots, and a corresponding reduction in plasma leptin. 
o KO mice have significantly reduced food intake over the 11-week HFD. 
o Decreased Lep transcription and serum leptin protein levels in KO mice allow KOs to 
retain leptin sensitivity, while WT mice become leptin resistant on HFD. 
o Decreased Lep transcription is the result of Tet1-mediated changes in 5mC and/or 
5hmC levels.  
3. The reduced adiposity of Tet1 KO mice on HFD also manifests in reduced MAT. 
o The amount of MAT in the bone marrow cavity of Tet1 KO mice is reduced when 
compared to their wildtype littermates. 
o The change in MAT is associated with changes in bone mineral density and bone 
structure. 
4. Cold exposure induces changes in hydroxymethylation levels as a result of altered levels of 
metabolites. 
o Increased glutamate uptake into the brown adipose tissue, as previously observed in 
humans [82], also occurs in mouse brown and beige adipose tissue when animals are 
exposed to a temperature of 4°C, but not in white (non-browning) adipose tissue. 
o This causes an increase in the levels of α-ketoglutarate in mouse brown and beige 
adipose tissue, but not in white (non-browning) adipose tissue. 
o Changes observed in glutamate and α-ketoglutarate levels in mouse brown and beige 
adipose tissue modulate TET activity. 
o Changes in TET activity as a result of cold-induced brown and beige adipose tissue 
activation cause global changes in CpG hydroxymethylation, particularly in genes 
key to thermogenic activation. 
o Changes in the hydroxymethylome are associated with modulation of gene expression 
in brown and beige adipose tissue. 
 
1.8.2. Aims: 
1. To further characterise the metabolic phenotype of Tet1 KO mice in vivo. 
o Investigate the energy expenditure, respiratory exchange ratio and activity levels of 
the Tet1 KO mouse. 
o Characterise the adipose tissue hydroxymethylome and transcriptome of Tet1 KO 
mice. 
o Characterise the effect of Tet1 depletion on adipocyte differentiation and function in 
vitro. 
2. To investigate physiological control of food intake in the Tet1 KO mouse 
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o Investigate Lep mRNA levels across a range of WT and KO mouse adipose tissue 
depots. 
o Investigate serum leptin protein levels in the WT and KO mice. 
o Investigate the food intake phenotype of the Tet1 KO and WT mice through weekly 
food intake tracking. 
o If a difference in food intake is observed over the 11-week HFD, carry out paired 
feeding studies to determine whether the difference in food intake is accountable for 
the difference in weight gain. 
o Investigate the leptin sensitivity of the WT and KO mice. 
o Investigate the role of CpG methylation and hydroxymethylation in Lep transcription 
by interrogating existing hMeDIP-seq data from WT and KO mouse mesenteric 
adipose tissue, and through bisulfite conversion pyrosequencing to obtain methylation 
data at a higher resolution (base-pair resolution). 
o Investigate whether knocking down Tet1 in vitro drives the same changes observed in 
the Tet1 KO in vivo.  
3. To investigate any changes in the levels of MAT in high fat-fed Tet1 KO mice. 
o Quantify the volume of bone marrow cavity occupied by MAT in high fat-fed Tet1 
KO mice. 
o Investigate the bone structure and bone mineral density phenotype of Tet1 KO mice 
challenged with a HFD. 
4. To interrogate the role of Tet1 in the activation of cold-induced thermogenesis in brown, 
white and beige adipose tissue 
o Confirm, using indirect calorimetry, that cold-induced BAT and beige upregulation 
occurs in the animals exposed to a temperature of 4°C. 
o Investigate changes in glutamate levels, α-ketoglutarate levels and TET activity in the 
brown, beige and white adipose tissue of mice exposed to cold (4°C), room 
temperature (21°C) and thermoneutrality (30°C) for 48 hours. 
o Investigate changes in DNA hydroxymethylation and associated alterations in gene 
expression in the brown, beige and white adipose tissue of mice exposed to cold 
(4°C), room temperature (21°C) and thermoneutrality (30°C) for 48 hours. 
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2. Methods 
2.1. Buffers and solutions 
Alkaline Lysis Reagent: 25mM NaOH, 0.2mM disodium EDTA, pH 12.0 was prepared by 
dissolving the salts in water prior to adjusting the pH. 
 
Tris-HCl 40mM pH8.0: Prepared by dissolving Tris-HCl in water, prior to adjusting the pH to 8.0. 
 
TBE buffer (10X): 1M Tris base, 1M boric acid and 0.02M EDTA was prepared in distilled water. 
100mL was diluted in 1L distilled water to make 1X solution. 
 
Krebs phosphate buffer: 118mM NaCl, 5mM KCl, and 1.2mM MgSO4 was prepared in 800mL 
distilled water. 120mls of 100mM Na2HPO4 was added, and pH 7.4 was achieved by dropwise 
addition of 100mM NaH2PO4. Volume was adjusted to 1L with distilled water. 
 
Full Krebs buffer: Full Krebs buffer was prepared on the day of use by adding the following to 
Krebs phosphate buffer: CaCl2 to a final concentration of 1.265mM, glucose to a final concentration 
1mg/ml, and bovine serum albumin to a final concentration of 1%. 
 
Sorenson’s buffer: 0.133M Na2HPO4 and 0.133M KH2PO4 was prepared in 1L distilled water. 
 
TE (Tris-EDTA) buffer: 10mM Tris-Cl and 1mM EDTA was prepared in 1L distilled water, with a 
pH of 7.4. 
 
DNA immunoprecipitation buffer:  100mM Na-Phosphate pH 7.0 (mono and dibasic), 1.4 M NaCl, 
and 0.5 % Triton X-100 were prepared in 10mL in distilled water and 0.22µm sterile filtered. 
 
Proteinase K digestion buffer:  50mM Tris-HCl pH 8.0, 10mM EDTA, 0.5% SDS were prepared in 
10mL prior to each procedure in distilled H20 and 0.22µm sterile filtered. 
 
 
2.2. Animal maintenance and in vivo experiments 
2.2.1. Tet1 global knock out mouse breeding 
B6;129S4-Tet1tm1.1Jae/J heterozygote mice (4 pairs) were purchased from Jackson Laboratories,   
Maine, US.  Heterozygote mice were interbred to generate homozygous knockout and wildtype 
progeny. The breeding population was maintained as heterozygous Tet1+/-. 
 
2.2.2. Genotyping of Tet1 knockout offspring 
Mouse genotype was determined by PCR for exon 4, the absent region in the knockout allele. Mouse 
DNA was prepared using a “HotSHOT” genomic DNA preparation method (first published by Truett 
et al. [406]). Ear clip biopsies were heated to 95⁰C in 75µL Alkaline Lysis Reagent for 30 minutes. 
When cooled to 4°C, 75µL Tris-HCl 40mM pH 8.0 was added. 
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2µL of this prepared DNA was added to 6µL Maxima Hot Start Green PCR Master Mix (Thermo 
Fisher Scientific, London UK); 0.06µL wildtype forward primer (100µM); 0.06µL mutant forward 
primer (100µM); 0.06µL common reverse primer (100µM); 3.82µL nuclease-free H2O. Primer 
sequences are shown in Table 2.1. Primer sequences for Tet1 genotyping PCR Thermal cycler steps 
are shown in Table 2.2. Products were run on a 3% agarose gel at 70V for 1.5 hours in TBE buffer.  
Mutant bands were determined to be 681bp and wildtype bands 300bp. 
 
Primer name Primer sequence (5'→3') 
Wildtype forward TCA GGG AGC TCA TGG AGA CTA 
Mutant forward AAC TGA TTC CCT TCG TGC AG 
Common reverse TTA AAG CAT GGG TGG GAG TC 
Table 2.1. Primer sequences for Tet1 genotyping PCR. 
 
Step no. Duration of cycle 
(hh:mm:ss) 
Temperature (⁰C)  
1 00:02:00 94  
2 00:00:20 94  
3 00:00:15 65  
4 00:00:10 68  
5 - - Repeat steps 2-4 for 10 cycles 
6 00:00:15 94  
7 00:00:15 60  
8 00:00:10 72  
9 - - Repeat steps 6-8 for 28 cycles 
10 00:02:00 72  
11 ∞ 10  
Table 2.2. Thermal cycler conditions for Tet1 genotyping PCR protocol. 
 
2.2.3. Animal husbandry and diets 
All experiments were carried out under UK home office licence. All animal experiments were 
reviewed by the University of Edinburgh Animal Welfare and Ethics Review Board prior to their 
initiation. C57BL/6J mice (Charles River, Tranent, UK) or B6;129S4-Tet1tm1.1Jae/J mice (Jackson 
Laboratories, Maine, USA) were maintained under conditions of controlled lighting (lights on 7:00 
am to 7:00 pm) and temperature (22°C ± 2⁰C). Between 12-23 weeks of age, male Tet1-/- (KO) mice 
and littermate Tet1+/+ (WT) controls were given free access to high fat diet (HFD) chow (58% fat by 
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caloric basis) (formula D12331; Research Diets Inc., USA) for 11 weeks to induce obesity, or control 
diet (formula D12328; Research Diets Inc., USA). Diet was obtained from Research Diets, New 
Brunswick, NJ, USA. Composition of the diet is shown in Table 2.3. Mouse body weight and food 
intake was measured weekly. 
 

















Sucrose  (g/kg) 175 0 
Maltodextrin 10 (g/kg) 170 170 
Coconut oil, Hydrogenated (g/kg) 333.5 40 
Soyabean oil (g/kg) 25 25 
Table 2.3. Composition of rodent diets. 
 
 
2.2.4. Paired feeding protocol 
The paired feeding study was carried out for 11 weeks to assess the impact of food intake on weight 
gain in WT and Tet1 KO mice. KO mice were given ad lib access to HFD and food intake was 
measured daily (weighed to the nearest 10mg). Cages were also checked daily to ensure there was no 
shredded diet on the floor of the cage or under bedding. Littermate WT food allowance was then 
paired to the mean KO food intake for the previous day. Body weights of WT and KO mice were 
measured weekly. 
 
At the start of the study, food intake was not normalised to body weight: WT mice were given exactly 
the same amount of food as KO. However, by week 3 of the paired feeding study it became apparent 
that the WT mice were not gaining weight, and were in fact losing weight. After a re-analysis of 
starting body weight it became apparent that, in this particular cohort of WT and KO mice, the KO 
mice had a significantly lower starting body weight than the KO mice, and pairing WT food intake 
exactly to KO food intake resulted in weight loss. Therefore, from week 3 onwards, I began 
normalising food intake to total body weight for each individual animal. 
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2.2.5. Indirect calorimetry 
Indirect calorimetry was carried out to analyse the source of respiration substrate. This can be 
determined using oxygen input and carbon dioxide output of the animals. Animals were kept in 
Metabolic PhenoCages under the TSE PhenoMaster system (TSE Systems, Germany). In the 
PhenoCages, animals were given bedding, access to food and water hoppers that were attached to 
weight sensors, and a dark tube also attached to weight sensors allowing intermittent measurement of 
body weight. The cages are also equipped with the ActiMot2 system (TSE systems), allowing 
measurement of locomotor activity using infrared light beams. The cages are fully sealed, allowing 
quantification of oxygen and carbon dioxide flow. Measurements for all parameters were taken at 15-
minute intervals throughout the experiment. 
 
Before entering the Metabolic PhenoCages, animals were trained on the TSE drinking water bottles 
for 7 days to adjust to the different nozzle. Also before the 24-hour measurement period, a 48-hour 
acclimatisation period was allowed so that animals were adjusted to the new environment. 
 
Respiratory exchange ratio (RER) was calculated within the TSE PhenoMaster software. RER can be 
used as a measure of respiratory substrate. E.g. an RER of 0.7 indicates a greater proportion of fatty 
acid oxidation, while an RER of closer to 1.0 indicates mostly carbohydrate metabolism. For a more 
detailed explanation, see the calculation below: 
Oxidation of one carbohydrate molecule: 
6 O2 + C6H12O6 => 6 CO2 + 6 H2O + 38 ATP 
 
Therefore: RER = VCO2/VO2 = 6 CO2/6 O2 = 1.0 
 
Oxidation of one fatty acid molecule: 
23 O2 + C16H32O2 => 16 CO2 + 16 H2O + 129 ATP 
 
Therefore: RER = VCO2/VO2 = 16 CO2/23 O2 = 0.7 
 
Energy expenditure (EE) is also be calculated within the TSE PhenoMaster software, using VCO2 and 
VO2, using an adapted Weir formula [407]. This value is then normalized to lean mass. 
 
EE= [3.941*(VO2) + 1.1068 (VCO2)] *1.44 
 
High fat diet indirect calorimetry 
All parameters were measured for two 24-hour periods at room temperature: once before starting the 
high fat diet, and once after 7 weeks of high fat diet. 
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Cold exposure indirect calorimetry 
Light was set to 80% between the hours of 7am and 7pm; humidity was set to a constant of 40%; and 
temperature was also set to a constant (either 4°C, 21°C or 30°C). Measurements were taken for a 
single 24-hour period during which time the desired temperature was stable. 
 
2.2.6. Venesection 
1mm of tail was snipped off at the distal end with fine scissors. Animals were allowed to move freely 
on the top of the cage and blood encouraged from the wound.  Blood was either collected into an 
EDTA tube (Microvette® CB 300 K2E; Sarstedt, Numbrecht, Germany) by capillary action, or 
applied directly to glucometer strip (Accu-check, Roche, Burgess Hill UK).  Tubes were spun at 
10,062 x g for 10 minutes at 4⁰C. The supernatant was removed and stored at -80. 
 
2.2.7. Glucose tolerance testing 
After 10 weeks maintained on high fat diet, glucose tolerance tests were performed on mice. Mice 
were fasted for 6 hours prior to insulin tolerance test. Mice were given an intraperitoneal injection of 
D-(+)-Glucose (Sigma-Aldrich G8270, Dorset, UK) at a concentration of 2g/kg body weight, diluted 
in 0.9% saline solution.  Blood glucose measurements were made at baseline, 15, 30, 60 and 90 
minute time points. 
 
2.2.8. Leptin treatment 
Leptin treatment was carried out before and after 6 week ad lib HFD. Before ad lib HFD, WT and KO 
animals were treated intravenously (tail vein) with 0.9% physiological saline (Thermo Fisher, 
Hampshire, UK) or 3mg/kg leptin (Sigma-Aldrich, Dorset, UK). Animals were held in mouse 
restrainers during treatment to ensure safe delivery of the injection. Both treatments were given to 
each animal, i.e. each animal served as its own saline control in order to provide paired analysis, with 
4 days recovery between treatments (with saline treatment being carried out prior to leptin treatment). 
Injections were carried out at 9am and food intake was then measured every hour for 12 hours 
following treatment (9am to 9pm). This process was repeated after animals were given ad lib access 
to HFD for 6 weeks. 
 
2.2.9. Carbon dioxide asphyxiation 
Mice were killed to obtain tissue by exposure to carbon dioxide gas in a rising concentration in a 
sealed box, followed by confirmation by cervical dislocation. 
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2.2.10. Tissue harvesting 
All mice were fasted overnight prior to culling and culled between 0800 and 1030 hours, to achieve 
consistency. Tissue was dissected immediately after culling, in order to preserve RNA integrity. 
Blood was collected by cardiac puncture. Liver, adipose depots (mesenteric, retroperitoneal, 
subcutaneous, epididymal and brown adipose) and bones (lumbar vertebrae, caudal vertebrae, femur 
and tibia) were dissected. All tissue was weighed, snap frozen on dry ice and stored at -80°C.  
Sections of epididymal adipose tissue and brown adipose tissue were fixed in 10% neutral-buffered 
formalin solution for 48 hours, and bones were also fixed in 10% neutral-buffered formalin solution 
for 24 hours. In the case of adipose tissue being taken for tissue culture, adipose depots were dissected 
and placed immediately into full Krebs phosphate buffer at 37⁰C. 
 
2.3. Bone phenotyping and bone marrow adipose tissue 
quantification 
2.3.1. X-ray 
After bones were fixed in 10% neutral-buffered formalin solution for 24 hours, they were X-rayed 
using a Faxitron (Biooptics, Arizona, USA). The exposure was set to 15 seconds at 22kV. X-ray 




Bones were washed 3 times for 10 minutes in distilled water on a shaker at room temperature, to 
remove traces of formalin. They then underwent decalcification in 14% EDTA solution on a shaker at 
4⁰C for 2 weeks. The EDTA solution was replaced every 3-4 days. After 2 weeks of decalcification, 
the EDTA solution was aspirated and replaced with PBS (Gibco, UK). At this stage, vertebrae were 
embedded in paraffin for histology, while the tibiae were stained using osmium tetroxide (Agar 
Scientific, UK). 
 
2.3.3. Osmium tetroxide staining of bone marrow adipose tissue 
Femurs and tibiae were immersed in a 1% osmium tetroxide (Agar Scientific, UK) solution for 24 
hours. Osmium tetroxide reacts with alkene bonds within unsaturated fatty acids, resulting in covalent 
incorporation of the osmium atom and allowing visualisation of adipose tissue within the bone 
marrow. After 24 hours staining, bones were washed three times in Sorenson’s buffer (two hours per 
wash). 
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2.3.4. X-ray microtomography 
Osmium-stained tibiae were embedded in 1% agarose in 7mL Bijou tubes of 22.5mm diameter. The 
Bijou tubes were placed in the SkyScanner 1172 µCT system (Bruker, MA, USA) and scanned using 
the following settings: source voltage 54kV, source current 185µA, exposure time 885ms. 
 
2.3.5. X-ray microtomography analysis 
Trabecular and cortical bone volume, bone surface area, and bone surface to volume ratio were 
quantified using CTan analysis software, ver. 1.13 (Bruker, MA, USA). Cortical bone was analysed in 
650 x 100µm sections, starting from the growth plate down. Trabecular bone was analysed in 225 x 
100µm sections, starting from the growth plate down. Marrow adipose tissue volume (post 
decalcification and osmium staining) was quantified using the same software. MAT quantification 
was divided into three regions of the marrow cavity: 100 x 100µm sections from the growth plate 
(proximal); from there to the tibia-fibula junction (medial); and from the tibia-fibula junction to the 
end of the marrow cavity (distal). 
 
2.4. Adipose tissue fractionation and culture 
2.4.1. Plastic Culture Materials 
The stromal vascular fraction (SVF) of adipose tissue was cultured and differentiated on collagen-
coated plates (Corning, Chester, UK) in a 12-well format. 
 
2.4.2. SVF culture media 
All chemicals were purchased from Sigma-Aldrich, Dorset, UK, unless otherwise stated. 
Initial SVF isolation was carried out in Full Krebs solution, consisting of 118mM NaCl; 5mM KCl; 
1.2mM MgSO4; adjusted to pH 7.4 with phosphate buffers using anhydrous solids Na2HPO4 and 
NaH2PO4; and made up to Full Krebs Buffer on the day of use with 1.265mM CaCl2; 1mg/mL 
Glucose; and 1% w/v Bovine Serum Albumin. 
 
Once isolated, the SVF was cultured in SVF Maintenance Media, consisting of DMEM/F-12 Hams 
(4.5g/L Glucose) (Thermo Fisher Scientific, Paisley, UK); 10% newborn calf serum (Thermo Fisher 
Scientific, Paisley, UK); 2mM Glutamine (Thermo Fisher Scientific, Paisley, UK); 100 units/mL 
Penicillin (Thermo Fisher Scientific, Paisley, UK); 100µg/mL Streptomycin (Thermo Fisher 
Scientific, Paisley, UK). 
 
On initiation of adipocyte differentiation, culture media was changed to Differentiation Media, 
consisting of normal SVF Maintenance Media with 1nM triiodothyronine (VWR International Ltd, 
Birmingham, UK). 
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In all procedures, all media and solutions used in cell culture were pre-incubated at 37⁰C. 
 
2.4.3. Adipose tissue fractionation 
Epididymal adipose tissue and brown adipose tissue was dissected and immediately collected in 8mL 
Full Krebs Buffer. The collected adipose tissue was washed twice in Dulbecco’s Phosphate Buffered 
Saline (Thermo Fisher Scientific, Paisley, UK), then transferred to Full Kreb’s Buffer with 2mg/mL 
collagenase (Worthington Biochemical Coorporation, New Jersey, USA). The tissue was finely cut 
into small pieces 1-3mm diameter, and incubated in a shaking water bath for 15 minutes at 37⁰C. The 
digest was stopped by removing it from the incubator to room temperature and adding 10mL Full 
Krebs Buffer. 
 
The digest was centrifuged at 1,500 x g for 15 minutes at room temperature and the pellet was 
resuspended in 5mL Krebs Buffer, before being strained through a plastic mesh (100μm aperture) to 
remove remaining adipocytes or undigested tissue. Cells were centrifuged again at 1,200 x g for 5 
minutes at room temperature. The supernatant was removed and the pellet resuspended in 3mL 
Maintenance Media. The cells were counted using a haemocytometer, before being plated into a 6-
well plate at a density of ~500+ cells/mm2. 
 
2.4.4. SVF culture 
The SVF isolate was maintained in an incubator at 37°C / 5% CO2 / 95% relative humidity until they 
reached 100% confluence. Maintenance Media was replaced every 2-3 days. 
 
2.4.5. Adipocyte differentiation 
Two days after 100% confluence was reached, the Maintenance Media was substituted for 
Differentiation Media, and the following factors were supplemented to the media to induce adipocyte 
differentiation: 1µM Rosiglitazone (Tocris Bioscience, Bristol, UK); 250µM IBMX (Cambridge 
Bioscience, Cambridge, UK); 33µM Biotin (Sigma-Aldrich, UK); 17µM Pantothenic acid (Sigma-
Aldrich, Dorset, UK); 200pM T3; 10μg/ml Apo-Transferrin (Sigma-Aldrich, Dorset, UK); 5μg/ml 
Insulin (Novo Nordisk, West Sussex, UK); 100nM Dexamethasone (Sigma-Aldrich, Dorset, UK). 
After 2 days, Rosiglitazone and IBMX supplementation was ceased. Two weeks were allowed for 
cells to develop into mature adipocytes. 
 
2.4.6. Oil Red O stain 
After two weeks of culture in Differentiation Media, the media was removed from one well per 
animal, and replaced with 2mL 10% formalin. Cells were incubated in formalin at room temperature 
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for 5 minutes. Formalin was gently removed using a P1000 pipette, and replaced with another 2mL 
10% formalin. Cells were incubated in formalin at room temperature for another 1 hour. After 1 hour, 
formalin was removed and washed out with isopropanol. The isopropanol was removed and cells were 
allowed to air-dry. Cells were then incubated with 1mL 3.5% Oil Red O solution (Sigma-Aldrich, 
Dorset, UK) for 10 minutes, before the solution was aspirated. Oil Red O binds to lipids within the 
adipocytes, allowing visualisation and quantification of lipid. A blank well was also stained for a 
background reading. Wells were then washed three times with dH2O, and imaged using the Axiovert 
200 (Zeiss, Birmingham, UK). 1mL isopropanol was then added to each well to elute the Oil Red O. 
200μL of the eluted Oil Red O stain was plated into one well of a microplate, and light emission was 
read at 500nm using a spectrophotometric OptiMax Tunable Microplate Reader (Molecular Devices, 
CA, USA). 
 
In parallel to Oil Red O staining, RNA was extracted from cells. Cells were washed and agitated in 
1mL of Qiazol (Qiagen, Manchester, UK), and RNA was subsequently extracted according to the 
protocol of RNeasy mini lipid kit (Qiagen, Manchester, UK), followed by reverse transcription-PCR 
(see below for further details). The resulting cDNA was used in qPCR for positive and negative 
markers of adipocyte differentiation and candidate genes of interest. 
 
2.4.7. siRNA transfection 
In vitro Tet1 knockdown was carried out in primary preadipocytes isolated from inguinal adipose 
tissue of wildtype C57BL/6J mice, cultured on collagen I-coated plates (Corning, Deeside, UK) for up 
to 3 passages, following a previously published protocol [408]. In the evening before the transfection, 
confluent preadipocytes in 12-well collagen I-coated plates were trypsinzed and seeded 1:1. The 
following afternoon (allowing enough time for the preadipocytes to adhere to the bottom of the well), 
cells were transfected with siRNA using HiPerFect reagent (Qiagen, Manchester, UK). For one well 
of a 12-well plate, 40nM siRNA was mixed with 6 µl HiPerFect reagent in a total of 200μl serum free 
α-MEM (without antibiotics) and incubated for 15 min at room temperature. During the incubation, 
200μl growth media (α-MEM with 10% FBS without antibiotics) was added to each well. The plate 
was swirled intermittently during the incubation to prevent cells from drying out. The pre-incubated 
siRNA-HiPerFect mix was added dropwise to the wells, resulting in total 400μl of α-MEM with 5% 
FBS. After gently rocking the plate, it was transferred to cell culture incubator. After overnight 
transfection, cells were re-fed with regular growth media and differentiation was initiated. Cells were 
differentiated using the protocol above (section 2.4.5) for 5 days, after which RNA was extracted.  
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2.5. Molecular biology 
2.5.1. RNA extraction 
Adipose RNA was extracted from tissue and purified using the RNeasy Lipid Tissue Mini Kit 
(Qiagen, Manchester, UK) with Qiazol (Qiagen, Manchester, UK), according to the manufacturer’s 
instructions in the ‘RNeasy Lipid Tissue Handbook’. Tissue was cut into small pieces 17-25mg and 
placed in a 2mL microcentrifuge. Tubes were placed at room temperature, and 1mL QIAzol Lysis 
Reagent was added. Tissue was homogenised using the TissueRuptor (Qiagen, Manchester, UK). 
Samples were then incubated at room temperature for 5 minutes, before 200μL chloroform (Sigma 
Aldrich, Dorset, UK) was added to each sample, and samples were incubated for 2-3 minutes at room 
temperature. Samples were then centrifuged at 10,000 x g for 15 minutes at 4⁰C. The upper, aqueous 
phase was transferred to a new tube, and an equal volume of 70% ethanol (Fisher Scientific, 
Loughborough, UK) added. Samples were vortexed and transferred to an RNeasy Mini spin column, 
which was then centrifuged at 7000 x g for 15 seconds. 700μL Buffer RW1 was added, and then tubes 
were centrifuged at 7000 x g for 15 seconds. Samples were washed twice with Buffer RPE, before 
RNA was eluted in 40μL RNase-free water. Once extracted, RNA was handled on ice and stored at -
80⁰C. 
 
2.5.2. RNA quantification and integrity 
RNA was quantified with the Qubit 2.0 Fluorometer (Invitrogen, Paisley, UK) using DNA “broad 
range” standards as per manufacturer’s instructions for DNA samples.  DNA integrity was determined 
by resolving extraction products on a 1.5% agarose gel and staining with gel red (Cambridge 
Bioscience, Cambridge, UK) 0.005% final concentration. 
 
2.5.3. Reverse transcription (RT) 
RT was carried out using the High-Capacity cDNA Reverse Transcription Kit (Thermo Fisher, UK) 
according to kit protocol. 800ng RNA was used per reaction. Reaction components are shown in 
Table 2.4. Tubes were sealed and briefly centrifuged, and then placed in the thermal cycler under the 
conditions shown in Table 2.5.  
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Component Volume (µL) 
10✕ RT Buffer 2.0 
25✕ dNTP Mix (100 mM) 0.8 
10✕ RT Random Primers 2.0 
MultiScribe™ Reverse Transcriptase 1.0 
Nuclease-free H20 4.2 









Table 2.5. Thermal cycler conditions for RT-PCR. 
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2.5.4. Reverse transcriction-quantitative polymerase chain reaction (RT-qPCR) 
2µl of the reverse-transcribed cDNA was used in the reaction mixture shown in Table 2.6. A list of all 
primer sequences used for RT-qPCR analysis of gene expression is shown in Table 2.7. A water and 
non-reverse transcriptase control were used routinely. All assays were carried out in triplicate. Once 
the mixture had been pipetted into a 384-well PCR plate (Thermo Fisher, West Sussex, UK), the plate 
was centrifuged for 2 minutes at 563 x g to ensure all liquid was mixed at the bottom of the well. The 
plate was inserted into the LightCycler® 480 Instrument (Roche, West Sussex, UK), and run on the 
program shown in Table 2.8. 
 
The LC480 Software (Roche, West Sussex, UK) measured fluorescence throughout the experiment 
and plotted fluorescence against PCR cycle number. The crossing point (Cp) was calculated as the 
maximum point of the second derivative of the amplification curve. Triplicates were considered 
acceptable if the standard deviation of the Cp was less than 0.3 cycles. Negative controls were 
considered acceptable if the Cp of any signal was greater than 10 cycles higher than that of the lowest 
standard. Each assay was considered acceptable if the reaction efficiency was between 1.8 and 2.1.  
Relative levels of mRNA of unknown samples were interpolated from the standard curve and 
expressed relative to the abundance of a reference gene. Student’s t-tests were carried out to ensure 
transcript quantities of reference genes were not significantly different between groups. 
 
Reagent Volume (μl) 
PerfeCTa® FastMix® II (Quanta Biosciences, Inc., USA) 6.00 
Forward Primer (100μM) 0.02 
Reverse Primer (100μM) 0.02 
Water 3.96 
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Forward primer sequence (5'→3') Reverse primer sequence (5'→3') UPL 
probe 
number 
Tbp GGGAGAATCATGGACCAGAA GATGGGAATTCCAGGAGTCA 97 
Actb CTAAGGCCAACCGTGAAAAG ACCAGAGGCATACAGGGACA 64 
Tet1 GGCTCCAGTTGCTTATCAAAA CCCTCTTCATTTCCAAGTCG 67 
Tet2 GGATGAGTTTGGGAGTACGG TGACTGCAGAACCTCAATGG 2 
Tet3 AGATGTGGCCTCAATGATGA CATATTTGCAGCCGTTGAAG 1 
Lep CAGGATCAATGACATTTCACACA GCTGGTGAGGACCTGTTGAT 93 
Pref1 CGGGAAATTCTGCGAAATAG TGTGCAGGAGCATTCGTACT 80 
Cd24 CTGGGGTTGCTGCTTCTG AACAGATGTTTGGTTGCAGTAAAT 68 
Cd34 GCACCACTGGTTATTTCCTGA TTTTCTTCCCAACAGCCATC 19 
Pdgfra GCGAGTTTAATGTTTATGCCTTG GGCACAGGTCACCACGAT 2 
Hsd-1 CGTTCCCAGAGCTTCAAAGT AGGAGGGCATCCTTGAGTC 98 
Tst CCAGCTGGTGGACTCTCG GTGGCCCGAGTCTAGTCCT 104 
Ucp1 TCAGGATTGGCCTCTACGAC TTAAGCCGGCTGAGATCTTG 34 
Tmem26 TGGGGAATATCCTTGAGCTG TCTAGTGATGGTGCCTCCAA 7 
Pgc1a CAGTCGCAACATGCTCAAG GGGTCATTTGGTGACTCTGG 6 
Cebpa CCGACCTCTTCCAGCACA GCTGTTCTTGTCCACCGACT 2 
Gata4 GGAAGACACCCCAATCTCG CATGGCCCCACAATTGAC 13 




Srebp1 CGTGGCAGCAGGACTGATA AGGCCTCTGGGTCATCTACA 68 
Hsl CCTACGGGAAGGACAGGAC CCTCCGTGGATGTGAACAA 1 






Slc27a1 GACAAGCTGGATCAGGCAAG GAGGCCACAGAGGCTGTTC 70 
Olr1 CCCTTATTGTACAGTGGACACAAT GATTCCTGTGAAGTGTTTTCTGC 3 
Fasn TCCACCAAATCCAACATGG GTTGTGGAAGTGCAGGTTAGG 1 
Fabp4 GGATGGAAAGTCGACCACAA TGGAAGTCACGCCTTTCATA 31 
Gk ATGGTCTCCATCCCACTGTC TCTTCTCATCCACTGATCCAAA 16 
Aqp7 GGCTCCAGCCAGAAGTCA GGGCCATTGTGGAGTTGT 84 
Pparg AAGACAACGGACAAATCACCA GGGGGTGATATGTTTGAACTTG 7 
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Ng2 CTTGGCCTTGTTGGTCAGAT CACCTCCAGGTGGTTCTCC 16 
Angptl4 GGGACCTTAACTGTGCCAAG GAATGGCTACAGGTACCAAACC 83 




Table 2.7. A list of all primer sequences and accompanying Roche Univeral Probe Library (UPL) probe number 












rate(°C/s) Number of cycles 
Preincubate 95 None 00:05:00 4.8 1 
Program 
95 None 00:00:10 4.8 
50 
60 Single 00:00:30 2.5 
Cool 40 None 00:00:30 2 1 
 
Table 2.8. LightCycler® 480 Instrument thermal cycling program used with Roche Universal Probe Library 
assays for RT-qPCR candidate gene expression analysis. 
 
 
2.5.5. RNA sequencing 
RNA was deemed to be of suitable quality and integrity for sequencing with a RNA Integrity Number 
(RIN) of >8.0, determined using the 2100 Bioanalyzer using the RNA 6000 Nano Kit (Agilent 
Technologies, UK).  
 
All library preparation, library quality control and sequencing was carried out by staff at the 
Wellcome Trust Clinical Research Facility, Edinburgh, UK. All products and kits were sourced from 
Illumina, Cambridge, UK, unless otherwise stated. 
 
Library Preparation 
Libraries were prepared from each total-RNA sample using the TruSeq Stranded Total RNA with 
Ribo-Zero kit according to the provided protocol. 500ng of total-RNA was processed to deplete rRNA 
before being purified, fragmented and primed with random hexamers. Primed RNA fragments were 
reverse transcribed into first strand cDNA using reverse transcriptase and random primers. RNA 
templates were removed and a replacement strand synthesised incorporating dUTP in place of dTTP 
to generate double stranded (ds) cDNA. AMPure XP beads (Beckman Coulter, High Wycombe, UK) 
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were then used to separate the ds cDNA from the second strand reaction mix, providing blunt-ended 
cDNA. A single 'A' nucleotide was added to the 3' ends of the blunt fragments to prevent them from 
ligating to another during the subsequent adapter ligation reaction, and a corresponding single 'T' 
nucleotide on the 3' end of the adapter provided a complementary overhang for ligating the adapter to 
the fragment. Multiple indexing adapters were then ligated to the ends of the ds cDNA to prepare 
them for hybridisation onto a flow cell, before 12 cycles of PCR were used to selectively enrich those 
DNA fragments that had adapter molecules on both ends and amplify the amount of DNA in the 
library suitable for sequencing. 
 
Library quality control 
Libraries were quantified by PCR using the Kapa Universal Illumina Library Quantification kit 
complete kit and assessed for quality using the Agilent Bioanalyser with the DNA HS Kit. 
 
Sequencing 
Sequencing was performed using the NextSeq 500/550 High-Output v2 (150 cycle) Kit on the 
NextSeq 550 platform. Libraries were combined in equimolar pools and run across 1 High-Output 
Flow Cell. All samples were sequenced to a depth of 33-63 million reads and percentage alignment 
was >94% for all samples. 
 
2.5.6. Enzyme-linked immunosorbent assays (ELISA) 
Both TET activity and plasma leptin levels were measured using ELISA-based assays according to kit 
instructions. 
 
The TET activity assay was carried out using the Epigenase 5mC-Hydroxylase TET 
Activity/Inhibition Assay Kit (Colorimetric) (Epigentek, NY, USA). Prior to use in the assay, nuclear 
protein extraction was required. This was carried out using the NE-PER™ Nuclear and Cytoplasmic 
Extraction Reagents (Thermo Fisher Scientific, Perth, UK). 20mg tissue was homogenised using a 
Dounce homogeniser, and nuclear proteins were extracted according to kit instructions. 10µg of the 
resulting nuclear extracts per sample were used in the assay. The assay was then carried out according 
to kit instructions, and light emission was read at 450nm using a spectrophotometric OptiMax 
Tunable Microplate Reader (Molecular Devices, CA, USA). Assays were carried out in duplicate. 
Sample data was interpolated from the standard curve as recommended by the kit manufacturer. 
 
The plasma leptin assay was carried out using the Mouse Leptin ELISA Kit (FineTest, China). 50µL 
fasted plasma sample was diluted 1:2 with Standard dilution buffer. The assay was then carried out 
according to kit instructions, and light emission was read at 450nm using the spectrophotometric 
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OptiMax Tunable Microplate Reader (Molecular Devices, CA, USA). Sample data was interpolated 
from the standard curve as recommended by the kit manufacturer. 
 
2.5.7. Gas chromatography-mass spectrometry (GC-MS) 
Sample preparation 
The starting material (whole adipose tissue) was weighed out on a petri dish on dry ice. 30-50mg of 
starting material was used for brown adipose tissue and 70-100mg for white adipose tissue. Tissue 
was minced and homogenised using a pestle & mortar pre-cooled on dry ice. 1mL of 1:1 methanol 
(Fisher Scientific, Loughborough, UK): water mixture was added (previously prepared and cooled by 
storing at -20°C) containing 0.5µg of the internal standard d6-glutaric acid (Qmx Laboratories, Essex, 
UK). The mixture was sonicated for 75-90 minutes using the Bioruptor® (Diagenode, Seraing, 
Belgium) in an ice bath to maintain a cold temperature, refilling the ice every 10 minutes. An equal 
volume of ice cold HPLC grade chloroform (Fisher Scientific, Loughboroguh, UK) was added and 
tubes were vortexed vigorously for 1 minute. The mixture was placed on a shaker at 4°C for 5 
minutes. Tubes were then centrifuged at 17,005 x g for 10 minutes at 4°C. The upper layer from the 
biphasic mixture was collected in a pre-cooled tube. Next, another cleaning step was carried out by 
repeating the addition of chloroform and continuing the protocol as above. Samples were dried 
completely using a Thermo Savant DNA 110 SpeedVac (Thermo Fisher, West Sussex, UK), then 
snap frozen and stored at -80°C until analysis. 
 
Derivatization 
All derivatization steps were carried out in a fume hood. The dried extract was incubated at 95°C in 
open tubes to remove any residual moisture in the samples. The dried extract was solubilised in 40µl 
of 2% methoxyamine HCl in pyridine (Sigma-Aldrich, Dorset, UK) followed by 60 minutes 
incubation at 60°C. Then 60μl N-tertbutyldimethylsilyl-N-methyltrifluoroacetamide (MTBSTFA) 
with 1% (w/v) tertbutyldimethyl-chlorosilane (TBDMSCI) (Sigma-Aldrich, Dorset, UK) 
derivatization reagent was added. The suspension was incubated for an hour at 60°C in a well-sealed 
tube to prevent evaporation. Finally the samples were centrifuged at 17,005 x g for 5 minutes and the 
clear supernatant was transferred to a chromatography vial with a glass insert (Thermo Fisher 
Scientific, Hertfordshire, UK) and proceeded immediately to GC-MS analysis. 
 
Gas chromatography-mass spectrometry 
Gas chromatography-mass spectrometry analysis was carried out by Dr Alpesh Thakker, University of 
Birmingham. For analysis of the derivatized samples, an Agilent 7890B Series GC/MSD gas 
chromatograph with a polydimethylsiloxane GC column coupled with a mass spectrometer (GC-MS) 
(Agilent Technologies UK Limited, Stockport, UK) was used. 
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Prior to sample analysis the GC-MS was tuned to a full width at half maximum (FWHM) peak width 
of 0.60 a.m.u. in the mass range of 50 to 650 mass to charge ratio (m/z) using PFTBA tuning solution. 
1μl of sample was injected into the GC-MS in split mode 1:10 with helium carrier gas at a rate of 
1.0mL min-1. The inlet liner containing glass wool was set to a temperature of 270°C. Oven 
temperature was set to 100°C for 1 minute before ramping to 280°C at a rate of 5°C min-1. 
Temperature was further ramped to 320°C at a rate of 10°C min-1 held at 320°C for 5 minutes. 
Compound detection was carried out in full scan mode in the mass range 50 to 650 m/z, with 2-4 
scans sec-1, a source temperature of 250°C, a transfer line temperature of 280°C and a solvent delay 
time of 6.5 minutes. The injector needle was cleaned with acetonitrile three times before measurement 
commencement and three times following every measurement thereafter. 
 
Gas chromatography-mass spectrometry analysis 
The raw GC-MS data was converted to common data format (CDF) using the acquisition software 
and further processing of the isotope data including isotope correction and mass isotopomer analysis 
was performed on MetaboliteDetector software [409]. CDF files were calibrated to the retention index 
using MetaboliteDetector software with a confidence limit of >70% and change in retention index 
tolerance (ΔRI) of <5 units. Values for relative metabolite levels were normalised to the internal 
standard (d6-glutaric acid) and then normalised to starting weight of tissue. Missing values (e.g. 
caused by peak interference) were substituted for using the mean imputation method. 
 
2.6. Epigenome profiling 
2.6.1. DNA extraction 
Adipose DNA extraction was carried out using DNeasy® Blood and Tissue kit (Qiagen, Manchester, 
UK), according to kit protocol for use on animal tissues, using a spin-column technique. Tissue was 
cut into small pieces (100mg), and 360μL Buffer ATL was added to each tissue sample in a 
microcentrifuge tube, followed by 40μL PureLink proteinase K (Qiagen, Manchester, UK). Tubes 
were vortexed and incubated at 56°C in a thermomixer overnight. Following incubation, tubes were 
vortexed thoroughly for 15 seconds, and 20μL RNase was added. The tubes were incubated at room 
temperature for 2 minutes, before 200μL Buffer AL was added, and vortexed again. 200μL 100% 
ethanol (Fisher Scientific, Loughborough, UK) was added, before mixing thoroughly again by 
vortexing. This mixture was transferred to a DNeasy mini spin column placed in a 2mL collection 
tube. Samples were centrifuged at 6000 x g for 1 minute. Flow-through was discarded. 500μL Buffer 
AW1 was added, samples were centrifuged again, and flow-through discarded again. This process 
was repeated using Buffer AW2. Samples were then eluted in 100μL Buffer AE. Once extracted, 
DNA was handled on ice and stored at -4⁰C. 
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2.6.2. DNA Quantification and Integrity 
DNA was quantified with the Qubit 2.0 Fluorometer (Invitrogen, Paisley UK) using DNA “broad 
range” standards as per manufacturer’s instructions for DNA samples.  DNA integrity was determined 
by resolving extraction products on a 1.5% agarose gel and staining with gel red (Cambridge 
Bioscience, Cambridge UK) to a final concentration of 0.005%. 
 
2.6.3. Ultra performance-liquid chromatography 
Sample preparation 
2.5µg DNA in 43µL water, per sample, was incubated at 95°C for 10 minutes. 5μL of 10x T7 DNA 
polymerase reaction buffer and 10 U T7 DNA polymerase (Thermo Scientific, Renfrew, UK) was 
then added. The reaction was incubated overnight at 37°C, followed by inactivation by incubation at 
75°C for 10 minutes. The samples were then centrifuged for 45 minutes at > 12,000 x g, the 
supernatant was aspirated and dried down using the speed vac, and stored at -80°C until time of 
analysis. 
 
Ultra performance-liquid chromatography 
UPLC was carried out by Dr Jimi Wills and Dr Andrew Finch of the mass spectrometry facility, 
Institute for Genetic and Molecular Medicine, University of Edinburgh. After reconstitution, 10µL 
polymerase-treated sample was loaded onto a HyperCarb column (Thermo Fisher Scientific, West 
Sussex, UK) and eluted using an Ultimate 3000 BioRS (Thermo Fisher Scientific, West Sussex, UK) 
system over a 5 minute gradient from 0 to 100% B, where A was 20mM ammonium carbonate and B 
was acetonitrile. Data were collected using a Q Exactive (Thermo Fisher Scientific, West Sussex, UK) 
scanning in negative mode at 70k resolution and a scan range of 300-350 m/z. 
 
2.6.4. Bisulfite conversion pyrosequencing 
All kits and hardware for this procedure were obtained from QIAGEN (Manchester, UK) unless 
otherwise specified. 500ng genomic DNA was used in the bisulfite conversion using the EZ DNA 
Methylation Kit (Zymo, CA, USA) according to kit instructions. Pyrosequencing assays were 
designed using the PyroMark Q24 Software v2.0.8. Biotinylated primers were HPLC-purified. 5µL 
AmpliTaq Gold® 360 Master Mix (Thermo Fisher Scientific, UK) was used for polymerase chain 
reaction amplification, with 1.5µL bisulfite-converted DNA and 5µM primer mix in a total reaction 
mixture of 10µL (made up with nuclease-free H2O. The PCR mix was placed in a thermocycler which 
was operated according to the program shown in Table 2.9. Primer sequences are shown in Table 
2.10. To confirm a single, correct product has been amplified, PCR products were run on 1.5% 
agarose gel for 25 minutes at 120V. Three water controls were routinely run and sequenced in parallel 
to all samples to ensure no contamination of reagents. 
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The PyroMark file for use on the PyroMark Q24 sequencing system was prepared with information 
regarding the well layout and amplicon sequence, in order to prepare the correct nucleotide 
dispensation order. Bisulfite conversion controls were added to the dispensation sequence before each 
potentially unconverted cytosine. 
 
All buffers (1X Wash Buffer, Annealing Buffer, Denaturation Buffer and Binding Buffer) were 
purchased as part of the Pyrosequencing kit from QIAGEN, UK. All buffers were acclimatised to 
room temperature before starting the sequencing, and 50mL of each was placed in the relevant wells 
at the PyroMark Q24 Workstation, as well as 70% ethanol (Fisher Scientific, Loughborough, UK) and 
MilliQ distilled water. The enzyme and substrate (PyroMark Gold 24 Reagents, QIAGEN, UK) were 
reconstituted in dH2O and kept in aliquots at -20⁰C until use. The annealing mix was prepared (0.3µM 
dilution of sequencing primer in Annealing Buffer) and the binding mix was prepared (40µL Binding 
Buffer, 18µL dH2O, 2µL streptavidin sepharose beads per well). 60µL binding mix and 20µL PCR 
product per sample was mixed in a single well of a PCR plate (Thermo Fisher Scientific, West 
Sussex, UK). Next, the plate was sealed and vortexed for 7 minutes at 1400rpm. Meanwhile, the 
capture probes were washed in ethanol, followed by dH2O, and the PyroMark plate was loaded with 
25µL annealing mix. Once the vortex had finished, the contents of the binding mix plate was 
immediately aspirated with the capture probes with the vacuum pump turned on, so that the beads did 
not have a chance to settle. They were then washed in 70% ethanol, Denaturation Buffer and Wash 
Buffer in that order, followed by a 15-second drying period with the vacuum pump turned on. The 
vacuum pump was then turned off and the capture probes were inserted into the PyroMark plate 
containing the annealing mix, and shaken gently until the beads were dislodged from the probes. The 
vacuum pump was turned back on and the capture probes were washed twice in dH2O, then air-dried 
for 30 seconds. The PyroMark plate containing the streptavidin-captured DNA and primer mix was 
incubated for 2 minutes at 80°C and then 5 minutes at room temperature. Meanwhile, the PyroMark 
cartridge was loaded with the appropriate amount of enzyme, substrate and nucleotides as dictated by 
the software. The cartridge was then inserted into the sequencer, and the cooled PyroMark plate was 
inserted after. The previously designed assay program was initiated. Analysis of the sequencing 
results was carried out on PyroMark Q24 Software v2.0.8, and was subject to the software’s in-built 
quality control measures (e.g. sufficient amplitude of peaks, no drift from baseline, no uncertainty of 
reading). 
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Temperature (⁰C) Time (hh:mm:ss) Number of cycles 
95 00:10:00 - 
95 00:00:20  
45 55 (annealing temp) 00:00:20 
72 00:00:20 
72 00:07:00 - 
4 ∞ - 
Table 2.9. Thermal cycler program for polymerase chain reaction amplification of bisulfite-converted DNA for 
use in bisulfite pyrosequencing. 
 
 
Primer name Sequence (5'→3') 
Forward TTTGTTTTTTGAGGTGTTGGAAGTATTAT 
Reverse (biotinylated) CATACCTACCTACCCCTCTTA 
Sequencing ATGGAGTATTAGGTTGT 
 
Sequence to analyse 
(5'→3') 
TGTTGTTATT GTTGTTGGTT YGTTGGGTGG 
GGYGGGAGTT GGYGTTYGTA GGGATTGGGG 
TTGGT 
Table 2.10. Leptin promoter bisulfite pyrosequencing assay details. Forward, reverse and sequencing primer 
sequences, and sequence to analyse. 
 
 
2.6.5. Hydroxymethylcystosine DNA immunoprecipitation (hMeDIP-seq) 
DNA shearing 
DNA was fragmented using the Covaris® E220 Focused-ultrasonicator (Covaris, Brighton, UK). 5µg 
DNA diluted in 130µL TE buffer was placed into a crimp cap microTUBE (Covaris, Brighton, UK). 
DNA was then sonicated in the conditions shown in Table 2.11. Quality of shearing was assessed by 
running in a 1.5% agarose gel in 0.5x TBE buffer for 90 minutes at 70 volts. Acceptable shearing was 
deemed as fragments between 100 and 600 base pair length with a mean of 200 to 300 base pairs and 
a uniform appearance between sheared samples. 
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Peak Incident Power (W) 175 
Duty Factor 10% 
Cycles per Burst 200 
Treatment time (s) 305 
Temperature (⁰C) 7 
Table 2.11. Covaris conditions for DNA shearing. 
 
Hydroxymethylcystosine DNA immunoprecipitation (hMeDIP) 
2.5μg of sheared DNA was diluted up to 450ul in TE buffer in a 1.5ml Eppendorf® LoBind 
microcentrifuge tubes (Eppendorf, UK) and then denatured by placing in boiling water within a heat 
block for 10 minutes.  Samples were immediately cooled on ice for 5 minutes.  50µl of 10X IP buffer 
was then added and vortexed briefly.  50µl ‘input’ was then removed and placed at 40C until the DNA 
clean up step below. 1µl of 5-Hydroxymethylcytosine (5-hmC) antibody (pAb) (Cat. No 39769; 
Active Motif, CA, USA) was then added to the remaining sample and incubated for 2 hours at 40C. 
 
40µl of Dynabeads® Protein G for Immunoprecipitation (Invitrogen, Paisley, UK) were prewashed 
with 0.1% BSA in PBS for 5 minutes on rotating wheel at room temperature. The beads were 
collected on a magnetic rack and the supernatant was removed. To ensure all supernatant was 
removed, the beads were briefly centrifuged at 402 x g for 5 seconds, bound to the rack and the 
supernatant removed again.  This washing step was repeated twice. The beads were then resuspended 
in 40µl of 1X IP buffer and added to the DNA/antibody mixture. This was then incubated for 1 hour 
at 4°C on a rotating wheel. The beads were then collected again on the magnetic rack. The supernatant 
was discarded, and the tube was centrifuged again at 402 x g for 5 seconds, beads bound to the 
magnetic rack and residual supernatant removed. The beads were then washed three times with 1mL 
of cold 1X IP buffer in the same manner as described above with BSA-PBS. The beads were then 
resuspended in 250µl of digestion buffer and 20ul of proteinase K 20mg/ml (Roche, UK) was added.  
The samples were then incubated in a thermoshaker overnight at 1000rpm and 55°C.  Following this, 
the tubes were spun at 402 x g for 5 seconds, the beads were collected on a magnetic rack and the 
supernatant collected, containing DNA fragments enriched with 5hmC.  Both the enriched fraction 
and input samples were then purified using the QIAquick PCR Purification Kit (Qiagen, UK) 
according to manufacturer’s protocol, with elution into 22μl of water. 
 
qPCR of immunoprecipitated products 
The immunoprecipitated product was analysed by qPCR to determine the efficiency of the 
immunoprecipitation. Regions from the adipose tissue genome with known high or low 5hmC levels 
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were selected as positive and negative control regions. 10µl of the eluted DNA from purification was 
diluted 1:5 in water, and was used in the reaction mixture shown in Table 2.12, with primer sequences 
for control regions shown in Table 2.13. 
 
A water control was used routinely. Standard curves were created using serial 1:2 dilutions of 
sonicated DNA. qPCR plates were centrifuged at 563 x g for 2 minutes prior to thermal cycling, to 
ensure all samples and mastermix were at the bottom of the well. The LightCycler® 480 Instrument 
(Roche, Sussex, UK) was used for temperature cycling (using the program shown in Table 2.14) and 
fluorescence quantifications. 
 
The LC480 Software (Roche) measured fluorescence throughout the experiment and data was 
analysed as previously described in section 2.5.4. 
 
Reagent Volume (μl) 
SYBR green Master Mix (Roche, Burgess Hill, UK) 5 
Forward Primer (100μM) 0.02 
Reverse Primer (100μM) 0.02 
Water 1.96 
Table 2.12. qPCR reaction components per well. 
 
 
Gene & region Control 
for 5hmC 
Forward (5'→3') Reverse (5'→3') 













Zc3h3 promoter Negative ACAGAAAGGGTCGTTTG
CAG 
AGATGTTCCCTCTCCCCAAT 
Table 2.13. Primer sequences used in qPCR of hmC-dIP. 
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Activation 95 None 00:10:00 4.8 1 
Denaturation 
95 None 00:00:15 4.8 
70 
60 Single 00:01:00 2.5 
Melting curve 
95 None 00:00:05 4.8 
1 




per °C) - 0.11 
Cool 40 None 00:00:10 2.5 1 
Table 2.14. LightCycler® 480 Instrument thermal cycling program used with SYBR Green assays for qPCR 
analysis of immunoprecipitated products. 
 
 
Whole genome amplification (WGA) 
WGA was performed using the SeqPlex Enhanced DNA Amplification Kit (SEQXE) (Sigma, UK), 
according to the manufacturer’s instructions. 10μl of immunoprecipitation product and input sample 
were used.  15 cycles of DNA amplification was performed in a standard PCR machine (Techne 
Prime, Bibby Scientific, Birmingham, UK).  For adaptor removal, all samples were quantified by 
nanodrop, the lowest DNA concentration was taken and volume required for 2.1μg calculated. This 
volume was then used for all samples in the adaptor removal step. Final elution was in 30ul of water. 
 
Ion Torrent Proton sequencing 
Proton sequencing was outsourced to the Wellcome Trust Clinical Research Facility at the Western 
General Hospital, Edinburgh, UK.  All kits and hardware for this procedure were from Life 
Technologies (Paisley, UK) unless specified.  Briefly, samples were quantified using the Qubit 
dsDNA HS kit and approximately 100ng of DNA was used to generate A DNA library from each 
sample using the Ion Xpress Plus Fragment Library Kit.  During this process, DNA fragments are end 
repaired and then ligated to Ion specific barcode adaptors before being amplified (8 cycles) and twice 
purified using the Agencourt AMPure XP PCR clean up kit (Beckman Coulter, High Wycombe, UK) 
which size selects fragments approximately 100–250bp in length. Libraries were then quality 
controlled using the Agilent Bioanalyser DNA HS kit (Agilent, Santa Clara, US) and pooled in 
equimolar pairs prior to template preparation using the Ion PI™ Hi-Q™ OT2 200 Kit and sequencing 
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on the Ion Torrent semiconductor sequencer using the Ion PI™ Hi-Q™ Sequencing kit and an Ion 
PI™ Chip Kit v3.  For consistency, each sample was sequenced on a PI chip with its own input. 
 
2.7. Bioinformatic and statistical analysis 
2.7.1. Statistical testing of null hypotheses 
Statistical analysis was performed using GraphPad Prism 5 software. Comparisons between two 
groups were made using unpaired student’s t-tests. Comparisons between two groups with repeated 
measures (e.g. weight gain measurements at multiple time points) were made using a two-way 
repeated measures ANOVA. Bonferonni post-hoc tests were also carried out to account for false 
discovery rate. The statistical analysis performed is listed in the legend of each figure. Data sets were 
routinely tested for normal distribution using the Shapiro-Wilks test. Non-parametric tests were used 
for data with non-parametric distribution. All values are represented as mean ± SEM with p < 0.05 
deemed significant. 
 
2.7.2. RNA-seq analysis 
Raw data produced by the NextSeq 550 was uploaded to BaseSpace, a cloud-based data management 
and analysis service provided by Illumina. Here it was converted into FASTQ files in order to allow 
analysis using a number of apps accessible directly through BaseSpace. First, FASTQ files were 
aligned to RefSeq genome mm10 (Dec. 2011 GRCm38/mm10) using the RNA-seq Alignment 
workflow (v1.0), which, in addition to reference genome read alignment using STAR Aligner, also 
carried out the following functions: 
 Fragments Per Kilobase of transcript per Million mapped reads (FPKM) estimation of 
reference genes and transcripts using Cufflinks 2. 
 Assembly of novel transcripts with Cufflinks 2. 
 Variant calling (single nucleotide variants and small indels) with the Isaac Variant caller. 
 
Differential expression analysis was then carried out between test groups using the TopHat Alignment 
& Cufflinks Assembly and Differential Expression (v1.0) application, which then allowed download 
of tables with mean expression values for all annotated genes. Subsequent analysis was carried out in 
Excel. 
 
Differential expression was deemed significant using a q value (p value adjusted for False Discovery 
Rate) of > 0.05 and a log2 fold change > 1.2. Pathway analysis was carried out on the Panther 
Classification System, using the statistical overrepresentation function, using input lists of 
significantly up- and down-regulated genes. 
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2.7.3. hMeDIP-seq analysis 
Raw sequence data analysis from the semiconductor sequencer was processed using Ion Torrent Suite 
software version 4.0.2 (Life Technologies, Paisley, UK). This carries out quality control of the reads 
and generates binary alignment map (BAM) files suitable for export. 
 
hMeDIP-seq analysis was carried out using the local university Galaxy Server (The Galaxy Project). 
The exported BAM files were uploaded to the server via a file transfer protocol client. BAM files 
were analysed using the “bamCompare” tool. This allowed binning of data into bins of 150 bases and 
subsequent subtraction of the input sequence values from the immunoprecipitated sequence values, 
allowing determination of 5hmC levels only in the immunoprecipitated sample and comparison 
between datasets. This step also allowed normalisation of read coverage to 1X to account for 
variations in the sequencing reactions. The output BIGWIG files were visualised in Integrated 
Genome Viewer (IGV, Broad Institute) and converted to WIG files using the “bigwigtowig” tool. 
WIG files were then converted to the mm9 build of the mouse genome Mouse July 2007 
(NCBI37/mm9) to allow mapping to mm9 reference gene coordinates (using the tool “convert 
genome coordinates”). The mapped output files were then sorted by genome locus (“filter and sort”) 
and sliding windows analysis was carried out to determine mean 5hmC levels at 5% intervals across 
every annotated gene (with all gene lengths normalised to 100%). This was carried out using the 
Galaxy tool named “Sliding window over length normalised regions of interest”. The resulting tables 
were downloaded and analysis was completed in Excel to visualise and compare mean 5hmC levels 
across all genes and various subsets of genes. 
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3. Global Tet1 knockout and the development of 
obesity 
3.1. Introduction 
Cytosine methylation (5mC) is associated predominantly with gene silencing [280], while cytosine 5-
hydroxymethylation (5hmC) is associated with active gene transcription [291]. 5hmC also plays a key 
role in the process of DNA demethylation, catalysed by the α-ketoglutarate dependent Ten-Eleven-
Translocation enzymes (TET1-3) [289]. The TET enzymes have been shown to play an important role 
in adipocyte differentiation and function [383, 410]. Peroxisome proliferator-activated receptor-γ 
(PPARγ), a master nuclear receptor critically involved in adipocyte differentiation and activation of 
adipocyte-specific gene expression, recruits TET1 to promote local demethylation around PPAR 
response elements (PPREs), thereby activating transcription of adipocyte-specific genes [383]. 
 
Previous studies in our lab, aimed at establishing genome-wide differences in hepatic gene expression 
and 5hmC profiles in Tet1 KO mice compared to littermate wildtype (WT) animals, have found that 
Tet1 KO mice are protected against diet-induced obesity (DIO), with maintenance of insulin 
sensitivity. However, the metabolic phenotype of the TET1 KO mouse has not been further 
characterised, and the mechanisms accounting for the differences in weight gain are still unclear. This 
project aimed to use the Tet1 KO mouse as a model in which to understand the effects of epigenetic 
dysregulation on obesity and metabolism, and investigate the mechanisms behind the differences in 
weight gain, focusing specifically on adipose tissue phenotype.  
 
3.2. Hypothesis & aims 
Hypothesis: 
Tet1 KO causes alterations in the adipose tissue hydroxymethylome and transcriptome, which lead to 
decreased adiposity. 
 Global deletion of Tet1 results in decreased 5hmC in adipose tissue DNA and subsequent 
transcriptional effects. 
 Global deletion of Tet1 results in reduced capacity for adipogenesis due to transcriptional 
effects mediated by the PPAR family of transcription factors. 
 
Aims: 
 To further characterise the metabolic phenotype of Tet1 KO mice in vivo. 
 To characterise the adipose tissue hydroxymethylome and transcriptome of Tet1 KO mice. 
 To characterise the effect of Tet1 depletion on adipocyte differentiation and function in vitro. 
  The role of TET1 in adipose tissue 
Chapter 3. Global Tet1 knockout and the development of obesity




Male WT and Tet1 KO mice (age range 12–23 weeks at the start of the diet intervention) were 
maintained on either control diet or HFD for 11 weeks. Body weight and food intake were tracked 
weekly, and Time-Domain Nuclear Magnetic Resonance (TD-NMR) was carried out to detect body 
composition. Indirect calorimetry (VO2, VCO2, respiratory exchange ratio, food & water intake, 
activity levels) was analysed immediately before the start of the diet intervention, and at 7 weeks 
HFD.  Glucose tolerance tests were carried out at the end of the diet intervention. 
 
After 11 weeks, mice were fasted for 16 hours, killed and adipose tissue and plasma were collected. 
The stromal vascular fraction, containing preadipocytes, was isolated from epididymal adipose tissue 
using the collagenase digestion method, cultured and differentiated in vitro on collagen-coated 6-well 
plates for 14 days using an adipogenic differentiation cocktail (1µM Rosiglitazone; 250uM IBMX; 
200pM T3; 10μg/ml Apo-Transferrin; 5μg/ml Insulin; 100nM Dexamethasone) to observe intrinsic 
capacity for adipogenesis and gene expression. Fixed cells were stained with Oil Red O to observe 
lipid accumulation, and RNA was extracted for gene expression analysis by RT-qPCR. 
 
RNA and DNA were extracted from mesenteric adipose tissue for RNA-sequencing (RNA-seq) and 
5hmC-DNA-immunoprecipitation sequencing (hMeDIP-seq) studies, respectively. RNA-seq was 
carried out on the NextSeq 550 platform (Illumina) to a depth of ~60 million reads per sample. 
Analysis of RNA-seq data was carried out using Illumina’s online platform, BaseSpace, using the 
differential expression application, Cufflinks. Genes were determined to be differentially expressed 
with a log2 fold change of > 1.2 and a q value < 0.05. hMeDIP-seq was carried out on the Ion Torrent 
platform.  Analysis of hMeDIP-seq data was carried out using Galaxy to determine mean 5hmC levels 
per gene or sliding window analysis across 150bp regions across the gene.  
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3.4. Results 
3.4.1. Weight gain, body composition and glucose and insulin tolerance of the Tet1 KO 
mouse 
Tet1 KO mouse resistance to DIO was confirmed in three independent cohorts (Figure 3.1a). A 
significant difference in weight gain was also observed between WT and KO mice on control diet 
(CD, Figure 3.1a). Time Domain Nuclear Magnetic Resonance (TD-NMR) quantification of body 
composition revealed that the difference in weight on HFD appears to be almost entirely due to a 
difference in fat mass (Figure 3.1b). On HFD, both WT and KO mice have significantly decreased 
glucose tolerance, with an inability to return glucose levels to baseline within 90 minutes (Figure 
3.1c) and no differences between genotypes were observed in glucose tolerance on glucose tolerance 
testing on control or HFD. However, insulin tolerance testing revealed that Tet1 KO mice retain 
insulin sensitivity on HFD as compared to WT littermates (Figure 3.1d). 
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Figure 3.1. Metabolic phenotyping of the Tet1 knockout mouse. 
a) Percentage body change in weight of male wildtype (WT, n = 15) and Tet1 knockout (KO, n = 14) mice on 
control diet (CD) (n = 6/group) and high fat diet over 11 weeks. ***p<0.001 by two-way repeated measures 
ANOVA. b) Body composition before and after high fat diet. ***p<0.001 by student’s t test. c) Glucose 
tolerance tests of WT and KO mice on CD (n=6/group) and HFD (n = 10/group). d) Insulin tolerance tests of 
WT and KO mice, n = 10/group. ***p<0.001 by one-way repeated measures ANOVA. Insulin tolerance tests 
performed by Marcus Lyall. All data displayed as mean ± SEM. 
 
3.4.2. Indirect calorimetry and activity levels 
On HFD, Tet1 KO mice expended fewer calories in total compared to WT littermates (Figure 3.2a). 
When analysed separately for light and dark phases, it is clear that the difference in energy 
expenditure occurs during the light phase – i.e. KO mice expended less energy than WT during the 
light or typically ‘inactive’ phase of the day (Figure 3.2b). This decrease in energy expenditure was 
not correlated with lean mass (Figure 3.2c). 
 
Respiratory exchange ratio (RER) – i.e. ratio of oxygen inspired to carbon dioxide expired – is an 
indicator of fuel metabolism. During carbohydrate metabolism, there is an equal amount of 
CO2 produced for O2 consumed (RER = 1.0). During fat metabolism, there is less CO2 produced 
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compared to O2 consumed. Therefore, an RER of 0.7 indicates mostly lipid metabolism, while an 
RER of close to 1.0 indicates predominantly carbohydrate metabolism. Analysis of RER over time 
revealed a marked and consistent increased RER in KO as compared to WT, indicating preservation 
of a greater proportion of carbohydrate metabolism in the KO animals (Figure 3.3). Analysis by two-
way ANOVA indicated that this change was statistically significant. Analysis of RER over time also 
showed that WT and KO mice had increased RER on chow as compared to HFD, and that on chow 
diet both WT and KO animals displayed normal diurnal variation in RER (increased RER during the 
dark phase, indicating increased carbohydrate metabolism during the ‘active’ phase). This diurnal 
variation was lost in both genotypes on HFD. 
 
 
Figure 3.2. Kcalorie expenditure estimated from indirect calorimetry studies, using measurements of VO2 and 
VCO2.  
a) Total kcal expenditure per kg lean mass per day of wildtype (WT) and knockout (KO) animals. *p<0.05 by 
student’s t test. b) Total kcal expenditure per kg lean mass during the light phase (7am-7pm) and the dark phase 
(7pm-7am). *p<0.05 by student’s t test. c) Kcal expenditure against lean mass values per animal. r = 
Spearman’s correlation coefficient. All data is expressed as mean ± SEM. n = 12 and 11/group.  
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Figure 3.3. Respiratory exchange ratio of wildtype (WT) vs knockout (KO) mice on chow diet and high fat diet 
(HFD). n = 12 and 11/group. All data expressed as mean ± SEM. ns, not significant; ***p > 0.001 as determined 
by 2-way ANOVA.  
 
 
The TSE PhenoMaster cages allowed measurement of movement by infrared light beams. While 
movement was markedly decreased in both genotypes on HFD compared to chow, no overall 
differences were seen between genotype on either diet (Figure 3.4a). However, analysis of the light 
and dark phases separately indicated that KO mice moved significantly more in the light phase 
compared to their WT littermates (Figure 3.4b). No differences were seen between genotypes in total 
distance travelled overall (Figure 3.4c) or when the light and dark phases were analysed separately 
(Figure 3.4d). 
 
No differences were found in total food intake, either on chow or HFD (Figure 3.5a), and no 
differences were found in the light or dark phases when analysed separately (Figure 3.5b). When 
plotted against time, no differences were observed in cumulative food intake over 24 hours (Figure 
3.5c). 
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Figure 3.4. Movement and activity of wildtype (WT) and knockout (KO) mice. 
a) Total movement of wildtype (WT) and knockout (KO) mice on both chow and high fat diet (HFD). b) Total 
movement of WT and KO mice on both chow and HFD in light and dark phases. **p<0.01 by student’s t test. c) 
Total distance travelled by WT and KO mice on both chow and HFD in 24 hours. b) Total distance travelled in 
24 hours by WT and KO mice on both chow and HFD in light and dark phases. n = 12/group. All data expressed 
as mean ± SEM. 
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Figure 3.5. Food intake in wildtype (WT) and Tet1 knockout (KO) mice. 
a) Total 24-hour food intake in wildtype (WT) and Tet1 knockout (KO) mice on chow and high fat diet (HFD). b) Food intake in light and dark phase on chow and HFD. c) 
Cumulative food intake in WT and KO mice over 24 hours on chow and HFD. n = 12/group. All data expressed as mean ± SEM. ns = not significant by two-way repeated 
measures ANOVA.
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3.4.3. In vitro adipogenesis 
Isolation and culture of preadipocytes from the stromal vascular fraction followed by in vitro 
differentiation revealed no differences in adipogenic capacity judging by the gross morphology of 
differentiated cells (Figure 3.6). This was the same for cells taken from WT and KO animals on a 
control diet (CD) or HFD. In addition, elution of the Oil Red O stain – which binds lipids within the 
cells – and quantification by photospectrometry revealed no difference in amount of lipid in the 
differentiated cells, on either CD (Figure 3.7a) or HFD (Figure 3.7b). 
 
Candidate gene expression analysis was carried out by RT-qPCR for key genes involved in 
adipogenesis, and further genes of interest (Figure 3.7c). No difference was observed in the mRNA 
levels of any candidate genes except for a dramatic and significant decrease in leptin mRNA (p < 
0.01). 
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Figure 3.6. Mature adipocytes differentiated in vitro from primary isolated stromal vascular fraction preadipocytes, and stained with Oil Red O. 
Cells taken from wildtype (WT) and knockout (KO) mice on both control diet (CD) and high fat diet (HFD). Images shown from biological replicates (BR) 1-3. Scale bar = 
100µm. 
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Figure 3.7. Lipid accumulation and gene expression of differentiated primary adipocytes from wildtype (WT) 
and knockout (KO) mice. 
Quantification of Oil Red O staining from differentiated primary adipocytes from wildtype (WT) and knockout 
(KO) mice on both a) control diet (CD); and b) high fat diet (HFD) n = 5/group. c) Gene expression of candidate 
genes in differentiated primary adipocytes from WT and KO mice. n = 12/group. All data expressed as mean ± 
SEM. **p<0.01 by student’s t test. 
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3.4.4. HFD mesenteric adipose tissue: RNA-sequencing analysis 
RNA-seq analysis of mesenteric adipose tissue from WT and KO mice allowed hierarchical clustering 
of genes by Euclidean distance into two distinct groups, WT and KO (Figure 3.8a). In addition, gene 
expression was plotted as a scatterplot to visualise significantly upregulated and downregulated genes 
with a log2 fold change > 1.2 (Figure 3.8b). Also identified were a group of genes involved in 
metabolism with significantly decreased gene expression (Figure 3.8b). Statistical overrepresentation 
pathway analysis via PANTHER revealed several pathways that had increased representation in the 
list of significantly up- and downregulated genes. Of the list of upregulated genes, muscle organ 
development pathway genes were the most highly overrepresented, followed closely by synaptic 
vesicle exocytosis and acyl-coA metabolic processes (Figure 3.8c). Of the list of downregulated 
genes, almost all overrepresented pathways were involved in metabolic processes (Figure 3.8d), the 
top hit being gluconeogenesis, followed by cellular glucose homeostasis and monosaccharide 
metabolic processes. Other pathways overrepresented in the list of downregulated genes include lipid, 
fatty acid and cholesterol metabolic processes, carbohydrate metabolic processes, and lipid transport. 
 
Of note, Tet1 expression was not found to be downregulated in the Tet1 knockout mouse mesenteric 
adipose tissue RNA-seq data (see Figure 3.9a). However, the absence of Tet1 mRNA and protein was 
confirmed in epididymal adipose tissue (see Figure 3.9b & c). Therefore, it is likely that lack of 
differential Tet1 expression in the mesenteric adipose tissue is due to the generally low expression of 
Tet1 in normal, WT mesenteric adipose tissue at this developmental stage, making the lack of Tet1 
expression in the Tet1 KO mouse mesenteric adipose tissue undetectable. However, lack of Tet1 could 
have had an impact in mesenteric adipose tissue at earlier developmental stages. 
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Figure 3.8. RNA-seq analysis. 
a) Heatmap showing all 1353 significantly (log2 fold change > 1.2; q < 0.05) differentially expressed genes clustered by Euclidean distance. b) Scatterplot showing 
significantly upregulated (red) and downregulated (blue) genes in knockout (KO) vs wildtype (WT) animals. In green are a subset of downregulated genes involved in 
metabolism. c) Statistical overrepresentation pathway analysis of significantly upregulated genes (log2 fold change > 1.2; q < 0.05); and d) significantly downregulated genes. 
False Discovery Rate > 0.05. n =3/group. 
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Figure 3.9. Tet mRNA and protein levels in mesenteric and epididymal adipose tissue from wildtype (WT) and 
Tet1 knockout (KO) mice. 
a) Tet mRNA levels in mesenteric adipose tissue (n = 3/group), determined by RNA-seq. b) Tet mRNA levels 
relative to TBP in epididymal adipose tissue, determined by qPCR (n = 4 and 3/group). Data expressed as mean 
± SD. *p<0.05 by student’s t test. c) Western blot for TET1 protein levels in epididymal adipose tissue from WT 
and KO mice. 
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3.4.5. HFD mesenteric adipose tissue: DNA immunoprecipitation-sequencing 
Genome-wide 5hmC levels, when compared across every annotated gene in the mouse genome, were 
not different in high fat-fed KO vs WT mouse mesenteric adipose tissue (Figure 3.10). In fact, a 
notably high correlation was observed between WT and KO average gene 5hmC levels, with a 
Spearman’s correlation coefficient value (r) of 0.9843 (Figure 3.11a). However, a subset of genes 
with significantly reduced 5hmC levels were identified (Figure 3.11a & Figure 3.11b). When analysed 
against the corresponding RNA-seq data, decreased average 5hmC levels correlated with decreased 
gene expression of only 3 genes (Angptl4, Bcap31 and Top2a) (Figure 3.11b). Statistical 
overrepresentation pathway analysis via PANTHER using lists of genes with significantly increased 
or decreased mean 5hmC generated no significant results. 




















































Figure 3.10. Sliding window analysis of 5-hydroxymethylcytosine DNA immunoprecipitation sequencing data. 
Gene length represents every annotated gene in the mouse genome normalised to 100%.  n = 3/group. Data 
expressed as mean ± SEM. 
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Figure 3.11. The relationship between mean 5hmC and gene expression. 
a) Correlation between mean 5hmC levels across genes of adipose tissue from wildtype (WT) and knockout 
(KO) mice. Spearman’s correlation coefficient (R2) is displayed above the trendline. Orange points represent 
mean 5hmC levels that are significantly decreased in KO adipose tissue genes as compared to WT. b) Scatter 
plot showing all genes with significantly decreased 5hmC, and their correlating gene expression taken from 
transcriptomics data. Orange data points represent genes that have both significantly decreased 5hmC and 
significantly decreased gene expression. Gene names for these points are annotated. n = 3/group. 
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3.5. Discussion 
In summary, I have confirmed that Tet1 KO mice are protected against DIO in a further three 
independent cohorts, and identified the difference in weight gain as a difference in fat mass 
deposition. Indirect calorimetry studies suggest that KO mice are paradoxically expending fewer 
calories, a measurement that is unrelated to lean mass. Calorimetry studies also suggest that the KO 
mice are metabolising a greater ratio of carbohydrate to fat compared to their WT littermates. In 
addition, there is a suggestion of increased movement during the light phase in KO compared to WT, 
which also contradicts the observation of decreased calorie expenditure. Meanwhile, no change was 
observed in the 24-hour food intake. 
 
In vitro studies using preadipocytes isolated from the stromal vascular fraction of WT and KO 
animals revealed no intrinsic differences in capacity for adipogenesis, except for a change in leptin 
expression. RNA-sequencing revealed a multitude of differentially regulated pathways, the top hits 
being muscle organ development (upregulated) and gluconeogenesis (downregulated). hMeDIP-seq 
data indicated a striking similarity in 5hmC levels between WT and KO animals with no difference in 
global 5hmC levels across the length of a gene. Of the genes that did have significantly decreased 
5hmC levels, only three had a corresponding decrease in gene expression. 
 
Based on these studies, the decrease in adipose tissue accumulation in KO mice does not appear to be 
the result of a primary adipose tissue phenotype. 
 
3.5.1. Calorie expenditure and activity levels 
Indirect calorimetry studies suggested that, on HFD, Tet1 KO mice expend fewer calories than WT 
mice. This is paradoxical in several ways: firstly, a lean phenotype would normally be associated with 
increased calorie expenditure; and secondly, analysis of movement and activity levels would suggest 
that the KO mice had increased activity levels, which again is normally associated with increased 
calorie expenditure. 
 
I considered that the decreased calorie expenditure could be accounted for simply by normalising to 
lean mass. However, this was not the case. When calorie expenditure is presented in association with 
lean mass, no correlation is observed (r = 0.04743, ns), suggesting that the decreased calorie 
expenditure is not simply a result of decreased lean body mass. 
 
It is possible that the KO animals are burning fewer calories as a result of having decreased fat stores. 
Despite having a lower metabolic rate compared to lean mass, adipose tissue still has a metabolic 
energy requirement. When calorie expenditure is presented in association with total body weight, 
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which accounts for the metabolic effects of both fat mass and lean mass, there is an increased 
correlation, although it is still not significant (r = 0.2595, p = 0.23) (see Figure 3.12). This suggests 
that the decreased calorie expenditure in Tet1 KO mice on HFD (and not on chow diet) could be 
simply the result of decreased total body weight. 
 
Furthermore, calorie expenditure was only significantly reduced in the light phase (i.e. when animals 
are moving less), suggesting that during the active (dark) phase, calorie expenditure is normal. Tet1 
KO mice did show significantly increased movement on HFD (measured by number of counts using 
infrared sensors) during the light phase only. However, this was not shown in the dark phase 
(typically the more active phase) and was not accompanied by an increase in distance travelled. 
 
Figure 3.12. The association between calorie expenditure and body weight. 
 
3.5.2. Food intake 
Food intake was measured over the 24-hour calorimetry measurement period. Although no significant 
changes were observed in food intake over 24 hours, this may not be a long enough time period to be 
able to accurately judge changes in food intake. Because the time period is short, small changes in 
food intake in individual animals (e.g. caused by being in a new environment: new cages, new food 
hoppers, new water hoppers) could skew the data. Ideally, food intake analysis should be carried out 
over the total 11-week diet period and this is explored further in Chapter 4. 
 
3.5.3. In vitro differentiation 
When primary preadipocytes from Tet1 KO and WT mice were cultured and differentiated ex vivo, no 
differences were observed in gross adipocyte morphology, lipid quantity (as measured by Oil Red O 
staining and spectroscopy) or gene expression of candidate genes. The only change observed was a 
significant and drastic reduction in leptin mRNA levels. Given that leptin is an adipokine secreted in 
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response to food intake, it was unexpected to see differential regulation of the gene ex vivo, when 
removed from food intake stimuli – and particularly such a marked reduction. In addition, reduced 
leptin mRNA was also identified in the RNA-seq data from mesenteric adipose tissue. This gives me 
further justification to investigate the food intake/leptin phenotype of the Tet1 KO mice (see Chapter 
5). 
 
3.5.4. RNA-seq analysis 
A large amount of differential gene expression was observed in mesenteric adipose tissue analysed by 
RNA-seq, and clustering analysis revealed two distinct groups of gene expression: WT and KO. 
 
In the list of significantly upregulated genes, the pathway “muscle organ development” was the most 
overrepresented, with 4 genes (Cacnb2, Unc13a, Unc13b and Myom1) being present against an 
expected occurrence of 0.37. The Unc13 gene products, which are homologous to human UNC13 
products [411], are members of the protein kinase C superfamily that lack a kinase domain, and 
mutations in this gene result in severely uncoordinated movement and increased accumulation of the 
neurotransmitter acetylcholine [412]. Of relevance, Unc13b expression is known to be both 
upregulated and activated in the kidney in hyperglycaemia, where it is thought to mediate apoptosis in 
glomerular cells [411, 413]. As hyperglycaemia is associated with apoptosis in multiple tissues [411], 
it could be plausible that Unc13b plays a role in hyperglycaemia-mediated apoptosis in adipose tissue. 
The caveat to this is that glucose tolerance tests of the Tet1 KO mouse indicated that both fasted 
plasma glucose levels and plasma glucose clearance following glucose injection were no different to 
those of WT mice, so there is no hyperglycaemia in KOs compared to WTs. Meanwhile, Myom1 
encodes the protein myomesin 1, which is a structural stabilising protein of the muscle filaments, and 
Cacnb2 encodes a calcium voltage-gated channel involved in muscle contraction. Upregulation of 
Myom1 and other genes in the “muscle organ development” pathway in Tet1 KO mice could be 
related to the increased percentage lean mass of the KO mice as compared to WTs. 
 
Of the list of downregulated genes, many pathways involving metabolic processes were 
overrepresented, including gluconeogenesis, cellular glucose homeostasis and monosaccharide 
metabolic processes. Other pathways overrepresented in the list of downregulated genes include lipid, 
fatty acid and cholesterol metabolic processes, carbohydrate metabolic processes, and lipid transport. 
The downregulation of genes in the gluconeogenesis pathway (Rbp2, Ranbp3l, Fbp2) ties in with the 
increased obesity of the WT mice, given that obesity is associated with an increased contribution of 
gluconeogenesis to glucose production [414]. In addition, 26 genes in the list of downregulated genes 
come under the pathway “lipid metabolic processes”, against an expected occurrence of 6.06. These 
are: Ptchd4, Fasn, Acss2, Hnf4a, Rdh7, Anxa2, Mttp, Cyp4f14, Pnpla3, Apoa4, Apoa1, Mup3, Mup20, 
Insig1, Prkag3, Acaa1b, Hacd2, Cyp3a13, Nsdhl, Cyb5b, Hnf4g, Cyp4a10, Me1, Dbi, Slc27a2, and 
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Cyp4a14. Decreased expression of lipid metabolic genes in the Tet1 KO mouse is probably secondary 
to its lean phenotype, given that the contribution of lipids to energy expenditure is higher in obese as 
compared to control subjects [415], a finding also supported by my indirect calorimetry respiratory 
exchange ratio data in WT and KO mice, which indicated that WT mice were burning a greater 
proportion of lipids to carbohydrates than KO mice. 
 
Conversely, a further 13 genes in the list of downregulated genes come under the pathway 
“carbohydrate metabolic processes”, against an expected occurrence of 4.19:  G6pdx, Fbp2, Rbp2, 
B3gnt3, Mgam, Pgd, Ranbp3l, Rgn, Gpt, Gys2, Nsdhl, Ntsr2 and Sis. These genes are involved in a 
range of processes including enzymes involved in the pentose-phosphate pathway (G6pdx, Pgd), 
generation of TCA cycle intermediates (Gpt), gluconeogenesis (Fbp2), polysaccharide digestion 
(Mgam) and glycogen synthesis (Gys2). The downregulation of carbohydrate metabolic processes in 
the Tet1 KO mouse could be secondary to its increased food intake and therefore decreased 
requirement for carbohydrate metabolism in adipose tissue. 
 
The same could be said for all of the metabolic processes downregulated in the KO mice. Indeed, 
previous RNA-seq studies using C57 mice on control or high fat diet have found genes involved with 
amino acid metabolism are enriched in the list of differentially expressed genes [416], suggesting 
some overlap in the differential expression of metabolism pathway genes between this study and my 
study. However, the pathway analysis used in this study was done using a list of all differentially 
regulated genes, and was not separated into up- and down-regulated genes. Also, it is important to 
bear in mind possible species differences in gene expression between humans and mice. An RNA-seq 
study of abdominal fat in genetically fat and lean chickens also found upregulation of genes involved 
in adipogenesis and lipogenesis [417], again providing an overlap in pathways with my own data (e.g. 
lipid transport is a key process required for local adipose lipogenesis). Moreover, a study using 
microarray data from subcutaneous WAT from 209 female and 95 male subjects of varying 
overweight and obese states reported downregulation of genes encoding TCA cycle enzymes, 
including mitochondrial pyruvate carrier 1 (MPC1), pyruvate carboxylase (PC), pyruvate 
dehydrogenase (PDHA1), and citrate synthase (CS), amongst others, in lean subjects [418]. Although 
these genes specifically are not altered in expression in the Tet1 KO mouse, this reinforces the idea 
that the changes observed in metabolic pathways are secondary to the lean phenotype of the Tet1 KO 
mouse. 
 
Furthermore, as none of these genes flagged in the pathway analysis overlap with the list of genes 
with significantly altered 5hmC, it is unlikely that these changes in expression are caused by the 
absence of Tet1, at least not the enzymatic effects of TET1. It is possible that TET1 is exerting effects 
on gene expression non-enzymatically, given that one 2011 study suggested that TET proteins might 
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also exert functions independently of their catalytic activity [325]. In this study, it was reported that 
the upregulation of TET1 target genes upon Tet1 knockdown can also be observed in DNMT triple 
knockout ES cells in which both 5mC and 5hmC modifications are absent, suggesting that TET1 
might repress gene transcription in a manner independent of their catalytic activity. However, it is also 
possible that TET1-mediated 5hmC is not in fact involved in the transcriptional regulation of these 
genes, but rather other epigenetic factors (e.g. histone modifications, non-coding RNAs) or 
transcription factors are responsible. 
 
Importantly, the RNA-seq data suggested that Tet1 expression was not downregulated in the Tet1 KO 
mouse mesenteric adipose tissue, a finding confirmed by qPCR. However, the downregulation of Tet1 
mRNA and protein in the Tet1 KO mouse was confirmed in epididymal adipose tissue (see Figure 
3.9). Therefore, it is likely that lack of differential Tet1 expression in the mesenteric adipose tissue is 
due to the generally low expression of Tet1 in normal, WT mesenteric adipose tissue at this 
developmental stage, making the lack of Tet1 expression in the Tet1 KO mouse mesenteric adipose 
tissue undetectable. However, lack of Tet1 could still have had an impact in mesenteric adipose tissue 
at earlier developmental stages. 
 
3.5.5. The Tet1 KO hydroxymethylome 
The highly significant correlation between WT and KO average 5hmC levels was one of the most 
surprising findings of this study. Previous studies have reported a drastically decreased global 
hydroxymethylome in the Tet1 KO liver tissue [308], although recent studies from our lab in older 
mice have found contradictory evidence for this (Lyall et al. unpublished). Regardless of the liver 
phenotype, the lack of changes in the adipose tissue hydroxymethylome may be due to a 
compensatory action of the other TET isoforms, although mRNA levels of Tet2 and Tet3 were 
unchanged (data previously displayed in Figure 3.9). However, mRNA levels of the Tet2 and Tet3 do 
not necessarily reflect protein levels or enzyme activity. Unfortunately there is currently no method 
for measuring enzyme activity of the individual TET isoforms. 
 
Statistical overrepresentation pathway analysis via PANTHER using lists of genes with significantly 
increased, decreased or all change (both up- and down-regulated) mean 5hmC generated no 
significant results, showing that no particular genes pathways were significantly altered in 5hmC 
levels and suggesting that TET1 is not involved in the regulation of specific pathways within obese 
mesenteric adipose tissue. 
 
Only 3 genes were reduced in both expression and mean 5hmC levels in KO mice. These were: 
Angptl4, Bcap31 and Top2a. These associations could be functionally relevant. For example, Angptl4, 
also known as Fiaf (fasting-induced adipose factor), encodes a novel adipokine that directly regulates 
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lipid metabolism, whose expression is under control of the PPAR family [419]. Given the previously 
discussed role of Tet1 in transcriptional activation of PPARγ target genes [420], it is plausible that 
Tet1 KO inhibits PPAR activation of Angptl4. On the other hand, it is well-established that Angptl4 
expression is decreased in states of hypoxia [421]. Given that hypoxia is increased in obese adipose 
tissue, it might be expected that Angptl4 expression would be increased in the KO mouse, which 
exhibits decreased fat mass (therefore probably has less adipose tissue hypoxia). In this regard, 
decreased Angptl4 expression in the Tet1 KO mouse does not necessarily fit with its lean phenotype. 
 
Top2a encodes DNA topoisomerase II, an enzyme that controls and alters the topologic states of DNA 
during transcription. Top2a has also been implicated in regulation of PPARγ activation of 
downstream genes [422, 423]. In 2015, Lehmann et al reported that topoisomerase II activity induces 
the recruitment of ADP-ribosyl transferase to the PPAR binding site upstream of PPAR target genes, 
which is necessary to communicate the signal of endogenous PPAR ligand binding [422]. Since TET1 
is also involved with PPAR activation of target genes [420], Top2a could be synergistically 
downregulated. However, Top2b, a paralogue of Top2a, has decreased mean 5hmC but its mRNA 
expression is unchanged, suggesting that perhaps 5hmC is unrelated to gene expression in this case. 
 
In fact, these three associations could be simply be associations without any functional relevance. To 
test this, I could carry out in vitro TET inhibition studies to determine if it is the enzymatic function of 
TET that causes decreased expression of these three genes (although this would not allow me to look 
at the activity of the different TET isoforms). 
 
To determine whether these three genes had altered expression as a primary result of Tet1 KO or as a 
secondary result of a lean phenotype, I carried out qPCR analysis of these genes in mesenteric adipose 
tissue from control-fed WT and KO mice. Although I was unable to design a working assay for 
Angptl4, the expression levels of Bcap31 and Top2a are displayed in Figure 3.13. As shown in Figure 
3.13, both Bcap31 and Top2a expression is unchanged in a range of adipose tissue depots taken from 
mice fed a control diet for 11 weeks. This suggests that the changes in the expression of these genes 
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Figure 3.13. Relative mRNA expression of Bcap31 and Top2a in mesenteric, inguinal and retroperitoneal 
adipose tissue depots from wildtype (WT) and Tet1 knockout (KO) mice fed a control diet for 11 weeks. 
 
3.5.6. A limitation of the high fat diet sequencing study 
The above findings highlight a limitation of the RNA-seq and hMeDIP-seq studies: control samples 
were not sequenced from animals on control diet. Therefore, it is impossible to tell from the 
sequencing analysis alone whether changes in gene expression are primary, due to the Tet1 KO, or 
secondary, due to the decreased fat of the KO mice. However, RNA from control diet-fed animals was 
used for validation of key genes of interest, such as the changes in Bcap31 and Top2a (shown in 
Figure 3.13) and the change in leptin mRNA (data shown in Chapter 4). 
 
In addition, findings from the indirect calorimetry may also be secondary to the obese/lean phenotype. 
For example, the observed decrease in respiratory exchange ratio (RER) in KO mice, indicating 
increased metabolism of carbohydrate, could simply be the result of decreased fat stores; therefore 
animals are obtaining a greater proportion of their energy from carbohydrate (i.e. directly from food) 
rather than lipid (i.e. from their own adipose stores). The fact that no difference was observed in RER 
between WT and KO on chow diet supports this hypothesis. 
 
Furthermore, it has been shown that changes in diet can strongly influence the serum metabolite 
profile of mice, especially those involved with energy metabolism and glucose utilisation, even when 
plasma is collected from animals in a fasted state [424]. The modified nutrient composition and lower 
protein availability of the high fat diet can instantly modulate serum metabolite levels even before the 
occurrence of obesity, because many metabolites derive from de novo synthesis from dietary 
components [425]. Indeed, it could be that in my study the expression of the enzymes involved in 
metabolic pathways may also be altered in response to altered dietary nutrient intake, rather than in 
response to obesity, or indeed the KO of Tet1. 
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In summary, I have shown in a further three independent cohorts that Tet1 KO mice are partially 
resistant to diet-induced obesity. This does not seem to be the result of an altered capacity for 
adipogenesis, or the result of 5hmC-mediated transcriptional changes. The mechanism behind the 
reduced weight gain of the Tet1 KO mouse will be explored further in Chapter 4.   
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4. Physiological control of food intake in the Tet1 
knockout mouse 
4.1. Introduction 
The findings from Chapter 3 indicated that that the obesity-resistant phenotype of the Tet1 KO mouse 
was not a primary adipose tissue phenotype, but may be a phenotype secondary to Tet1 deletion in 
other tissues. However, the observation that Lep mRNA levels (coding for the protein leptin) were 
significantly and markedly decreased in the mesenteric adipose tissue of Tet1 KO mice when 
compared to wildtype called for further examination of the leptin phenotype, and by extension, the 
food intake phenotype. 
 
While no significant differences were observed in the 24-hour food intake of the KO and WT mice, 
KO food intake was consistently lower than that of WT, indicating that analysis of food intake over a 
longer period of time, i.e. 11 weeks of high fat-feeding, may provide greater power to reveal any 
genotype differences. 
 
Leptin is the satiety hormone secreted from adipose tissue in response to eating. In particular, leptin is 
secreted at higher levels following feeding with foods with a high glycemic index [205]. Mutations in 
the LEP gene result in an insatiable appetite and severe obesity from childhood [155], and plasma 
leptin levels are negatively correlated with BMI [207]. The discovery of leptin as a satiety hormone 
was met with much excitement regarding its potential application as a treatment for obesity. However, 
while recombinant leptin therapy is effective in treating monogenic forms of obesity that involve 
mutations in the leptin gene and its signalling pathway [239], the possibility of its application in more 
complex, polygenic obesity was soon disregarded when it was found that leptin sensitivity, much like 
that of insulin, is plastic and overexposure to the hormone results in leptin resistance [240]. This is the 
case in obesity, in which high levels of leptin are secreted due to increased food intake and increased 
adipose tissue, but the subject no longer receives the satiety signals [241]. 
 
In this chapter I further investigated the food intake phenotype of the Tet1 knockout mouse, examined 
the Lep mRNA and leptin protein levels and its leptin sensitivity, and further probed the role of TET1 
in regulating Lep transcription. 
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4.2. Hypotheses & aims 
Hypotheses: 
 Tet1 KO mice have reduced transcription of Lep mRNA across all adipose tissue depots, and 
a corresponding reduction in plasma leptin. 
 KO mice have significantly reduced food intake over the 11-week HFD. 
 Decreased Lep transcription and serum leptin protein levels in KO mice allow KOs to retain 
leptin sensitivity, while WT mice become leptin resistant on HFD. 




 Investigate Lep mRNA levels across a range of WT and KO mouse adipose tissue depots. 
 Investigate serum leptin protein levels in the WT and KO mice. 
 Investigate the food intake phenotype of the Tet1 KO and WT mice through weekly food 
intake tracking. 
 If a difference in food intake is observed over the 11-week HFD, carry out paired feeding 
studies to determine whether the difference in food intake is accountable for the difference in 
weight gain. 
 Investigate the leptin sensitivity of the WT and KO mice. 
 Investigate the role of CpG methylation and hydroxymethylation in Lep transcription by 
interrogating existing hMeDIP-seq data from WT and KO mouse mesenteric adipose tissue, 
and through bisulfite conversion pyrosequencing to obtain methylation data at a higher 
resolution (base-pair resolution). 
 Investigate whether knocking down Tet1 in vitro drives the same changes observed in the 
Tet1 KO in vivo. 
 
4.3. Methods 
To investigate food intake, male WT and Tet1 KO mice (age 12-23 weeks at the start of the study) 
were maintained on CD or HFD for 11 weeks, and food intake and body weight was tracked weekly. 
In the case of the paired feeding study, KO food intake on HFD was measured daily and daily WT 
food allowance was matched to KO ad lib food intake for the previous day. See section 2.2.4 for 
further details on the paired feeding protocol. 
 
The leptin treatment study was carried out before and after 6-week ad lib HFD (section 2.2.8). 
Animals were treated with saline or leptin (3mg/kg) at 9am and food intake was measured hourly for 
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12 hours following treatment (9am–9pm). In all animal studies, after 11 weeks (or 6 weeks for the 
leptin treatment study), mice were killed, and adipose tissue and fasted plasma were collected. 
 
In vitro Tet1 knockdown was carried out in primary preadipocytes isolated from inguinal adipose 
tissue of wildtype C57BL/6J mice, cultured on collagen I-coated plates (Corning, Deeside, UK) for up 
to 3 passages, following a previously published protocol [408]. In the evening before the transfection, 
confluent preadipocytes in 12-well collagen I-coated plates were trypsinzed and seeded 1:1. The 
following afternoon (allowing enough time for the preadipocytes to adhere to the bottom of the well), 
cells were transfected with siRNA using HiPerFect reagent (Qiagen, Manchester, UK). For one well 
of a 12-well plate, 40nM siRNA was mixed with 6 µl HiPerFect reagent in a total of 200μl serum free 
α-MEM (without antibiotics) and incubated for 15 min at room temperature. During the incubation, 
200μl growth media (α-MEM with 10% FBS without antibiotics) was added to each well. The plate 
was swirled intermittently during the incubation to prevent cells from drying out. The pre-incubated 
siRNA-HiPerFect mix was added dropwise to the wells, resulting in total 400μl of α-MEM with 5% 
FBS. After gently rocking the plate, it was transferred to cell culture incubator. After overnight 
transfection, cells were re-fed with regular growth media and differentiation was initiated. Cells were 
differentiated using the adipocyte differentiation protocol (section 2.4.5) for 5 days, after which RNA 
was extracted.  
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4.4. Results 
4.4.1. Further analysis of food intake 
Food intake was examined throughout the whole 11-week high fat diet (HFD) and control diet (CD) 
rather than just during the 24-hour period in metabolic cages. Figure 4.1 shows that genotype had a 
significant overall effect on food intake over time on both CD (Figure 4.1a) and HFD (Figure 4.1b), 
with KO animals eating significantly fewer weekly calories over the 11 week diet intervention, as 
analysed by two-way ANOVA. However, t-tests analysing the total 11-week calorie intake indicated a 
significant decrease only on HFD (Figure 4.1d), not CD (Figure 4.1c). This suggested that decreased 
food intake in KO mice on CD was an emerging property of genotype that was dependent on the 
variable of time. These data support the hypothesis that the decreased adiposity of the Tet1 KO mouse 
is a result of decreased food intake. 
 
This decreased food intake observed has an effect on body weight on both diet interventions (Figure 
4.2). As discussed in Chapter 3, Tet1 KO mice gained significantly less weight on HFD (Figure 4.2). 
In the CD study, two-way ANOVA indicated that genotype had an overall significant effect on weight 
gain over 11 weeks on CD (Figure 4.2). 
 
In addition, feed efficiency (ratio of calorie input to weight gain) was analysed to indicate the 
efficiency with which WT and KO animals convert calories to kg body mass (Figure 4.3a). No 
significant difference was observed in feed efficiency, suggesting that there is no difference in the 
nutrient absorption or energy production of WT and KO animals, but rather that any differences 
observed are more likely to be a result of neuroendocrine control of food intake. Furthermore, analysis 
of covariance (ANCOVA) revealed that there was a correlation between food intake and weight gain 
(Figure 4.3b). Pearson’s correlation coefficient for these data is 0.5853 (p = 0.0009), indicating a 
highly significant positive correlation. 
 
 
  The role of TET1 in adipose tissue 
Chapter 4. Physiological control of food intake in the Tet1 knockout mouse
  90 
 
Figure 4.1. Food intake of Tet1 knockout (KO) and wildtype (WT) mice. 
Food intake of Tet1 knockout (KO) and wildtype (WT) mice maintained on a) control diet (n = 5/group) and b) 
high fat diet (n = 15/group) for 11 weeks. Mean ± SEM. *p<0.05; **p<0.01; ***p<0.001. Analysed using a 
repeated measures ANOVA with Bonferroni post-hoc tests. c) Total food intake over 11 weeks on control diet 
(n = 5/group) and d) high fat diet (n = 8/group). Analysed using student’s t-test. Mean ± SEM. 
 
 
Figure 4.2. Weight gain over time on control diet (CD) and high fat diet (HFD). 
*p<0.05; **p<0.01; ***p<0.001. Analysed using two-way repeated measures ANOVA with Bonferroni post-
hoc tests. 
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Figure 4.3. The relationship between food intake and weight gain. 
a) Feed efficiency in wildtype (WT) and Tet1 knockout (KO) mice on high fat diet. Mean ± SEM, n = 9/group. 
b) Analysis of co-variance in food intake and weight gain on high fat diet. Pearson’s correlation coefficient = 
0.5853 (p = 0.0009) 
 
 
4.4.2. Paired feeding 
To confirm that the difference in weight gain the Tet1 KO mouse was due to a decreased food intake, 
a paired feeding study was carried out (Figure 4.4) in which KO mice were given ad lib access to 
HFD, their food intake was measured daily and WT mice were fed exactly the same amount of HFD. 
Figure 4.4 showed that when WT mouse food intake was paired to KO, the weight gain of the two 
groups was comparable, indicating that the KO adipose phenotype is indeed due to decreased food 
intake. 
 
Figure 4.4. Weight gain in wildtype (WT) and Tet1 KO mice under paired feeding (PF) protocol on high fat diet. 
Mean ± SEM; n = 5/group. 
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4.4.3. Leptin expression 
Results from the RNA sequencing study in section 3.4.4 showed that leptin expression was 
significantly reduced in the mesenteric adipose tissue of Tet1 KO mice. To further investigate this 
phenotype, Lep mRNA levels were measured in various adipose tissue depots and also in RNA from 
primary adipocytes differentiated for two weeks in vitro (Figure 4.5a). In all adipose tissue depots, 
and even when adipocytes had been cultured in vitro for 2 weeks, leptin mRNA levels were 
significantly decreased. Consistent with the reduction in mRNA, leptin protein in fasted plasma 
samples was also significantly decreased (Figure 4.5b). The reduction in Lep mRNA is also observed 
in animals fed control diet for 11 weeks, but only in the inguinal adipose depot and in adipocytes 
differentiated in vitro (Figure 4.5c). This suggests that the reduction in leptin expression in Tet1 KO 
mice may be intrinsic, rather than an effect of reduced weight gain on HFD. Although, as the 
reduction in Lep expression is only present on CD in the inguinal adipose depot and in vitro, it could 
be that HFD can exaggerate the differences in Lep expression. 
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Figure 4.5. Leptin levels in wildtype and Tet1 knockout mice. 
a) Leptin mRNA levels in inguinal, mesenteric and retroperitoneal (retro) adipose tissue depots and in vitro 
taken from wildtype (WT) and Tet1 knockout (KO) mice on 11-week high fat diet. Mean ± SEM, n = 6/group. 
Analysed by student’s t test. b) Leptin protein levels in fasted plasma samples of WT and Tet1 KO mice after 
11-week high fat diet. Mean ± SEM, n = 6/group. Analysed by student’s t test. c) Leptin mRNA levels in 
inguinal, mesenteric and retroperitoneal (retro) adipose tissue depots and in vitro taken from WT and Tet1 KO 
mice on 11-week control diet. Mean ± SEM, n = 5/group. Analysed by student’s t test. *p<0.5; **p<0.01. 
 
4.4.4. Leptin sensitivity 
Reduced leptin transcription and circulating leptin levels were consistent with lower fat mass. 
However, reduced food intake implies that the KO mice are more sensitive to the reduced levels of the 
appetite-suppressing hormone. To test this, leptin sensitivity was tested by injecting leptin 
intraveneously (corrected for total body weight) at 9am and measuring the effect on food intake over 
the following 12 hours (9am to 9pm). WT and KO animals were treated with 3mg/kg recombinant 
leptin and food intake was tracked for the following 12 hours. This study was carried out immediately 
before (Figure 4.6a) and immediately after (Figure 4.6b) animals were given ad lib access to HFD for 
6 weeks. Food intake is decreased in KO animals after leptin treatment, as compared to vehicle 
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treatment, but WT food intake is unchanged. This occurs even before the 6-week HFD, indicating that 
the KO mice are intrinsically more leptin sensitive. 
 
 
Figure 4.6. 12-hour food intake of wildtype (WT) and Tet1 knockout (KO) mice treated with leptin. 
12-hour food intake of wildtype (WT) and Tet1 knockout (KO) mice treated with saline (Sal) or leptin (Lep) a) 
before 6-week ad libitum high fat diet; and b) immediately after 6 week ad libitum high fat diet. Statistical 
significance calculated using a student’s t-test. Mean ± SEM; n = 4 and 6/group, respectively. *p<0.05. 
 
4.4.5. Leptin promoter methylation status 
To investigate the upstream mechanisms of regulation of leptin transcription, the DNA 
immunoprecipitation sequencing (hMedIP-seq) data were mined to reveal 5hmC levels across sliding 
200bp windows of the Lep gene (Figure 4.7a) and the Lep promoter (Figure 4.7b) in mesenteric 
adipose tissue taken from WT and KO mice fed an 11-week HFD. No differences were observed in 
5hmC levels across sliding windows. In addition, mean 5hmC levels across the leptin gene (Figure 
4.7c) were unchanged. Bisulfite conversion pyrosequencing was carried out in DNA from inguinal 
adipose tissue of control diet-fed WT and KO mice (in which differences in Lep expression was 
observed – see Figure 4.5c), to determine 5mC levels at specific CpGs in a region of the leptin 
promoter proximal to the transcriptional start site (Figure 4.7d). Again, no significant differences were 
found in methylation levels in the leptin promoter. Based on these analyses, it appears that leptin 
promoter methylation/hydroxymethylation is not the main mechanism of transcriptional control under 
these circumstances. 
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Figure 4.7. Cytosine hydroxymethylation and methylation levels of the leptin gene in wildtype and Tet1 knockout mice. 
a) Gene hydroxymethylation (5hmC) levels across sliding 200bp windows in the Lep gene in wildtype (WT) and Tet1 knockout (KO) mice, as determined by DNA 
immunoprecipitation sequencing. Plotted against mean sliding window analysis for all genes for comparison. TSS = transcriptional start site; TES = transcriptional end site. 
Mean ± SEM, n = 3/group. b) An enlarged view of 5hmC levels across the leptin promoter (TSS ± 25%). c) Mean total gene hydroxymethylation levels in the Lep gene in 
WT and Tet1 KO mice, as determined by DNA immunoprecipitation sequencing. Mean ± SEM, n = 3/group. d) Leptin promoter percentage methylation levels in inguinal 
adipose tissue from control diet-fed wildtype (WT) and Tet1 knockout (KO) mice in the promoter region proximal to the transcriptional start site, as determined by bisulfite 
conversion pyrosequencing. Mean ± SEM, n = 6/group.  
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4.4.6. In vitro Tet1 knockdown 
Finally, a protocol for Tet1 knockdown by siRNA was optimised in primary preadipocytes, intended 
for use as an in vitro model to further investigate the mechanisms behind TET1-mediated 
downregulation of Lep transcription. Tet1 was successfully knocked down in primary preadipocytes 
(Figure 4.8a). However, Tet2 and Tet3 transcription appear to respond in a compensatory fashion with 
upregulation of transcription of these two isoforms. 
 
Furthermore, following 5 days of differentiation in order to produce cells that are mature adipocyte-
like, Tet1 expression decreased in the negative control, such that the knockdown no longer produced a 
significant effect on Tet1 transcription. To further confirm this, a timeline study was carried out in 
which Tet expression was measured daily over a period of 5 days of differentiation (Figure 4.8b). 
While this study was carried out only with n = 1 due to limitations of tissue availability, it appears that 
Tet1 expression does indeed decrease over 5 days of differentiation, while Tet2 may increase slightly, 
and Tet3 expression does not seem to change. 
 
No change was observed in leptin expression following Tet1 knockdown (Figure 4.8c). This model 
therefore requires further development if it is to be used to investigate the role of TET1 in regulating 
Lep transcription. 
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Figure 4.8. Tet1 knockdown in primary preadipocytes followed by 5 days of adipocyte differentiation. 
a) Tet1, Tet2 and Tet3 mRNA levels in preadipocytes and differentiated adipocytes treated with negative control 
RNA (NegRNA) or Tet1-targeted siRNA (Tet1 KD). Mean ± SEM, n = 4/group. Statistical significance 
determined using student’s t-test. *p<0.01; **p<0.001. b) Tet1, Tet2 and Tet3 mRNA levels measured daily in 
primary preadipocytes (Day 0) followed by 5 days of exposure to an adipocyte differentiation cocktail. n = 
1/group. c) Leptin mRNA levels in preadipocytes and differentiated cells treated with negative control RNA 
(NegRNA) or Tet1-targeted siRNA (Tet1 KD). Mean ± SEM, n = 4/group. Statistical significance determined 
using students t-test.  
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4.5. Discussion 
4.5.1. Tet1 knockout mice have decreased food intake 
In this chapter, I determined that Tet1 KO mice had significantly decreased food intake on an 11-week 
HFD and an 11-week CD. This reduction in food intake results in a significant reduction in weight 
gain on both diet interventions. Analysis of food intake by food conversion ratio suggests that the 
ratio of calorie input to weight gain is no different between WT and KO animals, indicating that the 
food intake is sufficient to account for differences in weight gain. To further support this, a highly 
significant (p = 0.0009) positive correlation was observed by analysis of covariance (ANCOVA) of 
food intake versus weight gain. ANCOVA analysis was chosen in these circumstances based on the 
recommendations of the Speakman guide to analysis of mouse metabolism [426]. In addition, a paired 
feeding HFD study revealed that reducing WT food intake to that of the KO food intake was sufficient 
to normalise any differences in weight gain on HFD, suggesting that the food intake phenotype of the 
KO mice is the predominant mechanism behind the KO lean phenotype. 
 
4.5.2. Leptin transcription is decreased in the Tet1 knockout mouse 
Further mRNA studies in this chapter found that leptin was significantly reduced in KO animals in a 
range of adipose tissue depots taken from WT and KO animals after 11-week HFD, a finding 
confirmed in the plasma protein levels of leptin. Furthermore, this reduction in leptin mRNA is also 
observed in certain adipose depots from animals fed for 11 weeks on CD, further reinforcing the idea 
that the reduction in leptin transcription in the Tet1 KO mouse is unrelated to decreased fat mass, 
opening up the possibility that leptin transcription is decreased due to a primary effect of Tet1 KO. 
 
4.5.3. Leptin sensitivity is increased in the Tet1 knockout mouse 
Leptin treatment studies revealed that KO mice have increased leptin sensitivity compared to WT 
mice, even before ad lib HFD. Since leptin sensitivity is decreased in obesity [241], we may expect 
KO mice to have increased sensitivity due to their decreased adiposity, but the fact that leptin 
sensitivity was increased even before ad lib HFD in the KO mice suggests that the increased leptin 
sensitivity in the KO mice is intrinsic rather than a result of decreased levels of obesity in the KO 
mice. My working hypothesis is that decreased Lep transcription occurs as a direct result of Tet1 KO. 
This results in decreased plasma leptin, allowing the KO mice to retain leptin sensitivity and moderate 
their food intake appropriately. Meanwhile, the WT mice have leptin levels that reflect their greater 
fat mass and the expected development of leptin resistance in obesity, so that they can’t moderate 
their food intake. 
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4.5.4. Leptin and epigenetics 
Melzer et al. demonstrated that methylation of the LEP promoter can modulate or silence LEP 
transcription when driving the expression of a luciferase reporter gene in a human adipose cell line 
[427], suggesting that leptin promoter methylation can modulate gene expression. The leptin promoter 
is methylated in both human and mouse somatic tissues and displays epigenetic variation which is 
highly associated with transcription [428, 429]. A mosaic pool of unmethylated and densely 
methylated Lep epialleles exists in mouse adipose tissue, compared to DNA from brain, liver and 
spleen in which Lep epialleles are mostly hypermethylated [429]. Analysis of dIP-seq data did not 
suggest that there was any overall difference in 5hmC levels in the Lep gene of Tet1 KO mice (neither 
across sliding 200bp windows nor across the total gene), and bisulfite conversion pyrosequencing did 
not reveal any difference in 5mC at specific CpGs upstream of the leptin promoter – a region in which 
methylation levels are thought to be important for transcriptional regulation [429]. Although bisulfite 
pyrosequencing does not distinguish between 5hmC and 5mC, based on the lack of changes observed 
in 5hmC in the dIP-seq data, it can be inferred that the levels of 5mC are unchanged too. My results 
do not fit with the suggestion that leptin expression is modulated by promoter DNA methylation: in 
inguinal adipose tissue taken from mice on an 11-week CD, although leptin expression is significantly 
reduced (p = 0.0358) in KO mice, leptin promoter methylation is unchanged. According to these 
previous studies, a significant reduction in leptin expression would be associated with an increase in 
leptin promoter methylation. One explanation could be that I only examined 4 CpGs within the leptin 
promoter due to the logistics of designing an effective assay for the promoter region. The sites of 
these CpGs within the leptin promoter are displayed in Figure 4.9. Perhaps examination of further 
CpGs in the proximal Lep promoter may reveal further differences. On the other hand, the 4 CpGs 
within my assay include a CpG that has been described as “key” for leptin modulation: the CpG 
within the C-EBPα binding motif (labelled position 4 in Figure 4.7b; or position 11 in Figure 4.9), 
which has been suggested to prevent C-EBPα binding when methylated, thus downregulating 
transcription [427]. Another CpG considered to be key in human leptin transcriptional regulation is 
the CpG in the TATA-box just upstream of the transcriptional start site, which is not present in the 
mouse promoter (see Figure 4.9), so I am unable to draw comparisons with this site. 
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Figure 4.9. The leptin promoter in human and mouse. 
CpG sites are highlighted in purple and numbered 1-21. The region covered by my bisulfite pyrosequencing 
assay is highlighted in yellow. Exon 1 is highlighted in red. The C/EBPα binding site and the TATA-box are 
underlined in bold and labelled. Base pairs homologous between human and mouse are indicated by a black line 
between lines. Figure adapted from Stöger et al. 2006 [429]. 
 
In 2008, Stöger speculated that the leptin gene may be responsive to environmental cues and can 
therefore acquire a “thrifty epigenotype”, i.e. an epigenome that confers greater energy efficiency in 
an individual or predisposes one to obesity [343]. For example, in Pima Indians, plasma leptin 
concentrations are lower in individuals with a tendency to gain weight, but no allelic LEP variants 
have been identified in this population [430, 431], suggesting that epiallele variants may be 
responsible for variation in plasma leptin. 
 
Indeed, it has been found that the methylation status of the proximal leptin promoter was highly 
correlated to transcriptional activation or silencing, and that in vitro demethylation (by decitabine) 
was sufficient to increase leptin transcription in primary fibroblasts, and even induce de novo leptin 
expression in HeLa cells [432]. Furthermore, in vitro differentiation of preadipocytes to adipocytes 
correlates with reduction of methylation at the promoter and induction of LEP expression [427, 433], 
while whole adipose tissue contains LEP epialleles with lower methylation levels compared to that of 
peripheral blood leukocytes [429], suggesting the importance of DNA demethylation in mature 
adipocyte expression of LEP. 
 
Regarding the role of LEP promoter methylation in obesity, much of the data is contradictory. As LEP 
expression is increased in obesity [434], and LEP promoter demethylation correlates with induction of 
LEP expression in adipocyte differentiation [427, 433], it could be hypothesised that the obesity-
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associated increase in LEP expression correlates with decreased methylation. Indeed, methylation of 
the LEP promoter in humans is negatively correlated with BMI [435]. In addition, in the adipose 
tissue of diet-induced obese (DIO) mice, leptin promoter methylation was decreased by HFD feeding 
during the first 8 weeks [436]. Contradictory to this, the same study reported that promoter 
methylation decreased after 12 weeks of HFD feeding compared to control diet fed mice, although 
Lep expression was still increased in DIO mice [436]. The authors suggested that the decrease in Lep 
promoter methylation in obesity was due to a transcriptional negative feedback mechanism, which 
was still insufficient to return Lep expression back to normal levels. Further studies support these 
observations. For example, in high fat-fed Wistar rats, the Lep promoter had increased methylation 
compared to control-fed rats [437]. Moreover, obese subjects who underwent weight loss of 5% body 
mass or higher had decreased leptin methylation compared to subjects who lost less than 5% body 
mass [438]. 
 
Finally, to further contradict the evidence, Fan et al. reported no difference in Lep promoter 
methylation in high fat-fed mice as compared to control-fed mice [439], and Okada et al. also reported 
that high fat-fed C57BL/6J mice displayed no differences in Lep promoter methylation as compared 
to control-fed animals [440], despite the observation of obesity-associated increase in Lep expression 
in both studies. 
 
Given that Lep promoter methylation was decreased by HFD during the first 8 weeks but then 
subsequently decreased after 12 weeks compared to control-fed mice [436], it could be possible that 
the contradictory findings in this field are dependent on the duration of study or the severity of obesity 
observed. If this is the case, this could explain the lack of changes observed in the methylation levels 
of the Lep promoter in the Tet1 KO mice, as my HFD intervention was 11 weeks, slightly shorter than 
the duration of study in the Shen study at which Lep promoter methylation was found to be increased 
[436]. At present, there are no reports of time course studies investigating the Lep methylation levels 
throughout the duration of HFD, but based on the current literature, I believe these studies would be 
insightful. 
 
It could also be possible that DNA methylation of the Lep promoter is a contributor to transcriptional 
regulation, rather than the sole or primary driver. Indeed, Shen et al. observed a whole host of 
epigenetic changes in the Lep promoter in concomitance with the changes in DNA methylation [436]: 
these included increased MBD2 binding; decreased H3 and H4 acetylation and H3K4 methylation; 
decreased binding of RNA polymerase II at the leptin promoter; increased HDAC1, 2 and 6 binding. 
These changes were associated with nucleosome compacting resulting in transcriptional repression. It 
was suggested that these epigenetic modifications were also part of the feedback regulation 
mechanism that occurs as a result of increased Lep gene expression [436]. 
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It could be that, in the particular case of the Tet1 KO mice, some of these other epigenetic 
mechanisms described above may be primarily responsible for transcriptional repression of Lep, 
which is why I have observed no differences in the methylation of the Lep promoter. On the other 
hand, DNA methylation of the Lep promoter may not play a role at all in the regulation of Lep 
transcription, but could instead be a by-product of chromatin state. In any case, based on my data, 
TET1 is not required for methylation or hydroxymethylation of the Lep promoter. 
 
While methylation has been shown to be an important regulator in tissue-specific and obesity-specific 
regulation of leptin transcription, hydroxymethylation of the Lep promoter remains unexplored. While 
the data from my hMeDIP-seq study can provide suggestions into this, unfortunately the resolution of 
such studies is insufficient, given that we can only examine the data across 200bp windows. To 
examine the 5hmC levels at base pair resolution in the Lep promoter, oxidative bisulfite sequencing 
would need to be carried out. 
 
4.5.5. Central control of obesity 
It is perhaps unsurprising that the mechanism behind the “lean” phenotype of the Tet1 KO mouse is 
involved in central pathways rather than peripheral adipose tissue pathways, given that the majority of 
approved pharmaceutical interventions for the treatment of obesity target pathways within the central 
nervous system. For example, Lorcaserin, approved for the treatment of obesity in 2012, selectively 
activates serotonin 2C receptors on anorexigenic neurons in the hypothalamus. It acts to inhibit 
appetite stimulation and promote satiety, although its exact mechanism remains unclear [441]. 
 
Another effective pharmaceutical strategy for obesity treatment is combination treatment with 
Bupropion (a dopamine and norepinephrine reuptake inhibitor) and Naltrexone (an opioid receptor 
antagonist) [442-444]. Again, although the precise mechanism of action is not entirely understood, 
activity has been observed in both the hypothalamic melanocortin system and the mesolimbic reward 
system, both of which are important for control of food intake and body weight [444]. Bupropion has 
been shown to stimulate POMC neurones in the arcuate nucleus of the hypothalamus, while the 
addition of naltrexone prevents the autoinhibition from β-endorphins, thus facilitating continued 
weight loss [444]. 
 
Phentermine and topiramate combination therapy is also used to treat obesity. Weight loss by 
phentermine, a sympathomimetic amine anorectic, is thought to be mediated by release of 
catecholamines in the hypothalamus, which mediates appetite suppression and decreased food 
consumption [441] The mechanism of action of topiramate, an antiepileptic drug and neurostabilizer, 
is unclear but it has been suggested to be related to appetite suppression and increased satiety by 
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increasing γ-aminobutyrate, modulating voltage-gated ion channels, inhibiting carbonic anhydrase, 
and inhibiting AMPA/kainite excitatory glutamate receptors [445, 446]. Topiramate is a histone 
deacetylase, which can be recruited by methyl-CpG binding proteins such as DNMTs, MBDs and 
MECP2 [445, 447]. Therefore, it is tempting to speculate that TET1 may also interact with this 
mechanism through its action on 5mC conversion and/or demethylation. 
 
These few examples demonstrate how central control of food intake and appetite are more desirable 
and effective pharmaceutical targets than targeting peripheral metabolism, digestion or nutrient 
absorption. This helps explain why we see such a prominent effect of Tet1 KO on weight gain, given 
that knockout of the gene seems to have an effect on the central leptin signalling pathway resulting in 
decreased food intake. 
 
4.5.6. An in vitro model for investigating the role of TET1 in leptin regulation 
The attempt to develop an in vitro model of Tet1 knockdown in adipocytes for further investigating 
the role of TET1 in leptin transcription was complicated by the compensatory upregulation of Tet2 
and Tet3 isoforms, as well as the observation that Tet1 transcription appeared to decrease throughout 
differentiation, thus rendering the knockdown insignificant after 5 days. In addition, while 5 days of 
exposure to the adipocyte differentiation cocktail was selected in an attempt to compromise between 
optimal differentiation time and siRNA knockdown duration, it seems that 5 days of differentiation is 
not long enough, given that Lep transcription is not significantly upregulated in this time, and its 
expression is also highly variable between replicates, indicating that the cells within each well have 
differentiated to varying degrees. Thus while this is not a suitable model to investigate the role of 
TET1 on leptin transcription, it has revealed interesting compensatory behaviour in the other TET 
isoforms. 
 
This is consistent with findings in studies in haematopoietic cells by the Rao group, which showed 
that TET2 and TET3 have overlapping and compensatory functions in haematopoietic cells [334, 
448]. In addition, other groups have demonstrated that TET1 and TET2 have overlapping and 
compensatory roles [326, 449], as knockdown or knockout of TET1 or TET2 result in only a partial 
decrease in 5hmC. Furthermore, Fujiki et al. also generated data to support this compensatory 
relationship in adipocytes, such that TET1 and TET2 appear to have complementary roles during the 
demethylation that occurs at key CpGs throughout adipogenesis [420]. Therefore, my finding of 
upregulation of Tet2 and Tet3 following knockdown of Tet1 is in agreement with the literature on this 
topic. 
 
My observation that Tet1 expression decreases throughout the first 5 days of adipogenesis may or may 
not be in agreement with the literature. In NIH/3T3 and 3T3-L1 cells, Western blotting of the three 
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TET proteins revealed that the amounts of TET1 and TET2 proteins were expressed constantly in both 
cell lines throughout adipogenic differentiation [420]. However, the Western blots in this study were 
interpreted in a binary manner (present or not present) and were not quantified. To look at the images 
of the Western blots in the supplementary figures of the study, TET1 bands appear to decrease by 5 
days of differentiation in the 3T3-L1 cells, and TET2 appears to increase, which is consistent with my 
findings. In the same study, the TET3 protein was present at lower levels [420], which is indeed in 
agreement with my results. Obviously any interpretation of the results from my Tet expression 
timeline should acknowledge the lack of an adequate number of replicates (n = 1), and so any 
interpretation is little more than speculation. It is also important to remember that mRNA studies may 
not always be representative of the amount of protein present or the activity of the protein. 
 
4.5.7. Therapeutic application of TET1-mediated effects on the leptin pathway 
While Tet1-mediated maintenance of leptin sensitivity is effective in reducing food intake and adipose 
tissue expansion, there are several pitfalls to using this strategy as a potential treatment for obesity. 
Firstly, we have not examined the other unknown effects of Tet1 KO. As Tet1 is expressed across a 
wide variety of tissues [289], it is likely to have other unknown effects. On the other hand, as we have 
already established that the TET isoforms have overlapping and compensatory roles [334, 420, 448], 
therapeutically inhibiting TET1 may not have any effect at all. In addition, the role of TET1 in obesity 
and control of food intake may not be conserved between species. In this respect, it would be an 
insightful pilot study to investigate Tet1 variants in human obese and non-obese populations. 
 
However, the knowledge that epigenetic regulators such as the HDAC inhibitor topiramate [445, 447] 
are an effective and current treatment for obesity provides justification to explore other epigenetic 
modifiers. Deacetylation of histones by HDACs is associated with chromatin condensation and of 
transcriptional repression. Consequently, HDACs inhibitors induce histone hyperacetylation and 
directly to alter transcription of a subset of genes [445, 450, 451]. 
 
Regardless of the direct clinical application of these findings, it is useful to understand the role of Tet1 
in the development of obesity, as it helps us to understand the mechanisms behind the development of 
obesity. A greater understanding of disease pathogenesis will bring us closer to developing new and 
more effective strategies to combat the epidemic. While there is still much to be discovered 
surrounding the role of TET1 in the development of obesity, I have determined that it exerts its effects 
centrally via the leptin signalling pathway, rather than peripherally in adipose tissue or other 
metabolic organs. Thus while this PhD began as an investigation into the adipose tissue phenotype of 
the Tet1 KO mouse, it has resulted in an investigation into the behaviour (food intake) and central 
signalling pathways (leptin). Further studies may investigate the effects of Tet1 on the downstream 
leptin signalling pathway in the brain: for example, is leptin transport altered in the Tet1 KO mouse? 
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Are the downstream pathways, such as Jak/STAT activation, altered? In addition, it would be useful 
to generate an adipose-specific Tet1 KO, in order to confirm that deletion of Tet1 in the adipose tissue 
is entirely responsible for the reduction of leptin transcription.  
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5. TET1 in marrow adipose tissue 
5.1. Introduction 
Marrow adipose tissue (MAT) is the adipose that is present in the bone marrow cavity. It has been 
recognised as an adipose tissue for around 100 years [104-107] but its function remains largely 
unknown. MAT has been compared to brown adipose tissue (BAT) due to its overlapping gene 
expression profile [109], but its histology [110] and its lipid profile [111] more closely resembles that 
of white adipose tissue (WAT). 
 
As discussed in Chapter 1, it has been shown that TET1 interacts directly with the transcription factor 
PPARγ, mediating CpG hydroxymethylation upstream of adipocyte-specific genes [420], thus 
providing a molecular mechanism by which TET1 expression or activity can influence adipose 
development. Furthermore, previous studies in our lab have found that, when fed a HFD, Tet1 KO 
mice display an obesity-resistant phenotype. Based on this evidence, I sought to characterise the 
effects of Tet1 KO on MAT development. Furthermore, an increase in MAT is often associated with a 
decrease in bone mineral density following the menopause [174] and in various human disease states, 
including ageing [127, 175] and anorexia nervosa [117]. Based on this evidence, my study also aimed 
to investigate the effect of global Tet1 KO on bone mineral density and bone structure, and its 
association with changes in MAT. 
 
 
5.2. Hypothesis & aims 
Hypotheses: 
 The reduced adiposity of Tet1 KO mice on HFD will also manifest in reduced MAT. The 
amount of MAT in the bone marrow cavity of Tet1 KO mice will be reduced when compared 
to their wildtype littermates. 




 Investigate the bone structure and bone mineral density phenotype of Tet1 KO mice 
challenged with a HFD. 
 Quantify the volume of bone marrow cavity occupied by MAT in high fat-fed Tet1 KO mice. 
 
 
  The role of TET1 in adipose tissue 
Chapter 5. TET1 in marrow adipose tissue  107 
5.3. Methods 
Male WT and Tet1 KO mice (age 12–23 weeks at the start of the study) were maintained on HFD for 
11 weeks. After 11 weeks, mice were killed and lumbar vertebrae, tail vertebrae, femurs and tibiae 
were collected. Bones were fixed in 10% neutral-buffered formalin solution for 24 hours, and then X-
rayed using a Faxitron (Biooptics, Arizona, USA). The exposure was set to 15 seconds at 22kV. X-ray 
images were analysed using ImageJ (NIH, USA), employing the measurement tool and the threshold 
tool. 
 
Bones were washed 3 times for 10 minutes in distilled water on a shaker at room temperature, to 
remove traces of formalin. They then underwent decalcification in 14% EDTA solution on a shaker at 
4⁰C for 2 weeks. Then the tibiae were immersed in a 1% osmium tetroxide (Agar Scientific, UK) 
solution for 24 hours. Osmium tetroxide reacts with alkene bonds within unsaturated fatty acids, 
resulting in covalent incorporation of the osmium atom and allowing visualisation of adipose tissue 
within the bone marrow. After 24 hours staining, bones were washed three times in Sorenson’s buffer 
(two hours per wash). 
 
Osmium-stained tibiae were embedded in 1% agarose in 7mL Bijou tubes. The Bijou tubes were 
placed in the SkyScanner 1172 µCT system (Bruker, MA, USA) and scanned using the following 
settings: source voltage 54kV, source current 185µA, exposure time 885ms. 
 
Trabecular and cortical bone volume, bone surface area, and bone surface to volume ratio were 
quantified using CTan analysis software, ver. 1.13 (Bruker, MA, USA). Cortical bone was analysed in 
650 x 100µm sections, starting from the growth plate down. Trabecular bone was analysed in 225 x 
100µm sections, starting from the growth plate down. Marrow adipose tissue volume (post 
decalcification and osmium staining) was quantified using the same software. MAT quantification 
was divided into three regions of the marrow cavity: 100 x 100µm sections from the growth plate 
(proximal); from there to the tibia-fibula junction (medial); and from the tibia-fibula junction to the 
end of the marrow cavity (distal). 
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5.4. Results 
5.4.1. Tet1 KO does not affect bone size, bone mineral density or bone structure. 
Bone structure and bone mineral density were assessed to investigate whether global Tet1 KO has any 
impact on these parameters. X-ray analysis of bones from Tet1 KO mice revealed no differences in 
bone mineral density of tibiae or femurs (see Figure 5.1 and Figure 5.2). Likewise, no differences 
were determined in bone length of tibiae or femurs (Figure 5.2). µCT analysis of tibiae before 
demineralisation confirmed that there was no difference in the amount of trabecular bone, the 




Figure 5.1. X-ray image of mouse wildtype (WT) and Tet1 knockout (KO) bones. 
Horizontally arranged: Lumbar (top) and caudal (bottom) vertebrae. Vertically arranged: Femur (left) and tibia 
(right). 
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Figure 5.2. Bone mineral density of wildtype (WT) and Tet1 knockout (KO) mice. 
Bone mineral density of (a) Tibiae; (b) Femurs; (c) Caudal vertebrae; and (d) Lumbar vertebrae. Bone length of 
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Figure 5.3. Bone structure in wildtype (WT) and Tet1 knockout (KO) mice. 
µCT analysis of a) Bone volume; b) Bone surface area; and c) Bone surface to volume ratio of trabecular and 
cortical bone of tibiae. Mean ± SEM. n = 4/group. 
 
5.4.2. Tet1 KO does not alter bone marrow adiposity 
µCT analysis of tibiae after demineralisation and osmium tetroxide staining allowed visualisation and 
quantification of adipose tissue. Three-dimensional renders were constructed to allow visualisation of 
adipose tissue within the bone marrow cavity (Figure 5.4). Quantification revealed no differences 
between WT and KO in the volume of adipose tissue as a percentage of bone marrow cavity volume. 
Regional analysis of MAT (Figure 5.5) revealed that most adipose tissue was present in the distal tibia 
(constitutive MAT). WT and KO MAT volume percentage did not differ at the regional level. 
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Figure 5.4. Three-dimensional renders of mouse wildtype (WT) and Tet1 knockout (KO) tibia and fibula. 
Bone is shown in grey and marrow adipose tissue shown in red. 
 
 
Figure 5.5. Percentage volume of tibia marrow cavity occupied by marrow adipose tissue (MAT). 
a) Total marrow adipose tissue volume. b) Marrow adipose tissue volume according to bone cavity region. 
Mean ± SEM. n = 4/group. 
 
  
  The role of TET1 in adipose tissue 
Chapter 5. TET1 in marrow adipose tissue  112 
5.5. Discussion 
In this diet-induced obesity mouse model, global knockout of Tet1 had no effects on bone marrow 
adiposity. Bone structure and bone mineral density were also analysed and no changes were found. 
This is in contrast to the effects of Tet1 deficiency in the visceral and subcutaneous white adipose 
tissue depot, which are markedly reduced in comparison to WT littermates following challenge with a 
HFD. This suggests that MAT development and deposition is controlled by an alternative mechanism 
to typical WAT. 
 
5.5.1. Tet1 KO response to HFD 
It is possible that differences in MAT accumulation between KO and WT were present in mice on 
HFD but were too small to detect in this study, although initial power calculations indicated that n = 5 
would be sufficient to determine a difference if there was one. The lack of an obvious difference in 
MAT accumulation between KO and WT is in contrast to the changes in non-MAT depots, in which 
the Tet1 KO mouse does exhibit reduced adipose tissue deposition on a HFD. Nevertheless, Tet1 KO 
mice do show an increase in non-MAT fat mass from baseline, albeit not to the same extent as WT 
littermates (see Chapter 3). In other words, both groups of animals have increased WAT that could be 
classed as ‘overweight’ or ‘obese’. Whether there are differences in MAT between lean Tet1 KO and 
WT mice (maintained on standard chow) is unknown, so that it is not possible to say whether any 
obesity-associated increase in MAT occurs in both groups of animals to the same extent. To further 
investigate this, analysis of WT and KO MAT at baseline (i.e. before starting the HFD) would need to 
be carried out. 
 
5.5.2. Adipose tissue deposition: MAT vs WAT 
Another potential explanation for the differential deposition of MAT and WAT in Tet1 KO mice is 
that MAT development and deposition is controlled by fundamentally different mechanisms to WAT; 
and that these mechanisms may not be affected by Tet1 depletion in the same way. However, 
evidence for the developmental origin of MAT, as discussed in section 1.2.4 (page 9), would suggest 
that MAT adipocytes differentiate from the same CD45−CD31−Sca1+CD24+/− adipocyte precursor 
population as WAT adipocytes [143]. This does not support the idea that alternative MAT 
accumulation explains the differential adipose tissue accumulation in WAT and MAT depots of the 
Tet1 KO HFD model. 
 
On the other hand, the dependence of adult MAT expansion on both hyperplasia and hypertrophy 
[122] in contrast to adult WAT expansion, which depends primarily on hypertrophy [120, 121], could 
provide an explanation for the differential accumulation of MAT and WAT in Tet1 KO mice on a 
HFD. The expansion of adipose tissue by either hyperplasia or hypertrophy is recognised to have both 
  The role of TET1 in adipose tissue 
Chapter 5. TET1 in marrow adipose tissue  113 
environmental and genetic determinants. In a high fat diet study using obesity-prone C57BL/6 mice 
and obesity-resistant FVB/N mice, C57BL/6 mice relied on adipocyte hyperplasia to a greater extent 
than the leaner FVB/N mice [452], indicating that genetic differences in adipocytes may play a 
fundamental role in determining inter-individual differences in adipose tissue expansion. 
 
Ehrlund et al. [453] described a specific transcriptional profile associated with adipocyte hypertrophy, 
showing that a number of genes that are normally expressed either transiently or specifically during 
late adipogenesis are also expressed in obese hypertrophic WAT. Furthermore, the expression of 
genes CCL2 [454], EBF1 [454], DUSP1 [454] and PLXND1 [455] have all been implicated in 
adipocyte hypertrophy. Thus, any effects of Tet1 deletion which predominantly affect the 
transcription of genes involved in hypertrophy may have more effects on WAT expansion – which 
depends primarily on hypertrophy – than on MAT expansion - which depends on both hypertrophy 
and hyperplasia. In this scenario, hyperplasia may provide a compensatory mechanism to allow 
adipose tissue expansion in the bone marrow when hypertrophy is inhibited. To assess this hypothesis 
further, it would be useful to compare MAT histology between WT and KO mice and analyse cell size 
and number. 
 
The implication that TET1 is involved in the transcriptional activation of genes downstream of the 
transcription factor PPARγ [420] (further discussed in section 1.6.1) may be important. In the mouse, 
adipose PPARγ activation in transgenic mice expressing a VP16-PPARγ fusion protein (that activates 
PPARγ independent of ligand availability) has been shown to reduce hypertrophy [456]. Given the 
finding that TET1 is required for PPARγ activation [420], it is plausible that knockout of Tet1 could 
influence adipocyte hypertrophy via the reduced activation of PPARγ. This again provides a 
mechanism by which WAT expansion (hypertrophy) could be reduced, while MAT expansion 
(hypertrophy and hyperplasia) may still be able to function due to the compensatory action of 
hyperplasia. 
 
To further assess the impact of HFD on MAT in Tet1 KO mice, future studies should analyse MAT 
adipocyte size and number to investigate the extent of hyperplasia and hypertrophy in WT and KO 
high fat-fed mice. It might also be insightful to analyse MAT volume in WT and KO mice on a 
standard chow diet to observe if differences are present at baseline. In addition, longitudinal studies 
could be carried out using high-resolution MRI to observe the changes in MAT content in WT and 
KO mice over time. In addition, it would be interesting to observe the effect of Tet1 KO in CR-
associated MAT expansion, as this may interrogate the role of Tet1 in different pathways involved in 
MAT expansion. 
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6. Metabolite availability and TET activity in cold-
induced thermogenesis 
6.1. Introduction 
The increase of research investigating brown adipose tissue (BAT) in the last 10 years reflects its 
potential for use in the treatment of obesity. In both humans and rodents, activation of BAT has been 
shown to significantly increase energy expenditure [49, 83], increase glucose and lipid oxidation [92], 
delay the development of Type 2 diabetes [92, 93], reduce triacylglycerol levels [94, 95] and reduce 
cholesterol levels, slowing down the progression of atherosclerosis [96, 97]. In addition, certain 
depots of white adipose tissue (WAT), known as “beige” adipose tissue, are able to exhibit properties 
of BAT, including the expression of a thermogenic gene programme [63, 99, 100]. The browning of 
WAT has been shown to have similar beneficial effects on metabolic health [75, 457, 458]. 
 
At the molecular level, BAT activation is controlled by transcriptional activation of a specific gene 
programme required for thermogenesis. The most notable of these genes is UCP1, coding for 
uncoupling protein 1, which acts as a proton leak in the mitochondrial membrane, and as such 
uncoupling proton transport and substrate oxidation from respiration. The result of this is a large 
increase in ATP requirements. Other genes considered to be crucial members of the thermogenic gene 
programme include β3-AR, CPT1b, GLUT-4, and ZFP516 [459]. Also frequently included are the 
transcription factors involved in regulation of the above genes, such as PGC1α, C/EBPβ, PPARα, 
PRDM16 and EBF2. 
 
Given the dependence of BAT activation upon transcriptional activation of the thermogenic gene 
programme, transcriptional regulation – including epigenetic control of transcriptional regulation – is 
obviously a key element of BAT activation. There is abundant evidence for the role of epigenetic 
modifications – in particular histone modifications – in BAT activation [396-399, 403]. Specifically, 
histone deacetylase 3 (HDAC3) has been implicated: BAT-specific Hdac3 ablation in mice exposed 
to cold temperatures results in the inability to regulate body temperature and subsequent severe 
hypothermia [399]. Furthermore, Hdac3 in mouse WAT was shown to contribute to maintenance of 
WAT identity and act as a “molecular brake” to prevent browning [400]. In addition, Jumonji C 
(JmjC)-domain-containing demethylase 1A (JMJD1A) was shown to demethylate H3K9me2 in the 
PPAR response elements of key genes such as Ucp1 and Adrb1 (β3-adrenoreceptor), permitting 
transcription of these genes and contributing to the transcriptional activation of the thermogenic gene 
programme [403]. 
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The JMJD enzymes are part of a group of α-ketoglutarate (α-KG) -dependent dioxygenases, a group 
of enzymes whose activity is dependent upon the availability of tricarboxylic acid cycle metabolite, α-
KG, as a co-factor [289]. Other members of this group include the ten eleven translocase 
methylcytosine dioxygenases (TETs) [289, 347]. The activity of these enzymes is also inhibited by 
other by-product metabolites of the TCA cycle (succinate and fumarate) [346]. The dependence of 
such epigenetic regulators on the availability of α-KG, and their susceptibility to inhibition by 
succinate and fumarate, provides a mechanism by which changes in the rate of TCA cycle metabolite 
oxidation (such as those that take place in BAT activation) may influence the activity of this group of 
enzymes. Indeed, it is plausible that such modulation in intracellular α-KG levels may be required for 
epigenetic activation of the thermogenic gene programme. 
 
Finally, our collaborators have demonstrated that in humans in mild cold exposure (18°C), there is a 
decrease in glutamate concentrations in the interstitial fluid within the supraclavicular brown adipose 
tissue [82]. This indicates an increased uptake of glutamate into the BAT, suggesting an increased rate 
of glutamate oxidation and uptake into the TCA cycle. Increased uptake of glutamate, the precursor to 
α-KG, into the TCA cycle of activated BAT could alter α-KG levels, and influence the activity of the 
α-ketoglutarate dependent dioxygenases with downstream effects on CpG methylation states. 
 
While the role of histone modifications in BAT and beige activation has been extensively studied, the 
role of changes in CpG methylation state (mediated by the TET enzymes) has not. I aim to investigate 
whether activation of the thermogenic gene programme is associated with changes in DNA 
methylation/hydroxymethylation. 
 
6.2. Hypotheses & aims 
Hypotheses: 
 Increased glutamate uptake into the brown adipose tissue, as previously observed in humans 
[82] will also occur in mouse brown and beige adipose tissue when animals are exposed to a 
temperature of 4°C, but not in white (non-browning) adipose tissue. 
 This will cause an increase in the levels of α-ketoglutarate in mouse brown and beige adipose 
tissue, but not in white (non-browning) adipose tissue. 
 Changes observed in glutamate and α-ketoglutarate levels in mouse brown and beige adipose 
tissue will modulate TET activity. 
 Changes in TET activity as a result of cold-induced brown and beige adipose tissue activation 
will result in global changes in CpG hydroxymethylation, particularly in genes key to 
thermogenic activation. 
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 Changes in the hydroxymethylome will be associated with modulation of gene expression in 
brown and beige adipose tissue. 
 
Aims: 
 To confirm using indirect calorimetry that cold-induced BAT and beige upregulation occurs 
in the animals exposed to a temperature of 4°C. 
 To investigate changes in glutamate levels, α-ketoglutarate levels and TET activity in the 
brown, beige and white adipose tissue of mice exposed to cold (4°C), room temperature 
(21°C) and thermoneutrality (30°C) for 48 hours. 
 To investigate changes in DNA hydroxymethylation and associated alterations in gene 
expression in the brown, beige and white adipose tissue of mice exposed to cold (4°C), room 
temperature (21°C) and thermoneutrality (30°C) for 48 hours. 
 
6.3. Methods 
Male C57BL/6J mice (aged 12 weeks at the start of the study) were maintained at 30°C, 21°C or 4°C 
for 48 hours. Indirect calorimetry was carried out during the temperature exposure to analyse the 
source of respiration substrate (determined by respiratory exchange ratio). This can be determined 
using oxygen input and carbon dioxide output of the animals. Food and water intake and activity 
levels were also measured during this time. After 48 hours exposure to temperature, animals were 
immediately killed and adipose tissue – epididymal (WAT), brown adipose (BAT) and inguinal 
adipose (beige) tissue – was dissected. 
 
30-100mg of whole WAT and BAT was used for gas chromatography-mass spectrometry (GC-MS) 
analysis of tissue polar metabolite levels. 1mL of 1:1 methanol: water mixture was added containing 
0.5µg of the internal standard d6-glutaric acid. The mixture was sonicated for 75-90 minutes. An 
equal volume of ice cold HPLC grade chloroform was added and tubes were vortexed vigorously for 
1 minute. The mixture was placed on a shaker at 4°C for 5 minutes. Tubes were then centrifuged at 
17,005 x g for 10 minutes at 4°C. The upper layer from the biphasic mixture was collected in a pre-
cooled tube. Another cleaning step was carried out by repeating the addition of chloroform and 
continuing the protocol as above. Samples were dried completely using a Thermo Savant DNA 110 
SpeedVac, then snap frozen and stored at -80°C until analysis. 
 
The dried extract was solubilised in 40µl of 2% methoxyamine HCl in pyridine followed by 60 
minutes incubation at 60°C. Then 60μl N-tertbutyldimethylsilyl-N-methyltrifluoroacetamide with 1% 
(w/v) tertbutyldimethyl-chlorosilane derivatization reagent was added, and the suspension was 
incubated for an hour at 60°C. Finally the samples were centrifuged at 17,005 x g for 5 minutes and 
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the clear supernatant was transferred to a chromatography vial with a glass insert and proceeded 
immediately to GC-MS analysis. For analysis of the derivatized samples, an Agilent 7890B Series 
GC/MSD gas chromatograph with a polydimethylsiloxane GC column coupled with a mass 
spectrometer (GC-MS) was used. GC-MS was carried out by our collaborators from the University of 
Birmingham (Dr Alpesh Thakker, Dr Christian Ludwig, Prof Gareth Lavery and Dr Daniel Tennant). 
 
RNA and DNA were extracted from BAT, WAT and beige adipose for RNA-sequencing (RNA-seq) 
and 5hmC DNA-immunoprecipitation sequencing (hMeDIP-seq) respectively. RNA-seq was carried 
out on the NextSeq platform (Illumina) to a depth of ~33 million reads per sample. Analysis of RNA-
seq data was carried out using Illumina’s online platform, BaseSpace, using the differential expression 
application, Cufflinks. Genes were determined to be differentially expressed with a log2 fold change 
of > 1.2 and a q value < 0.05. hMeDIP-seq was carried out on the Ion Torrent platform. Analysis of 
hMeDIP-seq data was carried out using Galaxy to determine mean 5hmC levels per gene or sliding 
window analysis across 150bp regions across the gene. In addition to hMeDIP-seq, global 5mC and 
5hmC levels were analysed by Ultra Performance Liquid Chromatography (UPLC). 
 
The TET activity assay was carried out using the Epigenase 5mC-Hydroxylase TET 
Activity/Inhibition Assay Kit (Epigentek, NY, USA). Prior to use in the assay, nuclear protein 
extraction was carried out. 10µg of the resulting nuclear extracts per sample were used in the assay, 
which was carried out according to kit instructions. 
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6.4. Results 
6.4.1. Indirect calorimetry 
Animals were kept in PhenoCages in the TSE PhenoMaster system, a closed system that allows 
measurement of oxygen and carbon dioxide flow and animal locomotor activity. System temperature 
was maintained at either 30°C (thermoneutrality), 21°C (room temperature) or 4°C (cold exposure) 
for 48 hours. Figure 6.1 displays indirect calorimetry data obtained from this study. Due to technical 
issues associated with the gas calibration process, unfortunately no useable indirect calorimetry data 
was obtained from the experiment at 30°C. Therefore 21°C is used as the control temperature for all 
indirect calorimetry/TSE data. 
 
Calorie expenditure was significantly increased in mice exposed to 4°C when compared to room 
temperature controls (36.4 ± 2.6 vs 24.6 ± 0.3 kcal/hour/kg; p = 0.0005; n = 8/group) (Figure 6.1a), 
and food intake was increased accordingly (51.3 ± 2.5 vs 23.5 ± 3.1 kcal/hour/kg; p = 0.000008; n = 
8/group) (Figure 6.1b). VO2 and VCO2 were significantly increased (Figure 6.1c and Figure 6.1d), 
indicating a greater metabolic rate, while respiratory exchange ratio (RER) was significantly 
decreased (Figure 6.1e), indicating a biological preference for fatty acid metabolism over 
carbohydrate metabolism under cold exposure. Movement and activity data shows that animals are 
inclined to reduce locomotor activity under cold exposure, presumably in an attempt to further 
conserve energy for heat. Daily distance travelled was significantly decreased (Figure 6.1f), as was 
daily counts of movement (Figure 6.1g). When movement was analysed separately as ambulatory 
(movement around the cage) and fine (small movements such as twitching of the ears and tail), both 
forms of movement were significantly decreased at 4°C compared to room temperature (Figure 6.1h). 
 
Figure 6.2 shows the indirect calorimetric response during the first 12 hours of cold exposure, 
including the transient decrease in temperature to 4°C from ambient. The mean cage temperature 
appears to stabilise at around 5-6°C, which is slightly higher than the target system temperature of 
4°C, most likely due to the body heat produced by the animals slightly raising temperature 
measurements within the cages. By observing the initial 12 hours including the transient decrease in 
temperature, we can observe the acute reaction to cold exposure. 
 
Figure 6.2a shows the initial 12 hour response of RER with change in temperature. During the initial 
decrease in temperature from ambient to 4°C (the first 4 hours), RER decreases rapidly from 0.86 to 
0.76. After 4 hours, RER increases again almost to starting level. This transient decrease in RER 
could be explained by a delay in the increase of food intake (Figure 6.2b). Rate of food intake appears 
to remain constant until around 16:00 hours, at which point the gradient of the slope increases. This 
delay in food intake increase may mean that the animals are forced to use adipose stores in order to 
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account for the increased energy expenditure (decreasing RER). When food intake is increased 
accordingly (after 16:00 hours) animals appear to metabolise more carbohydrate for respiration 
(increasing RER). Figure 6.2c displays the acute response of energy expenditure to cold exposure. 
 
Figure 6.1. Indirect calorimetry data from mice maintained at 21°C (room temperature) and 4°C (cold 
exposure). 
All calculations performed on data over 24 hours. All data presented as mean ± SEM or sum ± SEM (where 
appropriate, e.g. distance per day, movement per day). n = 8/group.  a) 24-hour mean kcalorie expenditure. b) 
24-hour mean food intake. c) VO2 (volume of oxygen input). d) VCO2 (volume of carbon dioxide output). e) 
Respiratory exchange ratio (RER): the ratio of VO2 to VCO2. f) Distance travelled over 24 hours. g) Total 
movement over 24 hours, measured by number of breaks of the detection lasers. h) Movement over 24 hours, 
represented as ambulatory movement (Amb) and fine movement. *p<0.05; **p<0.01; ***p<0.001; analysed by 
student’s t test. 
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Figure 6.2. The indirect calorimetric response during the first 12 hours of cold exposure, including the transient 
decrease in RER following the initial reduction in temperature from room temperature. 
Mean ± SEM. n  = 8. a) Respiratory exchange ratio. b) Cumulative food intake. c) Energy expenditure. 
 
6.4.2. Metabolite levels 
Steady state levels of polar metabolites in whole brown and white adipose tissue were measured using 
gas chromatography-mass spectrometry. TCA cycle metabolite levels are shown in Figure 6.3. Every 
detectable TCA cycle intermediate follows the same pattern: TCA cycle intermediate levels are 
increased in adipose tissue from animals exposed to 4°C when compared to 30°C. In addition, 
glutamate, a precursor for α-ketoglutarate, also follows the same pattern. This increase is observed in 
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both brown and white adipose tissue, although metabolite levels are consistently higher in BAT 
compared to WAT per mg tissue. All increases in metabolites are statistically significant (p < 0.05) 
except for those in α-ketoglutarate and succinate in BAT, which still follow the same pattern but the 
changes are not significant. It is possible that an increased number of biological replicates would yield 
significant changes in these metabolites. 
 
The increase of TCA cycle metabolites in BAT from animals under cold exposure could represent 
increased rate of cycling in an effort to produce a greater amount of substrates to feed into the 
respiratory chain. However, we would not expect to observe the same phenomenon in white adipose 
tissue, which plays no role in thermogenesis. 
 
Meanwhile, Figure 6.4 shows the levels of amino acids (and pyruvate) that feed into the TCA cycle. 
The levels of these precursor metabolites are likely to directly influence the levels of TCA cycle 
metabolites. For example, the decrease in histidine levels in BAT at 4°C could suggest an increased 
utilisation of histidine for generation of increased levels of glutamate. 
 
While the scope for interpretation of steady state metabolite levels can be limited due to lack of 
information about carbon cycling, the ratios of certain metabolites can suggest further information. 
Figure 6.5a shows the ratio of α-ketoglutarate:(succinate + fumarate). As previously discussed, α-
ketoglutarate is required as a substrate for the action of the TET enzymes, while succinate and 
fumarate can competitively inhibit the TET enzymes. Therefore changes in the ratio of TET-
activating metabolites to TET-inhibitory metabolites could potentially influence TET activity. The 
ratio of α-ketoglutarate:(succinate + fumarate) is unchanged in BAT at 4°C, but it is trending towards 
an increase in WAT at 4°C. 
 
Figure 6.5b (ratio of citrate:α-ketoglutarate), Figure 6.5c (ratio of malate:citrate) and Figure 6.5d 
(ratio of pyruvate:citrate) each represent NADH-forming steps in the TCA cycle. While there is no 
change in the pyruvate:citrate ratio, the citrate:α-ketoglutarate ratio is decreased in WAT at 4°C, and 
the malate:citrate ratio is increased in BAT at 4°C. A change in these ratios could indicate changes in 
the levels of NADH. In addition, Figure 6.5e shows the serine:glycine ratio, which is associated with 
1C metabolism. The serine:glycine ratio is significantly increased in BAT at 4°C. 
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Figure 6.3. Levels of metabolites of the tricarboxylic acid cycle in whole brown adipose tissue (BAT) and white adipose tissue (WAT) from mice maintained at 30°C and 4°C 
for 48 hours. 
As determined by gas chromatography-mass spectrometry (GC-MS). All data expressed as mean ± SEM, n = 5/group. Where “no data” is indicated, metabolites are 
unmeasurable using GC-MS due to chemical instability. *p<0.05; **p<0.01; ***p<0.001; ns = not significant; analysed by student’s t test. 
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Figure 6.4. Levels of some of the amino acids that can feed into the tricarboxylic acid cycle in whole brown 
adipose tissue (BAT) and white adipose tissue (WAT) from mice maintained at 30°C and 4°C for 48 hours. 
As determined by gas chromatography-mass spectrometry. All data expressed as mean ± SEM, n = 5/group. 
*p<0.05; **p<0.01; ***p<0.001; ns = not significant; analysed by student’s t test. 
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Figure 6.5. Metabolite ratios in whole brown adipose tissue (BAT) and white adipose tissue (WAT) from mice 
maintained at 30°C and 4°C for 48 hours. 
Data presented as mean ± SEM, n = 5/group. a) Ratio of α-ketoglutarate:(succinate + fumarate). b) Ratio of 
citrate:α-ketoglutarate. c) Ratio of malate:citrate. d) Ratio of α-ketoglutarate:succinate. e) Ratio of 
serine:glycine. *p<0.05; **p<0.01; ***p<0.001; ns = not significant; analysed by student’s t test. 
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6.4.3. RNA-sequencing 
Initial analysis of RNA-sequencing data allowed hierarchal clustering of biological replicates by gene 
expression. Figure 6.6a, Figure 6.6c and Figure 6.6e show heatmaps illustrating significantly 
differentially expressed genes between groups, with a log2 fold change > 1.2, clustered by Euclidean 
distance, for BAT, beige and WAT, respectively. In BAT and WAT, gene expression profiles are 
replicable between samples and allow clustering into the two treatment groups (30°C and ●4°C). 
However, in beige adipose tissue, gene expression appears to be more variable between biological 
replicates, which prevents clustering into two distinct groups. Scatterplots in Figure 6.6b, Figure 6.6d 
and Figure 6.6f illustrate significantly up- and down-regulated genes with a log2 fold change > 1.2 in 
BAT, beige and WAT, respectively. In BAT, this comprises 2796 genes upregulated and 3087 
downregulated; in beige: 582 upregulated and 80 downregulated; in WAT: 1890 upregulated and 
1000 downregulated. 
 
In BAT, activation of the thermogenic gene programme was observed (Figure 6.7a). In addition, Ucp1 
upregulation is observed at expected levels in BAT and beige (Figure 6.7b) (please note the break in 
scale of the y-axis). While Ucp1 expression is technically upregulated in WAT, its expression is 
negligible compared to BAT and beige. 
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Figure 6.6. RNA-sequencing performed on whole brown adipose tissue (BAT), beige and white adipose tissue 
(WAT) from mice maintained at 30°C and 4°C for 48 hours. 
Heatmaps illustrating significantly differentially expressed genes with a log2 fold change > 1.2, clustered by 
Euclidean distance, for BAT, beige and WAT are shown in a, c & e respectively. Blue circles (●) indicate 
samples from animals from the group exposed to 4°C. Scatter plots displaying genes that are significantly 
upregulated in the 4°C group (in red) and significantly downregulated (shown in blue) for BAT, beige and WAT 
are shown in b, d & f respectively. 
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Figure 6.7. RNA-seq analysis of activation of the thermogenic gene programme. 
a) Thermogenic gene programme activation in whole brown adipose tissue from mice exposed to 30°C or 4°C 
for 48 hours. b) Ucp1 gene expression in whole brown adipose tissue (BAT), beige adipose tissue and white 
adipose tissue (WAT) from mice exposed to 30°C or 4°C for 48 hours. n = 3/group. *q<0.05; **q<0.01; 
***q<0.001; significance determined by q-value estimation for false discovery rate control. 
 
Pathway analysis revealed the most upregulated (Figure 6.8a, b & c) and downregulated (Figure 6.9a, 
b & c) pathways in BAT, beige and WAT, respectively. Many of the upregulated hits in BAT and 
beige support activation of the thermogenic gene programme, such as mitochondrial transport and 
organisation, TCA cycle, lipid & carbohydrate metabolic processes and generation of precursor 
metabolites. In WAT, the top upregulated hits suggest that WAT may be undergoing anabolic 
processes in order to store as much energy as possible. For example, the pentose-phosphate shunt (2nd 
upregulated hit) is a metabolic pathway parallel to glycolysis, whose primary function is to generate 
reducing equivalents, in the form of NADPH, used in reductive biosynthesis reactions within cells 
(e.g. fatty acid synthesis). It is considered an anabolic pathway, rather than catabolic. 
 
Taking the RNA-seq data in combination with the GC-MS data, we can look at the changes in both 
genes and metabolites in the same pathway. Figure 6.10 shows changes in metabolites of the TCA 
cycle in a) BAT and b) WAT. 
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Figure 6.8. Pathway analysis of significantly upregulated genes in cold exposure 
Pathway analysis of significantly upregulated genes in cold exposure in: a) brown adipose tissue; b) beige 
adipose tissue; and c) white adipose tissue. 
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Figure 6.9. Pathway analysis of significantly downregulated genes in cold exposure. 
Pathway analysis of significantly downregulated genes in cold exposure in: a) brown adipose tissue; b) beige 
adipose tissue; and c) white adipose tissue. 
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Figure 6.10. Up- and down-regulation of enzymes and metabolites of the tricarboxylic acid cycle. 
Up- and down-regulation of enzymes and metabolites of the tricarboxylic acid cycle in a) whole brown adipose tissue; and b) whole white adipose tissue of mice exposed to 
4°C for 48 hours. 
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6.4.4. TET expression and activity 
Analysis of RNA-seq data showed that while Tet1-3 mRNA levels appear to be reduced with cold 
exposure (Figure 6.11a-c), the only significant changes in mRNA levels are Tet2 in BAT and Tet1 in 
WAT. This correlates with a decrease in TET activity in WAT at 4°C (Figure 6.11d). 
 
Figure 6.11. TET expression and activity in whole brown adipose tissue (BAT), white adipose tissue (WAT) and 
beige adipose tissue taken from mice maintained at 30°C or 4°C for 48 hours. 
a) Tet1 expression; b) Tet2 expression; c) Tet3 expression (mean, n = 3/group; significance determined by q-
value estimation for false discovery rate control); d) overall TET activity (mean ± SEM, n = 5/group; 
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6.4.5. Global methyl- and hydroxymethylcytosine 
No differences were observed in global 5-methylcytosine (5mC) or 5-hydroxymethylcytosine (5hmC), 
as detected using ultra performance-liquid chromatography (UPLC) (see Figure 6.12). No changes 
were observed in either BAT or WAT, although BAT has significantly lower 5mC levels compared to 
WAT. 
 
Figure 6.12. Global methyl- and hydroxymethyl-cytosine levels in brown and white adipose tissue at 
thermoneutrality or cold exposure. 
a) 5-methlycytosine (5mC) and b) 5-hydroxymethylcytosine (5hmC) levels in whole brown adipose tissue 
(BAT) and white adipose tissue (WAT) from mice exposed to 30°C or 4°C for 48 hours, expressed as a 
percentage of total G. n = 5/group. 
 
6.4.6. 5hmC DNA immunoprecipitation-sequencing (hMeDIP-seq) 
Analysis of hMeDIP-seq data showing 5hmC levels across every gene, normalised to 100%, is shown 
in Figure 6.13a. Based on these data, 5hmC levels in BAT and WAT appear to decrease globally with 
48 hours cold exposure, although with only one biological replicate, no solid conclusions can be 
drawn. In contrast to previous hMeDIP-seq data in WAT (see section 3.4.5) , a trough occurs in 5hmC 
levels specifically at the 10% position of the gene body in BAT at 30°C, BAT at 4°C, and WAT at 4°, 
but not in WAT at 30°C (Figure 6.13a). Previously, I have demonstrated a relative 5hmC peak at 
around 10% gene length in WAT, as shown in Figure 6.13b. Therefore, the epigenetic signature of 
BAT differs from WAT at this locus. In addition, cold exposure induces large changes in WAT 5hmC 
at this locus that closely resemble the 5hmC signature of BAT. 
 
Further analysis identified a subset of genes with decreased 5hmC at 10% gene length in WAT at 4°C. 
I carried out statistical overrepresentation pathway analysis to investigate the genes that are decreased 
in 5hmC at 10% gene length in response to cold exposure (Figure 6.13c). The most highly enriched 
pathways are neuromuscular synaptic transmission, sensory perception of smell and perception of 
chemical stimuli. High correlations were observed between mean 5hmC levels at thermoneutral and 
cold exposure in both BAT (Figure 6.13d) and WAT (Figure 6.13e), with Spearman’s correlation 
coefficient (R2) > 0.95 in both cases, although statistical significance tests cannot be carried out due to 
the lack of biological replicates. 
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Figure 6.13. Analysis of 5-hydroxymethylcytosine DNA immunoprecipitation sequencing data for brown 
adipose tissue and white adipose tissue taken from animals exposed to 30°C or 4°C for 48 hours. 
a) Sliding window analysis of 5-hydroxymethylcytosine DNA immunoprecipitation sequencing data for brown 
adipose tissue (BAT) and white adipose tissue (WAT) taken from animals exposed to 30°C or 4°C for 48 hours. 
Gene length represents every annotated gene in the mouse genome normalised to 100%.  n = 1/group. b) Sliding 
window analysis of 5-hydroxymethylcytosine DNA immunoprecipitation sequencing data for WAT in wildtype 
(WT) and Tet1 knockout (KO) mice (n = 3/group); compared to that of BAT and WAT taken from animals 
exposed to 30°C or 4°C for 48 hours (n = 1/group). c) Statistical enrichment pathway analysis for genes 
decreased in 5hmC (5hmC < 0) at 10% gene length in WAT. d) Mean gene 5hmC levels for thermoneutral 
(30°C) plotted against mean gene 5hmC levels in cold exposure (4°C) in BAT. e) Mean gene 5hmC levels for 
thermoneutral plotted against mean gene 5hmC levels in cold exposure in WAT. R2 = Spearman’s correlation 
coefficient. 
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6.5. Discussion 
6.5.1. Validation of the cold exposure model 
Indirect calorimetry 
To summarise, my in vivo mouse model of cold exposure was validated by the observation of several 
of the effects of cold-induced thermogenesis. Firstly, indirect calorimetry showed a highly significant 
(p = 0.00054) increase in energy expenditure in animals maintained at 4°C for 48 hours with a 
concomitant increase in food intake. Respiratory exchange ratio was significantly decreased in cold 
exposure, indicating that animals are using a greater proportion of lipid for energy metabolism 
compared to carbohydrate, suggesting that they are using their adipose stores. Movement and activity 
levels were significantly decreased, suggesting that animals are preserving energy for heat generation. 
My findings agree with existing literature for the effects of cold exposure. It is well-established that 
fatty acids are a major energy source in activated BAT [460], thus RER would be expected to 
decrease. In male athletes, a seasonal reduction in the RER occurs during acute cold exposure (10°C) 
in winter [461] and a further study demonstrated that some individuals have increased VO2 during a 
24-h period of cold exposure (10°C) in winter [462]. Furthermore, in 17 male subjects, RER was 
significantly lower during both thermoneutral and cold exposures in winter than it was during the 
same periods in summer [463]. In addition, oxygen consumption increases between 2 to 4-fold in 
rodents after both acute and chronic cold exposure (4°C) [464, 465], a finding that supports the 
increased VO2 and increased calorie expenditure observed by indirect calorimetry in my model. 
 
In the first 5 hours of cold exposure, the decrease in RER is much greater. After 5 hours, RER returns 
to near-baseline levels. This indicates a difference in RER between acute and chronic cold exposure. 
Although there are no published data available on RER response in acute vs chronic cold exposure, 
there are known differences in other responses to acute vs chronic cold exposure. Most prominently, 
shivering is responsible for part of the acute response to cold exposure, but with cold adaptation, the 
shivering response goes away [464, 465] and the role of brown adipose tissue becomes more 
important. Therefore, the initial large decrease in RER observed in the first 5 hours of cold exposure 
could be a result of shivering thermogenesis. In addition, it could be the result of animals having to 
use their fat stores. Rodents often increase food intake in response to cold exposure [466, 467]. 
However, in my study, rate of food intake does not seem to increase until around 5 hours. Once food 
intake has increased to account for the extra energy expenditure, animals will be relying less heavily 
on their adipose stores for energy and therefore will use a greater proportion of carbohydrate, 
increasing RER. 
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Transcriptomics 
In addition, RNA-seq data further validates my model of cold exposure. Upregulation of the 
thermogenic gene programme [468], including Ucp1, Ppara, Cebpb, Dio, Elovl3 and Pgc1a, is 
observed. Furthermore, clustering of BAT & WAT RNA-seq samples by Euclidean distance allowed 
clustering into two distinct groups: cold exposure and thermoneutrality. On the other hand, beige 
adipose tissue RNA-seq data did not allow for clustering into their respective groups. This is probably 
due to large amount of transcriptional and metabolic heterogeneity within activated beige adipose 
tissue [469]. 
 
A large number of genes were up- and down-regulated in BAT (2974 up; 3087 down) and WAT 
(1890 up; 1000 down), and a distinctly lower amount of differential gene expression was observed in 
beige adipose tissue (582 up; 80 down). This could be again due to heterogeneity of the tissue and 
variability of gene expression from cell to cell compromising the analysis and the significance of 
RNA-seq results. The heterogeneity of beige adipose tissue is demonstrated in the seminal study by 
Wu et al., which showed that only ~40% of preadipocytes in subcutaneous adipose tissue can 
differentiate into UCP1-expressing beige adipocytes upon stimulation [99]. 
 
One surprising finding was the large number of changes in gene expression that occurred in WAT. 
Pathway analysis revealed that many of these transcriptional changes were related to fatty acid 
oxidation, lipid metabolic processes, catabolic processes and oxidative phosphorylation. It is already 
established that adrenergic stimulation increases catabolic metabolism in both BAT and WAT [470, 
471] and upregulates de novo fatty acid synthesis, which allows cells to meet oxidative demand with 
enhanced synthesis [472-474]. This could account for many of the transcriptional changes observed in 
WAT, and indeed agrees with the results of the pathway analysis. Many of the changes in gene 
expression in WAT agree with previously published data of WAT in cold exposure: for example, 
decreased Trib3 expression (a negative regulator of protein kinase B, which has been associated with 
improved adipose insulin sensitivity), increased Hsd3b7 expression (hydroxy-delta-5-steroid 
dehydrogenase, a gene responsible for steroid biosynthesis) and increased Dio2 (thyroid deiodinase I 
– a gene associated with increased thyroid action on cellular respiration) were all reported as “changes 
of note” in a 2013 study investigating gene expression in WAT in cold exposure [468], and these 
findings were all replicated in my sequencing data (see Figure 6.14). 
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Figure 6.14. mRNA levels of Trib3, Hsd3b7 and Dio2. 
mRNA levels of Trib3, Hsd3b7 and Dio2 in WAT taken from mice maintained at thermoneutrality (30°C) or 
cold exposure (4°C) for 48 hours, determined by RNA-seq. n = 3/group. **q<0.01; ***q<0.001. Significance 
determined using q-value estimation for false discovery rate control. 
 
6.5.2. Novel findings from the cold exposure model 
Analysis of whole tissue steady-state metabolite levels 
Although gene expression of activated BAT is well studied [475, 476], a surprisingly small amount of 
research has been published regarding metabolite levels in adipose tissue under cold exposure. Lu et 
al. examined the acute (up to 6 hours) metabolomic response in BAT and WAT [477] and found that 
lipid metabolism was activated within the first two hours of cold exposure, resulting in an increase in 
many lipid species including diglyceride, monoglyceride and fatty acids. They also reported 
significant changes in metabolites in the glycolysis and pentose-phosphate pathway after 4 hours of 
cold exposure. In particular, glutathione depletion in BAT was observed. With regards to the lipid 
species, I am unable to compare studies as I did not investigate the apolar fraction in my samples. 
However, my findings in the polar fraction reveal that all TCA cycle metabolites are increased in both 
BAT and WAT under cold exposure (with the exception of BAT levels of succinate and α-
ketoglutarate), while Lu et al. did not observe any significant changes in polar metabolites in WAT, 
but nearly all polar metabolites were significantly altered in BAT with cold exposure. Similarly, this 
study reported that glutamate levels were increased in BAT but not WAT [477]. In my study, TCA 
cycle metabolite levels are higher in BAT than WAT, but fold-change increases with cold exposure 
are similar between tissues. This again highlights the difference between the acute response (as 
reported by Lu et al) and the chronic response to cold exposure (as investigated here). 
 
A further study demonstrated that loss of the mechanistic target of the rapamycin complex 1 
(mTORC1) affected glucose, lipid, and oxidative metabolism in the BAT of mice following chronic 
cold exposure (2 weeks) [478]. More recently, Hiroshima et al. [479] reported lower levels of 
glycolysis and gluconeogenesis intermediates in the BAT of rats exposed to 4°C for 48 hours 
compared to the group maintained at 22°C. In agreement with my data, they also reported higher 
levels of the TCA cycle metabolites. The decrease of glycolysis and gluconeogenesis intermediates 
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reported by Hiroshima et al. is contradictory to my study given that glycolysis-related genes were 
found to be overrepresented in the list of upregulated genes in WAT in cold exposure, but not BAT, 
and not enriched at all in the list of downregulated genes (in either tissue). Of the metabolites detected 
in my study, glycolysis and gluconeogenesis intermediates would include glycerol-3-phosphate (3-
PG) and pyruvate. 3-PG is an intermediate in pyruvate generation. Hiroshima et al. reported a large 
decrease in 3-PG in BAT in cold exposure, but no change in pyruvate levels. On the other hand, I 
observed no changes in 3-PG or pyruvate in either BAT or WAT (see Figure 6.15). Therefore, despite 
the upregulation of glycolysis/gluconeogenesis intermediates reported in both studies, my data fail to 
support these findings. One difference between studies that could account for contradictory findings is 
that in my study thermoneutrality was used as a temperature control (30ᵒC) whereas in the study 
mentioned above, room temperature (22ᵒC) is used. However, these studies do support my findings of 
increased levels of TCA cycle metabolites in BAT. 
 
Meanwhile, Nagao et al. [480] published a study investigating the metabolomic profile of obese 
adipose tissue and reported an increase in glutamate levels in obesity, accompanied by an decrease in 
transcription of the predominant glutamate transporter in adipose tissue, GLAST (Glutamate 
Aspartate Transporter) suggesting that downregulation of GLAST occurred in response to a negative 
feedback loop initiated by build-up of intracellular glutamate. By mining RNA-seq data from this 
study, I was able to show a similar decrease in GLAST expression in both BAT and WAT in cold 
exposure, as displayed in Figure 6.16. This suggests that GLAST could be responsible for the increase 
in intracellular glutamate levels in cold exposure, and that a similar negative feedback mechanism 
occurs in cold exposure as does in obesity. 
 
 
Figure 6.15. Relative levels of glycolysis/gluconeogenesis intermediates. 
Relative levels of glycolysis/gluconeogenesis intermediates in brown adipose tissue (BAT) and white adipose 
tissue (WAT) from mice maintained at thermoneutrality (30ᵒC) or cold exposure (4ᵒC) for 48 hours. 3-PG = 
glycerol-3-phosphate. n = 5/group. 
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Figure 6.16. mRNA levels of the Glutamate-Aspartate Transporter, determined by RNA-seq. 
mRNA levels of the Glutamate-Aspartate Transporter (GLAST), the predominantly expressed glutamate 
transporter in adipose tissue, under thermoneutrality (30°C) and cold exposure (4°C) in brown adipose tissue 
(BAT) and white adipose tissue (WAT). n = 3/group. **q<0.01; ***q<0.001. Significance determined using q-
value estimation for false discovery rate control. 
 
The increase in TCA cycle metabolites observed in my study could indicate increased flux rate of the 
TCA cycle. Alternatively, it could indicate decreased metabolite clearance. Unfortunately these data 
represent static mass spectrometry measurements and give little indication as to metabolite flux, so we 
can only speculate as to the cause of metabolite increase. A more informative method to use would be 
to use carbon-labelling methods, which would allow analysis of carbon cycling and from which we 
would be able to draw conclusions about metabolite flux. Furthermore, as whole tissue was used 
rather than isolated cells, there is no way of telling whether the increase in metabolites is intracellular 
or extracellular. 
 
However, a potential approach to overcome this limitation is to estimate metabolic flux ratios (the 
relative contributions of each reaction feeding into a specific metabolite pool), as reviewed in [481]. 
Here I have analysed NADH-forming reactions (see Figure 6.5), given that these ratios can be used as 
substitutes for NAD+:NADH ratios, indicating the levels of oxidation or reduction. As the ratio of 
substrate:product is linked to the oxidation or reduction of NAD+/NADH, then a change in one 
suggests that there is a change in the other. For example, the conversion of α-ketoglutarate to 
succinate also reduces the reduction of NAD+ to NADH in a 1:1 ratio, i.e. for every mole of succinate 
produced, one mole of NADH is also formed. 
 
However, in substrate:product ratios (e.g. α-KG:succinate), an increased ratio would suggest that the 
build-up of the substrate is not being matched by the degradation of the product, or that degradation of 
the product is more rapid that the production of the substrate. Given that the reaction also reduces 
NAD+ to NADH, an increase in the ratio could suggest that less NAD+ is being reduced – but could 
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also mean that the rate stays the same, and the product is being removed more rapidly. Changes in the 
NAD+:NADH ratio in the mitochondria could indicate an alteration in respiration. 
 
Of the three reaction ratios representing NAD+:NADH, (citrate:α-KG; malate:citrate; α-
KG:succinate), the results are contradictory. Two of the reaction ratios (malate:citrate in BAT; and α-
KG:succinate in WAT) indicate an increased product:substrate ratio in cold exposure, suggesting a 
greater rate of product generation or decreased product clearance. This would also indicate greater 
levels of NAD+ reduction, suggesting that there is an increase in respiration. However, citrate:α-
ketoglutarate is significantly decreased in WAT in cold exposure, suggesting lower levels of NAD+ 
reduction and decreased respiration rate. In addition, malate:citrate in WAT, α-KG:succinate in BAT, 
and citrate:α-KG in BAT all have unchanged ratios under cold exposure, indicating no change in 
NAD+ reduction and no change in rate of respiration. While these ratios can sometimes be helpful to 
analyse, in this case the amount of conflicting evidence makes it difficult to draw any conclusions. 
 
I also analysed the ratio of (α-KG:succinate + fumarate) given that α-KG is a cofactor for TET 
enzymes and succinate and fumarate can inhibit TETs, so looking at this ratio can give an indication 
of TET inhibition or activation. There was no significant change in either BAT or WAT, although a p 
value of 0.07 in WAT suggests that the increase in (α-KG:succinate + fumarate) ratio may be trending 
towards significance and may just be underpowered. However, an increase in (α-KG:succinate + 
fumarate) ratio is inconsistent with the decrease in TET activity observed in WAT (discussed further 
in section 6.5.3). 
 
Furthermore, analysing the serine:glycine ratio may be insightful, as this reaction produces one-
carbon units for biosynthesis and methylation reactions [482, 483]. One-carbon metabolism integrates 
carbon units from amino acids (serine and glycine), and generates diverse outputs, such as the 
maintenance of redox status, the biosynthesis of lipids, nucleotides and proteins, and the substrates for 
methylation reactions, particularly those mediated by SAM (S-adenosyl methionine). The epigenetic 
reactions mediated by SAM involve the transfer of methyl groups onto the arginine and lysine 
residues of proteins, DNA histones, RNA and intermediary metabolites [484]. Therefore, one-carbon 
metabolism is thought to be tightly linked to histone methylation [485, 486]. The serine:glycine ratio 
is unchanged in WAT in cold exposure but increased in BAT. This suggests that BAT activation may 
increase the production of one-carbon units, which may have an impact on histone methylation. This 
provides justification to investigate the histone status of key genes in BAT in cold exposure. 
 
Furthermore, analysis was carried out on mass spectrometry data of amino acid levels. Different 
amino acids can feed into the TCA cycle by acting as precursor molecules to TCA cycle metabolites. 
For example, aspartate, which feeds into oxaloacetate; and glutamate, which feeds into α-
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ketoglutarate, follows similar patterns to the constitutive TCA cycle metabolites (increased at 4°C 
compared to 30°C; and increased in BAT compared to WAT). This suggests that these feeder amino 
acids are indeed involved with forming the relevant constitutive TCA cycle metabolites. On the other 
hand, asparagine, which also feeds into oxaloacetate, does not follow this same pattern, suggesting 
that aspartate is more closely involved with oxaloacetate formation compared to asparagine in this 
system. 
 
Pathway analysis combining RNA-seq data of mRNA levels and mass spectrometry data of 
metabolite levels can provide a bigger overall picture as to what is changing in the TCA cycle. In 
BAT, there is upregulation of the expression of the majority of measured enzymes and metabolites, 
but a reduction is observed in the metabolite glycine and the enzyme pyruvate carboxylase, possibly 
suggesting lower rates of glycolysis in cold exposure in BAT, contrary to the published literature 
[477, 479]. On the other hand, pyruvate is unchanged. The combined pathway analysis also shows 
downregulation of the 2-oxoglutarate dehydrogenase (also known as α-ketoglutarate dehydrogenase), 
the enzyme that converts α-ketoglutarate to succinyl co-A. This could be an effect of the increased 
levels of α-ketoglutarate in cold exposure, such that 2-oxoglutarate dehydrogenase expression is 
decreased in order to limit the conversion of α-ketoglutarate to downstream succinate, thus acting to 
control the rate of reaction. 
 
However, combined pathway analysis in WAT suggests that there is a greater upregulation of TCA 
cycle enzymes and metabolites in WAT compared to BAT, with a greater number of enzymes and 
metabolites upregulated. This TCA cycle upregulation could be occurring in WAT in order to fuel 
lipolysis. It is well-established that WAT contributes to BAT thermogenesis by mobilising energy 
stores in the form of lipolysis [460]. Indeed, this is the basis of many of the significantly upregulated 
gene pathways in WAT (e.g. β-oxidation, lipid metabolic processes – see Figure 6.8c). The reaction 
for one cycle of β-oxidation (fatty acid hydrolysis) is as follows: 
 
Cn-acyl CoA + FAD + NAD+ + H2O + CoA    → Cn-2-acyl CoA + FADH2 + NADH + H+ + acetyl CoA ; 
 
where n = number of carbons in the acyl CoA chain. The substrates to this reaction are not generated 
from the TCA cycle, but rather the product (acetyl CoA) feeds into the TCA cycle. Therefore there is 
no obvious reason why upregulation of the TCA cycle enzymes and metabolites, or increased rate of 
TCA cycle flux, would be required from WAT under cold exposure. Indeed, increased levels of TCA 
cycle metabolites could be the result of either increased metabolite production or decreased metabolite 
clearance. In either case it is likely that these increases are the result of increased TCA cycle flux, 
although we cannot categorically conclude that using steady-state GCMS. 
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Glucose uptake studies have reported that 48 hours cold exposure increases glucose utilisation 4- to 
20-fold in WAT, as well as 8-fold in the heart and 2- to 5-fold in skeletal muscle (compared to 110-
fold in BAT) [487], suggesting increased rate of respiration in all these tissues. However, insulin 
responsiveness increased during cold acclimation in WAT, but decreased in BAT [487]. Another 
difference between BAT and WAT in cold exposure was that this increase in insulin responsiveness 
persisted in WAT after return to the warm for 18 hours, but in BAT, heart and skeletal muscle, 
glucose uptake returned to normal levels. This suggests that cold exposure produces more permanent 
alterations in glucose metabolism in WAT compared to the other tissues. 
 
Clearly some of the functions of WAT in cold exposure are not fully understood, and further research 
is required in this area to determine the cause of/requirement for the increased glucose uptake, 
upregulation of TCA cycle enzymes and metabolites in WAT in cold exposure. 
 
6.5.3. The effects of cold exposure on epigenetic factors 
Tet1 mRNA levels were reduced in WAT and Tet2 mRNA levels were reduced in BAT. Furthermore, 
cold exposure significantly decreased overall TET activity in WAT but not BAT. This is perhaps 
unexpected given the near-significant finding of increased ratio of α-ketoglutarate:(succinate + 
fumarate) in cold exposure in WAT. This increase was not significant but a p value of 0.07 suggests 
that the experiment may simply have been underpowered. Indeed, power calculations suggest that a 
sample size of 10 per group would be required to give sufficient statistical power (0.8). An increased 
ratio of α-ketoglutarate:(succinate + fumarate) would indicate that there is a greater proportion of TET 
substrates as compared to TET inhibitory factors, which could theoretically be associated with an 
increase in TET activity, but this is not observed. 
 
Decreased TET activity may be associated with an increase in 5mC and a decrease in 5hmC levels 
due to decreased demethylase activity upon 5hmC modifications. Indeed, Tet1 KO embryonic stem 
cells (ESCs) have decreased global 5hmC by around 35% [326]. However, this is not reflected in 
5mC or 5hmC levels as determined by ultra-performance liquid chromatography, as there is no 
change in the levels of either modification resulting from cold exposure. 
 
hMeDIP-seq analysis provided interesting findings regarding the pattern of 5hmC in adipose tissue. In 
contrast to previously analysed hMeDIP-seq data from WAT (see Chapter 3), 5hmC in BAT across all 
genes (with normalised gene length) generally appears to trough at around 10% gene length, with 
another smaller trough at around 70% gene length. This was shown in BAT 30ᵒC and 4ᵒC and WAT 
at 4ᵒC; but in WAT at 30ᵒC, the 5hmC profile more closely resembles the 5hmC profile previously 
demonstrated in WAT (see section 3.4.5 and Figure 6.13b). Therefore, the epigenetic signature of 
BAT differs from WAT at this locus, suggesting that BAT has a unique 5hmC profile compared to 
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that of WAT. This alternative 5hmC profile may be involved in activation of the thermogenic gene 
programme, although further investigation is required into this hypothesis. 
 
In addition, cold exposure induces large changes in WAT 5hmC at this locus that closely resemble the 
5hmC signature of BAT. This finding suggests that changes in 5hmC at this locus occur in WAT as a 
result of cold exposure, and these changes may be involved with some of the transcriptional or even 
metabolomic changes that occur in WAT under cold exposure. However, this study only demonstrates 
an association between cold exposure and changes in 5hmC, and a tentative one at that given that the 
number of biological replicates is only one per group. Further study is required to determine whether 
these changes in 5hmC in WAT in cold exposure are causative of changes in gene expression. 
 
The 5hmC profile in both BAT and WAT contrasts with the 5hmC profile published in other tissues 
including mouse liver [308, 488, 489], mouse brain [488], human chondrocytes [490], mouse 
embryonic fibroblasts [491], human embryonic stem cells [492], and human colon mucosa [493], 
which exhibit a large trough in 5hmC at the transcriptional start site (0% gene length) with fluctuating 
5hmC levels intragenically; a pattern that is altered in various states including liver cancer [308] and 
states of active transcription [309]. Given that the pattern of 5hmC in WAT at room temperature and 
at thermoneutrality was the same in two separate experiments (the Tet1 KO study and the cold 
exposure study, with a total n of 10), I propose that WAT and BAT have a distinct epigenetic 
signature with regards to 5hmC. The reason for this is unknown: perhaps it is the result of using whole 
tissue rather than a single isolated cell type. Whole adipose tissue is composed of many different cell 
types, including adipocytes, preadipocytes, stem cells, macrophages, neutrophils, lymphocytes, and 
endothelial cells [494]. With this mix of cells, many genes will be transcriptionally heterogeneous, 
and this could cause “noise” in the 5hmC signal at the transcriptional start site. The reason for the 
peak in 5hmC at 10% gene length in WAT (or trough in BAT) is unknown, and no published 
information is available on the typical hydroxymethyl state or its function this gene locus. Further 
work is required to determine the reasons for the unique 5hmC profile of adipose tissue. 
 
The relevance of the subset of genes that have decreased levels of 5hmC specifically at 10% gene 
length is debatable. Statistical overrepresentation pathway analysis suggests that this subset of genes 
(5hmC > 0 at 10% gene length) are involved predominantly in synaptic transmission, sensory 
perception of smell and perception of chemical stimuli.  However, many genes within the pathways 
“sensory perception of smell” and “perception of chemical stimuli” are notably small in gene length. 
For example the Olfactory Receptor (Olfr) genes, of which there are 800 in humans and 1400 in mice 
[495], make up a large part of these two gene pathways. Olfr genes are often only 2-5 Kb in length. 
This leaves them highly susceptible to analytical bias, given that a change in the 5hmC of these genes 
will weigh more heavily on the overall total gene (e.g. 200bp window of a 2 Kb gene = 10%; 200bp 
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window of a 15 Kb gene = 1.3%). Furthermore, the high number of these genes within the genome 
also predisposes the pathway “sensory perception of smell” to bias. 
 
In addition, the relevance of the upregulated pathway “synaptic transmission” is also debatable. This 
pathway mainly includes synaptic neurotransmitter receptors such as gamma-aminobutyric acid 
receptor subunit gamma-2 (Gabrg2), acetylcholine receptor subunit beta (Chrnb1), neuronal 
acetylcholine receptor subunit beta-3 (Chrnb3), 5-hydroxytryptamine receptor 3B (Htr3b) and glycine 
receptor subunit alpha-4 (Glra4). It seems unlikely that the differential 5hmC profile of these genes in 
WAT would have any functional significance, given that these genes are largely expressed in 
neurones of the brain. Therefore, it is possible that the decrease in 5hmC at 10% gene length in WAT 
genes is not functionally relevant. 
 
Comparison of methods: UPLC vs hMeDIP-seq 
UPLC suggested that, while there was no difference in 5mC or 5hmC in WAT or BAT taken from 
mice at 30°C or 4°C, global 5mC levels – but not 5hmC levels – were significantly higher in BAT 
compared to WAT. While this cannot be compared with the hMeDIP-seq data as a 5mC assay was not 
carried out by this method, we can compare 5hmC data between methods. Indeed, DIP data supports 
the UPLC findings that there is little difference in 5hmC between tissues and between temperatures. 
DIP also provides further information as 5hmC levels can be compared at different regions within the 
gene, for example, allowing us to investigate 5hmC levels in promoter or intragenic regions. 
 
6.5.4. Benefits and drawbacks of the mouse model of cold exposure 
There is some debate surrounding the scope for the use of mice as a model for cold-induced 
thermogenesis. Although BAT has been identified to be functional in human adults [49, 50] with a 
high glucose demand that increases in response to cold exposure [51], species-specific differences 
have recently been identified in UCP-1 regulation [496]. Ramage et al. demonstrated that 
glucocorticoid treatment has opposing actions in BAT in humans and mice [496]: in vitro in human 
primary brown adipocytes, glucocorticoid treatment increased isoprenaline-stimulated respiration and 
UCP-1 expression. Similarly, in vivo in healthy male subjects exposed to the cold, glucocorticoid 
treatment increased BAT glucose uptake, increased supraclavicular skin temperature, and increased 
energy expenditure. However, in mouse primary brown adipocytes, glucocorticoid treatment 
displayed the opposite effect, decreasing isoprenaline-stimulated respiration and UCP-1 expression. 
 
In addition to this, other differences exist between rodent and humans regarding BAT function. For 
example, cold exposure increases food intake in animal species including mice (as observed in this 
study), piglets [497], rats and birds [498], but not in humans [499]. Furthermore, it has been suggested 
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recently that human BAT may be more closely related to rodent beige adipose, rather than the 
classical rodent BAT [48, 500, 501]. This is important to bear in mind when considering the 
translatability of research in rodent models of cold-induced thermogenesis. 
 
6.5.5. Conclusions 
In summary, I have validated my mouse model of cold-induced thermogenesis with indirect 
calorimetry and transcriptomic data, although the differences between rodent and human BAT must 
be acknowledged. I have observed increases in all TCA cycle metabolites in cold exposure in both 
BAT and WAT (with the exception of succinate and α-ketoglutarate in BAT). The increase of these 
metabolites in BAT is supported by two independent studies, but these increases in WAT have not 
been previously reported and the reason behind the need for their upregulation requires further 
research. In the absence of any significant changes in the ratio of α-KG:succinate+fumarate, 
decreased TET activity was observed in WAT, but not BAT or beige adipose tissue. However, no 
changes were observed in the 5hmC levels globally (UPLC) or across genes (hMeDIP-seq). 
Interestingly, a large trough in 5hmC was observed at 10% gene length in BAT at 30°C and 4°C and 
WAT at 4°C, whereas in other WAT samples, a peak in 5hmC levels usually occurs at 10% gene 
length. The subset of genes with large decreases in 5hmC at this particular locus BAT at 30°C and 
4°C and WAT at 4°C include genes involved with sensory perception of smell. The relevance of this 
in BAT and WAT is debatable. In conclusion, TET enzymes and 5hmC do not appear to be solely 
responsible for driving changes in gene expression on cold exposure, although they may act alongside 
other mechanisms to alter gene expression. 
  
  The role of TET1 in adipose tissue 
Chapter 7. Discussion  148 
7. Discussion 
7.1. Summary 
In this thesis I have investigated the role of TET1 in adipose tissue in both diet-induced obesity and in 
cold exposure. The current extent of the obesity crisis highlights the need for a better understanding of 
adipose tissue biology and an option of pharmacological interventions. I have demonstrated that a lack 
of the Tet1 gene causes decreased susceptibility to diet-induced obesity by reducing food intake, and 
that this may be linked to a reduction in Lep transcription. I have also demonstrated that TET activity 
is significantly decreased in white adipose tissue in cold exposure, but not in brown adipose tissue, 
although this is not associated with any significant changes in the ratio of TET “activating” to 
“inhibitory” metabolites, or with any global changes in 5hmC. 
 
7.2. Novel findings of this thesis 
7.2.1. The role of TET1 in obesity 
A role for the TET enzymes in adipose tissue was first discussed in 2012 in a publication by Fujiki et 
al., which demonstrated that PPARγ recruits TET enzymes and directs local demethylation around 
PPREs resulting in the transcription of adipocyte-specific genes [383]. Further work demonstrates that 
this recruitment of the TET enzymes occurs in a process facilitated by the CCCTC-binding factor 
(CTCF) [382]. Enrichment of 5hmC has been identified at over 20% of PPARγ binding sites, 
suggesting this modification is functionally important in gene regulation at these sites [384]. Further, 
double knockout (DKO) of Tet1 and Tet2 inhibited the adipogenic differentiation of mouse embryonic 
fibroblasts (MEFs) in vitro, associated with pronounced hypermethylation of promoter regions of 
genes involved in adipogenesis and adipocyte function [385]. However, the work covered in this 
thesis explores for the first time the effects of Tet1 deletion in adipose tissue in vivo. A schematic 
representing a summary of these findings is displayed in Figure 7.1. 
 
 
Figure 7.1. A summary of the effects of Tet1 knockout (KO) on the metabolic phenotype of mice exposed to 
high fat diet (HFD), as compared to wildtype (WT) littermates. 
Firstly, these data support the hypothesis that Tet1 deletion reduces fat accumulation in diet-induced 
obesity. However, after analysis of indirect calorimetry, in vitro adipocyte lipid accumulation and 
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transcriptomics, it can be concluded that this reduction in fat mass is not a primary result of Tet1 
deletion in adipose tissue. Analysis of food intake and paired feeding revealed that Tet1 deletion is 
associated with decreased food intake. I proposed that decreased leptin transcription, decreased serum 
leptin and increased leptin sensitivity in the Tet1 KO mouse is the mechanism or a contributing 
mechanism behind this decreased food intake. While leptin transcription and serum leptin were indeed 
decreased resulting in increased leptin sensitivity in the Tet1 KO mouse, evidence from global 
hMeDIP-seq and bisulfite pyrosequencing of the leptin promoter suggested that the decrease in Lep 
transcription is not the result of TET1-mediated changes in 5hmC or 5mC in adipose tissue. This is in 
contrast to a number of studies demonstrating the close association between the methylation status of 
the Lep promoter and Lep transcriptional status [343, 427-433]. Thus, while this study adds novel 
findings to the field of obesity regarding TET1 in the central control of obesity, its contribution to the 
field of Lep epigenetics is inconsistent with much of the current literature. 
 
While Tet1 KO mice were found to have lower levels of most adipose tissue depots, the bone marrow 
adipose levels were unaltered in KO mice. This is unusual, given the fact that obesity is associated 
with increased MAT in both humans [158, 159] and rodents [160, 162], so even if TET1 does not 
directly affect MAT development or deposition, decreased levels of MAT would be expected in the 
Tet1 KO mouse as a secondary result of decreased overall adiposity. A possible explanation for this 
lack of change is that, while KO mice were ‘lean’ relative to their WT littermates, they still gained 
some fat mass on HFD and therefore displayed increased adipose tissue levels compared to non-high 
fat-fed mice. Thus, it is possible that both WT and KO levels of MAT increased to similar extents. To 
confirm this hypothesis, a control diet study investigating MAT in WT and KO mice should be carried 
out. 
 
7.2.2. The role of TET1 in cold exposure 
While various histone modifiers have recently been reported to have influence over transcriptional 
activation of the thermogenic gene programme [399-405], this study is the first to my knowledge to 
investigate the role of CpG modifications in cold-induced thermogenesis. I found that, while global 
levels of 5hmC and 5mC are unchanged in whole brown and white adipose tissue in cold exposure, 
there is a key difference in BAT and WAT 5hmC profiles at 10% gene length (further discussed in 
Section 6.5.3). In addition, although a handful of publications have reported changes in metabolite 
levels in cold-exposed adipose tissue [477-479], this thesis demonstrates for the first time large 
changes in metabolite levels in whole WAT under cold exposure, contrary to the study by Lu et al. 
[477], which reported a lack of significant changes in the metabolite response to cold exposure in 
WAT. The increase in TCA cycle metabolites could indicate increased flux rate of the TCA cycle or 
decreased metabolite clearance. Further work is required to determine the cause of increased 
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metabolite levels in cold exposure. In summary, this thesis makes novel contributions to both fields of 
epigenetics in cold exposure, and metabolomics in cold exposure. 
 
7.2.3. The role of TET1 in adipose tissue 
Tet1 expression in primary adipocytes 
For the first time to my knowledge, this thesis examines the expression of Tet1 in preadipocytes 
throughout early differentiation, and finds that Tet1 expression decreases throughout differentiation 
This is logical, given that TET1 has previously been reported to be associated with the pluripotent 
state [325, 326, 502]. Therefore, as preadipocytes differentiate away from the pluripotent state, Tet1 
expression decreases. Furthermore, Tet2 and Tet3 expression seem to increase with differentiation. 
This would perhaps be predicted for Tet2, which is more highly expressed in somatic cells [503], but 
not for Tet3, which is most highly expressed at the oocyte to zygote stage of development [504]. 
However, with n = 1, this study needs repeating if we are to draw any valid conclusions. 
 
Abnormal 5hmC patterns in adipose tissue 
This thesis has also revealed that 5hmC patterns in WAT and BAT differ from those published in 
mouse liver [308, 488, 489], mouse brain [488], human chondrocytes [490], mouse embryonic 
fibroblasts [491], human embryonic stem cells [492], and human colon mucosa [493], which exhibit a 
large trough in 5hmC at the transcriptional start site (TSS) with fluctuating 5hmC levels 
intragenically. Here, no trough was observed at the TSS in WAT, but a relative 5hmC peak was 
observed at ~10% gene length. While WAT displays a peak in 5hmC at 10% gene length, BAT 
displays a relative trough at this locus, suggesting that BAT has a unique 5hmC profile compared to 
that of WAT. This alternative 5hmC profile may be involved in activation of the thermogenic gene 
programme, although further investigation is required into this hypothesis. Furthermore, cold 
exposure induces large changes in WAT 5hmC at this locus that closely resemble the 5hmC signature 
of BAT, suggesting that changes in 5hmC occur at this locus in WAT as a result of cold exposure, and 




7.3.1. Limitations of the Tet1 knockout model 
The Tet1 KO mouse model used in this study is a global knockout. This has two main limitations: 
firstly, any effects observed in this model may be the result of Tet1 deletion in other tissues. For 
example, the reduction in food intake observed in the Tet1 KO mouse could be caused by 5hmC and 
associated gene expression changes in the brain. Secondly, the global Tet1 KO mouse lacks Tet1 
throughout embryonic and postnatal development. Therefore, any changes observed in the KO mouse 
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may not be the direct result of Tet1 deletion in adulthood, but rather secondary changes that occurred 
due to the lack of Tet1 in development. This is particularly relevant given that Tet1 is expressed more 
highly throughout development than in adulthood. To overcome these limitations, the development of 
an inducible Adipoq-Cre Tet1 KO mouse would be beneficial. This would allow the deletion of Tet1 
specifically in WAT and BAT (adiponectin-expressing cells) at the desired stage of development. 
 
A further limitation of this model is that the effects of Tet1 deletion are difficult to discern from the 
effects of the altered HFD response of the KO mice. Although a control diet study was carried out to 
validate any findings of interest, the sequencing studies were not carried out control diet-fed animals 
due to constraints on number of animals and financial considerations. Therefore, the analysis of the 
sequencing studies is limited by this. 
 
7.3.2. TET1 as a pharmacological target 
In any study proposing to investigate the science of human disease, the clinical relevance should be 
assessed. TET1 may not be an appropriate pharmacological target in the treatment of obesity because 
of the ubiquitous nature of its expression and activity. Interfering with the expression or activity of 
TET1 in vivo is likely to have unknown off-target effects which could negatively impact on human 
health. Although there are a range of epigenetic therapies currently in clinical use and/or clinical 
trials, including DNA methylation inhibitors [505], bromodomain inhibitors [506], HAT inhibitors 
[507], histone methylation inhibitors [508], and HDAC inhibitors [509], these are generally approved 
for the use of cancers in which known epigenetic modulation occurs. Meanwhile, more work is 
required to investigate the epigenetic changes which underlie obesity. In addition, while rapid and 
often aggressive drug therapy is often required for the treatment of cancers, the off-target effects such 
as diarrhoea, fatigue, nausea, and anorexia [510] are tolerated. However, for obesity, in which 
treatment is less time-pressing, these side effects would be avoided. 
 
Furthermore, the work in this thesis assumes that the role of TET1 in mouse adipose tissue is 
homologous to that of human adipose tissue. However, this may not be the case. As a pilot study in 
humans, it would be beneficial to examine the expression of TET1 and the abundance of 5mC/5hmC 
in different adipose tissue depots and compare it to measures such as body mass index, hip-to-waist 
ratio and daily calorie intake. Furthermore, the role of adipose tissue may differ between mice and 
humans, particularly that of BAT. Although BAT has been identified to be functional in human adults 
[49, 50] with a high glucose demand that increases in response to cold exposure [51], species-specific 
differences have recently been identified in UCP-1 regulation [496]. Therefore, this work should be 
pursued in human cells or in human in vivo studies. 
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Finally, in this thesis, I demonstrate associations between 5hmC and gene expression but not 
causation. Epigenetics research often demonstrates associations between epigenetic changes and gene 
expression, or epigenetic changes and disease state, but determining functional changes is more 
challenging. However, while further work is required to assess the potential of TET1 as a 
pharmacological target, this thesis has begun to shed light on the role of TET1-mediated epigenetic 
changes in adipose tissue, a research field that was relatively unpursued. 
 
7.4. Future directions 
A number of future directions could be pursued following the findings of this thesis. Firstly, given the 
food intake and leptin expression phenotype of the Tet1 KO mouse model, the role of TET1 in central 
control of food intake should be investigated further. I hypothesise that understanding the mechanism 
behind the reduced food intake of the KO mice could yield further avenues for therapeutic 
intervention, since the majority of approved pharmaceutical interventions for the treatment of obesity 
target pathways within the central nervous system, one of which is even an epigenetic modifier 
(topiramate). To investigate this, a neurone-specific Tet1 knockout should be generated, for example 
using the mouse neurofilament-H (mNF-H)-cre transgenic mouse line, which specifically targets 
neurones in the cortex and hippocampus. This is particularly relevant given the importance of the 
hippocampus in control of food intake. Following the generation of neuronal Tet1 KO mice, 
phenotypic screening should be carried out to determine food intake and indirect calorimetric 
response. In addition, gene expression and 5hmC/5mC profiling may reveal specific gene sets in 
which TET1 is likely to cause its effect. 
 
The abnormal 5hmC profile of adipose tissue should be further investigated, with emphasis on 
determining any functional significance of the 10% gene length locus, despite the fact that pathway 
analysis of genes with altered 5hmC with cold exposure in WAT at this locus did not reveal highly 
enriched pathways of particular significance. I suggest that analysing the adipose tissue phenotype in 
Adipoq-Cre Tet1 knockout mice would give insight into this. For example, it could be possible that 
TET1 does not play a large role in the regulation of adipose tissue gene expression, in which case, no 
changes would be observed in the Adipoq-Cre Tet1 knockout. 
 
An interesting avenue for further investigation would be to determine the cause of metabolite changes 
in cold exposure. For this, carbon labelling studies would be insightful, to determine the carbon flow 
within the TCA cycle and associated metabolites. This would demonstrate whether increased levels of 
TCA cycle metabolites in BAT and WAT in cold exposure are caused by increased metabolite 
production or decreased metabolite clearance. This knowledge would allow us to further understand 
metabolomic changes in cold exposure. Furthermore, novel findings could be generated from the 
  The role of TET1 in adipose tissue 
Chapter 7. Discussion  153 
investigation of these changes in WAT, which have not been previously reported. Understanding the 
reason for increased TCA cycle metabolite levels in WAT would be very interesting and may reveal a 
novel role for WAT in cold exposure. To further investigate this, carbon labelling may again be 
insightful to observe the carbon flow within the TCA cycle. Following this, in vitro manipulation of 
the TCA cycle in adipocytes (e.g. by inhibiting various enzymes within the cycle) may reveal 
important roles for WAT in cold exposure. 
 
I further propose that studies should be carried out in human adipose tissue to investigate expression 
levels of the TET enzymes in association with various metabolic parameters such as body mass index, 
hip-to-waist ratio and daily calorie intake. This will help determine the translatability of these studies. 
 
7.5. Conclusions 
In conclusion, this thesis begins to shed light on the roles of TET1 in adipose tissue. I have confirmed 
that Tet1 gene deletion results in a level of protection against obesity, which is associated with 
decreased food intake and increased leptin sensitivity, but the mechanism for this appears not to be a 
primary effect of Tet1 deletion in adipose tissue. Further work should investigate the role of TET1 in 
central control of food intake. I also report an unusual 5hmC profile in adipose tissue, which appears 
to differ in BAT and changes in WAT in response to cold exposure. This should be confirmed in 
studies with a higher number of replicates. Although TET1 is an unlikely therapeutic target, 
identification of TET1-mediated changes in obesity could reveal downstream molecules or pathways 
that offer potential therapeutic intervention. 
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